Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.78905465831837,-2.0212265459201797,0.0,0.01619357551033119,0.013,13/19,13.39%,GRM7;GRIA2;GRM5;GRIA1;GRM1;GRM3;GRIK4;GRIA4;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.7455070127303626,-1.8428824520779115,0.0023923444976076554,0.15029662270526137,0.226,6/15,8.84%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH2;ALDH7A1;ALDH1L1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.7652491631100952,-1.8354399462000854,0.002403846153846154,0.10998136700766599,0.247,6/13,8.84%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH2;ALDH7A1;ALDH1L1
prerank,retinoid binding (GO:0005501),-0.6827813499253104,-1.8295635870981732,0.0,0.09108886224561293,0.268,7/22,8.11%,ALDH1A2;PTGDS;RBP1;ABCA4;RBP4;CYP26B1;CRABP2
prerank,metalloendopeptidase activity (GO:0004222),-0.5229020853694527,-1.8256577035992632,0.0,0.07631222459243572,0.278,18/76,7.91%,TRABD2B;ADAMTS12;THSD4;ADAMTS2;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS10;ADAMTS5;ADAMTSL1;ADAMTS17;ADAMTSL4;MMP14;MMP16;ADAMTS15;ADAM19;ADAMTS1;ADAM33
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7734929199638577,-1.8199276546307728,0.0,0.06949742823183802,0.304,7/14,15.75%,SLC7A11;SLC1A3;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,adenylate cyclase binding (GO:0008179),-0.8267744052714355,-1.7941324476013087,0.0020876826722338203,0.08414875845547101,0.402,5/10,5.90%,ADCY5;ADCY2;AKAP12;AKAP6;CAP2
prerank,platelet-derived growth factor binding (GO:0048407),-0.8098651932446401,-1.787802036545391,0.0,0.0808413652429815,0.43,7/11,2.26%,COL1A2;COL3A1;COL1A1;PDGFRB;PDGFRA;COL5A1;COL6A1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.7295147460911474,-1.7852179971692343,0.0,0.07410809903686287,0.44,7/15,15.75%,SLC1A3;SLC1A5;SLC1A2;SLC25A12;SLC25A13;SLC1A1;SLC25A18
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7616151332607947,-1.7841204823130996,0.0022371364653243847,0.06750696790869314,0.445,4/13,2.91%,BMP6;BMP5;BMP7;BMP4
prerank,BMP receptor binding (GO:0070700),-0.7616169421351324,-1.7631528655564157,0.008658008658008658,0.08336011029750032,0.559,4/12,2.91%,BMP6;BMP5;BMP7;BMP4
prerank,pre-mRNA binding (GO:0036002),-0.618314173937845,-1.739597696775848,0.002631578947368421,0.10264365310454718,0.652,9/28,15.84%,CELF2;DDX5;CELF4;U2AF2;RBM4;CELF1;HNRNPU;HNRNPA1;RNPC3
prerank,sialyltransferase activity (GO:0008373),0.7396433809137299,1.7385705378090348,0.014285714285714285,1.0,0.788,6/20,7.41%,ST3GAL6;ST6GALNAC3;ST6GAL1;ST3GAL1;ST8SIA4;ST6GALNAC2
prerank,leak channel activity (GO:0022840),-0.6648966203248295,-1.7271973998551369,0.002531645569620253,0.11039658689254628,0.697,3/18,2.70%,KCNK2;NALCN;KCNK5
prerank,death receptor activity (GO:0005035),0.84280289472346,1.7033147367000814,0.007194244604316547,1.0,0.927,6/11,7.15%,TNFRSF19;FAS;TNFRSF11A;TNFRSF1B;TNFRSF25;TNFRSF1A
prerank,pyridoxal phosphate binding (GO:0030170),-0.6395196516130642,-1.688101652095214,0.007125890736342043,0.15976697266889253,0.839,9/20,22.63%,PYGB;ABAT;PYGM;ACCS;OAT;CBS;PDXK;CTH;PNPO
prerank,phospholipid transfer activity (GO:0120014),0.7352035746849775,1.6851230730040414,0.015358361774744027,1.0,0.96,10/21,13.62%,CERT1;PLTP;PRELID2;PITPNM2;GLTP;ABCA3;PLEKHA8;PITPNC1;C2CD2L;PITPNB
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5972094817439437,-1.682885815628388,0.005291005291005291,0.15707768245021256,0.856,13/29,13.39%,GRIA2;GABRG2;GABRA2;GRIK4;GRIA4;GABRB1;GRIK2;GRIK5;GRID2;GABRG3;GRIK1;GABRB3;GRIN2D
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.7239997162337045,-1.6793144508971842,0.012376237623762377,0.15333291811344846,0.868,5/12,9.04%,SULF1;SULF2;ARSI;ARSB;ARSG
prerank,cadherin binding (GO:0045296),0.5120583940620758,1.677230295226196,0.0,1.0,0.968,99/315,16.77%,PTPRB;MRTFB;TJP1;DOCK9;FNBP1L;CLINT1;PKP4;BMPR2;KDR;ITGA6;EHD4;SPTBN1;EPN2;F11R;PPFIBP1;FLNB;PTPRM;CD2AP;LRRFIP1;TJP2;MYH9;WASF2;IQGAP1;DAB2IP;FASN;PTPRJ;SLC3A2;BSG;NCK1;ESYT2;COBLL1;STK24;PROM1;SWAP70;NUMB;PKN2;PAK2;TMOD3;PDLIM1;CDH2;TES;LASP1;CTNNA1;TAGLN2;RPL34;CHMP2B;FMNL2;ACVR1;SH3GLB1;UBAP2;UNC45A;HNRNPK;TBC1D2;TRIM25;CDH15;RPL15;PSEN1;CHMP4B;RPL14;SLK;PTPN1;CDH23;GAPVD1;SERBP1;CBL;TWF2;SPTAN1;FSCN1;SFN;STK38;PICALM;DBNL;RAB11B;RPL6;LIMA1;RACK1;CAPZA1;HSP90AB1;CAST;RARS1;CNN3;TMPO;CDH5;GIPC1;APC;ERC1;RPL29;GLOD4;PAK4;EIF5;STXBP6;NIBAN2;RDX;PACSIN2;STAT1;ABI1;PRDX1;CTNNB1;CEMIP2
prerank,phosphatidylinositol binding (GO:0035091),0.576446490866733,1.676569101051541,0.006631299734748011,0.8607927059625716,0.97,34/91,14.35%,EPB41;MCF2L;PARD3;HIP1;HIP1R;SCARB1;PITPNM2;DENND1B;MTM1;ESYT2;FCHO2;WDFY3;CCDC88A;EEA1;GRB7;ITPR3;PIGU;MYO1E;PLEKHF2;SNX24;MREG;SH3YL1;PITPNC1;AIDA;PIGK;ANKFY1;PICALM;PARD3B;SNX11;C2CD2L;EXOC8;ESYT1;PITPNB;SNX13
prerank,amino acid:sodium symporter activity (GO:0005283),-0.7561418497174734,-1.671961071906159,0.0045871559633027525,0.1571729387767439,0.892,6/11,7.36%,SLC6A13;SLC1A3;SLC6A1;SLC6A12;SLC6A15;SLC1A2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7675842511714506,1.6713321367645921,0.01020408163265306,0.6537145463472553,0.975,4/16,5.24%,PTPRB;PTPRG;PTPRM;PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7675842511714506,1.6713321367645921,0.01020408163265306,0.6537145463472553,0.975,4/16,5.24%,PTPRB;PTPRG;PTPRM;PTPRK
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.8012666880633533,1.6589413358887783,0.02681992337164751,0.6521720977268329,0.983,1/10,0.03%,MECOM
prerank,anion transmembrane transporter activity (GO:0008509),0.813031653251693,1.6582765952371785,0.012433392539964476,0.584672733769272,0.984,3/12,0.93%,SLCO2B1;ABCG2;SLC39A8
prerank,phosphatidylcholine transporter activity (GO:0008525),0.7370374779423534,1.6418432329916293,0.023178807947019868,0.6213195794594893,0.993,9/17,15.84%,ATP8B1;PLTP;ATP10A;PITPNM2;ABCA3;PITPNC1;ABCG1;PITPNB;ABCA1
prerank,glycerophospholipid flippase activity (GO:0140333),0.7990082192620461,1.6414251417521155,0.018315018315018316,0.5668216623094211,0.993,6/11,8.06%,ATP8B1;ATP8A1;ATP10A;ATP11C;ABCA3;ATP11A
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.5109862408994843,1.6400774271035345,0.0,0.5263709338075625,0.993,39/254,8.69%,MECOM;ERG;LEF1;ELK3;FOXO1;ESR1;MEF2C;ZBTB16;SMAD1;ZIC3;NFATC1;IRF2;HHEX;STAT3;NR3C1;HIF1A;KLF7;RREB1;SOX17;TCF12;SOX18;MAFF;FOSL2;GTF2I;SOX9;FOXF1;ELK4;TCF4;FOXF2;HOXA10;KLF10;ATMIN;NR1I3;TCF3;HOXD8;NFKB1;NEUROD1;NRL;CREB1
prerank,poly(U) RNA binding (GO:0008266),-0.619559573779397,-1.6231633029213872,0.011655011655011656,0.23458193412882541,0.977,5/20,7.04%,RBMS3;HNRNPH1;ATXN1;DAZAP1;RBMS1
prerank,ligand-gated channel activity (GO:0022834),-0.5658287384289136,-1.6198998176865251,0.013550135501355014,0.22974635255282375,0.979,14/29,13.39%,GRIN3A;GRIA2;GRIA1;GRIA3;ANXA6;GRIK4;GRIA4;GABRB1;GRIN2A;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,ligand-gated ion channel activity (GO:0015276),-0.561980326800701,-1.6186055659089587,0.01358695652173913,0.2205362564813229,0.98,14/30,13.39%,GRIN3A;GRIA2;GRIA1;GRIA3;ANXA6;GRIK4;GRIA4;GABRB1;GRIN2A;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D
prerank,estrogen receptor binding (GO:0030331),0.6489463727033005,1.616188863208587,0.023255813953488372,0.6160193386828233,0.999,9/32,11.99%,LEF1;TACC1;ESR1;DDX54;NCOA1;NRIP1;CNOT1;MMS19;DCAF1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.6772884556316678,-1.6107289851956246,0.024017467248908297,0.22545698284919435,0.982,5/14,5.63%,TIMP3;COL4A3;TIMP2;RECK;NGF
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6205912282665207,1.5856505320045307,0.0265625,0.7626433316791477,1.0,10/35,7.32%,PEAK1;LYN;PTK2B;YES1;FYN;SRMS;DYRK1A;BMX;LCK;PTK2
prerank,metallopeptidase activity (GO:0008237),-0.42287226501821684,-1.5794720247533116,0.0,0.28449167885195475,0.996,22/113,10.71%,TRABD2B;ADAMTS12;THSD4;ADAMTS2;ADAMTSL3;ADAMTS6;ADAMTSL5;PAPPA;ADAMTS10;ADAMTS5;ADAMTSL1;ADAMTS17;ADAMTSL4;MMP14;MMP16;ADAMTS15;ADAM19;ADAMTS1;ADAM33;ADAM12;MMP2;ADAMTS14
prerank,actin monomer binding (GO:0003785),0.6702152991029101,1.5786194923237156,0.03648424543946932,0.7568092118397572,1.0,8/22,12.61%,NOS3;MTSS1;TMSB4X;MRTFA;TWF2;ABL2;PFN4;LIMA1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.47833901615420155,-1.5761955847533127,0.006734006734006734,0.27960320324088145,0.997,10/55,4.76%,SLC7A2;SLC6A13;SLC13A3;SLC16A12;PDPN;SLC6A12;SLC16A6;SLC38A11;SLC22A4;SLC16A11
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5777054850764562,-1.5604435425277488,0.029925187032418952,0.3035451992795935,0.999,6/23,9.79%,RBMS3;HNRNPH1;ATXN1;DAZAP1;RBMS1;U2AF2
prerank,growth factor receptor binding (GO:0070851),0.52635346199278,1.5594300665981882,0.0078125,0.834358327881541,1.0,20/95,8.44%,IL1R1;IL6ST;ERN1;PDGFB;VEGFC;HIP1;IL6R;PDGFD;PTPRJ;FYN;FGF23;SDCBP;VEGFD;IL27RA;CCDC88A;PDGFC;ITGA5;TGFA;ERAP1;PSEN1
prerank,calcium channel activity (GO:0005262),-0.44178876939107375,-1.5555242311404456,0.00796812749003984,0.30217211902277996,0.999,19/84,10.19%,SLC24A3;CACNA1C;CACNA2D3;CACNA2D1;CACNA1D;PKD1;P2RX4;MCU;CACNB2;ITGAV;TRPC3;ANXA2;TRPC6;ANXA6;TRPC1;RYR2;SLC24A2;CACNB1;TRPC4
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.5274791686755818,-1.5532160719909667,0.03116883116883117,0.29607772916244957,0.999,10/29,15.75%,SLC13A3;SLC26A7;SLC1A5;SLC26A2;SLC25A12;SLC25A13;SLC26A6;SLC19A1;SLC1A1;SLC25A18
prerank,solute:anion antiporter activity (GO:0140323),-0.6518865809198778,-1.5517632107133694,0.05286343612334802,0.28803572736431676,0.999,6/14,14.22%,SLC7A11;SLC26A7;SLC26A2;SLC4A3;SLC4A2;SLC26A6
prerank,voltage-gated calcium channel activity (GO:0005245),-0.5202124777304704,-1.5452890453987156,0.01694915254237288,0.29097830995126356,0.999,7/37,5.66%,CACNA1C;CACNA2D3;CACNA2D1;CACNA1D;CACNB2;CACNA1G;ITGAV
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.720973360039604,1.5395064989287057,0.06338028169014084,0.9203047330591086,1.0,8/13,7.81%,IL1R1;ERN1;PDGFB;PDGFD;PTPRJ;VEGFD;PDGFC;ITGA5
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.7716489945077818,1.5361291766486687,0.03773584905660377,0.8911846565575592,1.0,4/10,7.68%,CASP4;CASP8;CASP7;CASP1
prerank,SH3 domain binding (GO:0017124),0.554463862974907,1.5332407011386158,0.01862464183381089,0.8651298512666992,1.0,13/62,6.31%,SHANK3;ABI3;CD2AP;ELMO1;PTPN12;WASF2;DAB2IP;AFAP1L1;AFAP1L2;ARHGAP27;EVL;SKAP1;ADAM15
prerank,ion channel activity (GO:0005216),-0.43241624213095636,-1.5312542609135547,0.0,0.3110283296294646,1.0,23/80,13.39%,TRPM3;NALCN;PIEZO2;GRIN3A;GRIA2;ABCC9;GRIA1;GRIA3;TRPC6;ANXA6;TRPC1;CALHM5;GRIK4;GRIA4;UNC80;GABRB1;GRIN2A;GRIK2;GRIK5;TMEM63A;GRID2;GRIK1;GRIN2D
prerank,cation channel activity (GO:0005261),-0.42402695956790404,-1.5306489386372066,0.0041841004184100415,0.30221260296155583,1.0,22/94,9.99%,SLC24A3;TRPM3;NALCN;PIEZO2;CACNA1D;KCNK5;PKD1;MCU;ANO1;ABCC9;CACNB2;TRPC3;ANXA2;TRPC6;ANXA6;TRPC1;KCNQ4;CALHM5;RYR2;SLC24A2;UNC80;TMEM38A
prerank,alkali metal ion binding (GO:0031420),-0.6548039808755621,-1.5282566007828038,0.0367965367965368,0.29811197174361714,1.0,2/13,2.14%,ATP1A2;HDAC4
prerank,gap junction channel activity (GO:0005243),-0.5598673897694479,-1.5272156207469794,0.043037974683544304,0.29138947495445555,1.0,3/22,3.57%,GJB6;GJA1;GJB2
prerank,wide pore channel activity (GO:0022829),-0.5527684430262706,-1.5264273072805308,0.04884318766066838,0.28406230374372626,1.0,3/23,3.57%,GJB6;GJA1;GJB2
prerank,protein kinase C activity (GO:0004697),0.6978256708282988,1.5259119390589173,0.053003533568904596,0.8669483170086707,1.0,4/14,4.40%,PRKCH;PRKD1;PRKD3;PKN1
prerank,ligand-gated anion channel activity (GO:0099095),-0.6089232611497685,-1.5199591135146706,0.05393258426966292,0.28931132423696476,1.0,10/17,23.23%,GLRB;GABRG2;GABRA2;GABRB1;GABRG3;GABRB3;CFTR;GABRA1;GABRA5;GABRA3
prerank,cytokine receptor activity (GO:0004896),0.5286468334647335,1.515437061979291,0.03050397877984085,0.8958257918700941,1.0,12/83,6.10%,IL1R1;IL6ST;LIFR;IL6R;FZD4;OSMR;GHR;CSF2RB;IL27RA;CX3CR1;IFNAR1;IFNAR2
prerank,potassium ion leak channel activity (GO:0022841),-0.6040380356324907,-1.5079301943722285,0.03333333333333333,0.3050753957749894,1.0,2/15,2.70%,KCNK2;KCNK5
prerank,protein phosphatase 2A binding (GO:0051721),0.6552198644108369,1.505756167500515,0.05930807248764415,0.9186482291377848,1.0,4/23,2.50%,FOXO1;CTTNBP2NL;DAB2IP;MFHAS1
prerank,fatty acid synthase activity (GO:0004312),0.7419629498435658,1.5051648354597125,0.06498194945848375,0.8819876921030672,1.0,2/10,3.90%,ELOVL7;ELOVL5
prerank,phospholipase inhibitor activity (GO:0004859),-0.6920351443848269,-1.5048075204886857,0.04842105263157895,0.30317971927675613,1.0,6/10,18.06%,ANXA5;ANXA1;ANXA2;ANXA4;SNCA;ANGPTL3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.7171207069915829,1.5044928637988835,0.06928838951310862,0.8490854618359179,1.0,9/12,22.63%,CNOT6;PAN3;CNOT6L;CNOT1;CNOT2;CNOT7;PAN2;TOE1;NOCT
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.592683104677568,-1.5043725695114956,0.04608294930875576,0.2958336472030943,1.0,7/16,20.36%,SLC13A3;SLC1A5;SLC25A12;SLC25A13;SLC1A1;SLC25A18;SLC25A14
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.632055888305101,1.4985826615590112,0.04746317512274959,0.8510628691477697,1.0,6/25,4.08%,NOS3;FMO4;FMO2;FMO1;CH25H;CYP26A1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5890575826451101,-1.496848826593948,0.05063291139240506,0.3037360774996988,1.0,5/18,10.91%,ALDH1A1;ALDH1A2;AKR1B1;ALDH2;FAR1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6462050318419569,-1.494115442600942,0.05907172995780591,0.30165724636552843,1.0,8/12,23.23%,GABRG2;GABRA2;GABRB1;GABRG3;GABRB3;GABRA1;GABRA5;GABRA3
prerank,Hsp90 protein binding (GO:0051879),0.5922243103379776,1.4930929631948435,0.05448717948717949,0.8518571415408148,1.0,7/33,6.63%,KDR;ERN1;AHR;NR3C1;HIF1A;UNC45B;UNC45A
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6712544556985862,-1.4898823617027974,0.06762295081967214,0.3025162325023745,1.0,4/10,9.02%,CACNA1C;CACNA1D;CACNB2;CACNB1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5711915457947372,-1.489865593814032,0.043478260869565216,0.2951871584642384,1.0,11/19,23.23%,GABRG2;GABRA2;GRIK4;GRIK2;GRIK5;GRID2;GABRG3;GRIK1;GABRA1;GABRA5;GABRA3
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.555194765924631,-1.4865219111083692,0.04918032786885246,0.2940146053594506,1.0,4/22,3.78%,RBMS3;CPEB1;CPEB2;CPEB3
prerank,FMN binding (GO:0010181),0.721818806963521,1.4833844577502557,0.0650994575045208,0.8771561881341016,1.0,1/11,0.33%,NOS3
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6731923342252226,-1.4816480039594837,0.06431535269709543,0.2969214463122499,1.0,3/10,2.72%,SLC6A13;SLC6A1;SLC6A12
prerank,GTPase activator activity (GO:0005096),0.4463083259147713,1.4693761879156029,0.001095290251916758,0.9284831523162768,1.0,68/313,10.46%,CHN2;FGD5;TBC1D8;ARHGAP31;RGS3;DOCK9;GNAQ;PREX2;RAPGEF5;DENND5B;RALGAPA2;TBC1D30;ARAP3;ARHGEF15;RASGRF2;DOCK1;RIN3;CYTH1;ELMO1;TBC1D4;IQGAP1;FGD6;ARHGEF2;BCR;SRGAP2;DENND4C;DENND1B;SPATA13;DOCK4;RALGAPA1;ARHGAP27;SGSM1;RASGRP3;PLCB1;TBC1D22A;ADRB1;KALRN;TBC1D15;ARHGAP8;PREX1;SIPA1L3;HERC2;DENND2D;ARHGAP17;RAP1GDS1;MYCBP2;OPHN1;CCDC88A;RAPGEF2;TBC1D12;PGAM5;SMAP1;ARRB1;RASA1;RAP1A;BNIP2;TBC1D2;RASA4;EIF2B5;LLGL1;ARHGEF7;GAPVD1;CYTH2;ARHGAP28;NPRL2;OCRL;RGL2;LARS1
prerank,1-phosphatidylinositol binding (GO:0005545),0.6796536332527934,1.468496988694237,0.08056042031523643,0.9011910431950353,1.0,5/15,11.68%,EPB41;SCARB1;WDFY3;EEA1;PICALM
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.7262568533201206,1.4679465528748614,0.07434944237918216,0.8741298632291197,1.0,4/11,7.68%,CASP4;CASP8;CASP7;CASP1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.7210679429051168,1.4676767378373696,0.08611599297012303,0.8475334813367389,1.0,2/11,2.08%,LEF1;GATA2
prerank,GABA receptor activity (GO:0016917),-0.5412894012951102,-1.4652876375575032,0.04523809523809524,0.3245615773448481,1.0,11/21,23.23%,GPR156;GABRG2;GABRA2;GABRB1;GABBR1;GABRG3;GABRB3;GABRA1;GABRA5;GABBR2;GABRA3
prerank,hexose transmembrane transporter activity (GO:0015149),0.6927046514834057,1.4574655082093444,0.10661764705882353,0.8803702794005179,1.0,3/12,6.89%,SLC2A1;MFSD4A;PPBP
prerank,antiporter activity (GO:0015297),0.6338225183259122,1.4562966373347999,0.0757825370675453,0.8605520173586186,1.0,6/20,9.91%,SLC25A16;SLC35E4;CLCN3;ATP1A3;SLC35D2;SLC25A30
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.45982587953817744,-1.455710553774149,0.02280130293159609,0.3377934869300891,1.0,9/47,3.64%,SLC7A11;SLC7A2;SLC6A13;SLC47A1;PDPN;SLC6A1;SLC1A5;SLC38A11;SLC22A4
prerank,peptidase inhibitor activity (GO:0030414),-0.48376902552724976,-1.453052696446913,0.0481283422459893,0.33610470040192836,1.0,7/33,6.35%,GPC3;TIMP2;TFPI;ITIH2;RENBP;RECK;SERPIND1
prerank,endopeptidase inhibitor activity (GO:0004866),-0.41182384004926503,-1.4513942553631975,0.018796992481203006,0.33289426039123654,1.0,18/82,12.13%,TIMP3;SERPING1;COL4A3;TIMP2;TFPI;SERPINH1;ITIH2;RENBP;RECK;SERPINE2;NGF;SERPIND1;ANXA2;SERPINF1;BIN1;SERPINE1;CST3;SPOCK3
prerank,TBP-class protein binding (GO:0017025),0.6189021793107572,1.4493539019331518,0.07432432432432433,0.8734952240131081,1.0,6/21,12.86%,ESR1;AHR;HHEX;TAF1B;YEATS2;GTF2A2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.6784496498664939,1.446961275908258,0.1,0.8615586114844364,1.0,2/15,6.41%,PLA2G4A;PLA2G2D
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5879551224468301,-1.4446503352651705,0.06060606060606061,0.34021268341040856,1.0,11/17,13.39%,GRIN3A;GRIA2;GRIA1;GRIA3;GRIK4;GRIA4;GRIN2A;GRIK2;GRIK5;GRIK1;GRIN2D
prerank,actin binding (GO:0003779),0.4637590497707739,1.4430658991490637,0.01597051597051597,0.8569040807049552,1.0,21/170,5.16%,MYRIP;FLII;NOS3;PARVB;ABLIM1;SLC6A2;UTRN;LCP1;EPS8;FLNB;MYH9;KLHL2;MTSS1;ACTN4;SSH2;SHROOM2;TMSB4X;PDLIM1;MRTFA;SORBS1;CEACAM1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.5992711166722862,1.4428846798661237,0.08235294117647059,0.8346836843938948,1.0,6/24,9.26%,CERT1;PLA2G4A;DAB2IP;PLEKHA5;SNX3;PLEKHA8
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4667671612150601,1.442411479434671,0.017094017094017096,0.8154878267013836,1.0,26/147,6.24%,FGD5;DOCK9;PREX2;RAPGEF5;DENND5B;ARHGEF15;RASGRF2;DOCK1;RIN3;CYTH1;ELMO1;FGD6;ARHGEF2;BCR;DENND4C;DENND1B;SPATA13;DOCK4;ADRB1;KALRN;PREX1;HERC2;DENND2D;MYCBP2;CCDC88A;RAPGEF2
prerank,retinoic acid receptor binding (GO:0042974),0.6420589285736599,1.4397123414681596,0.07692307692307693,0.8078666705413967,1.0,6/17,14.78%,TACC1;ACTN4;NRIP1;CNOT1;ASXL1;SNW1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.599109200887126,1.4380877732178747,0.09693053311793215,0.7955382646714643,1.0,10/29,15.85%,GCH1;NFATC1;PTPRJ;PPM1D;DUSP16;TNIP1;MAPKAPK3;DUSP2;DUSP7;ACE
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6976891214589545,1.4285394072382216,0.07806691449814127,0.8223382986407565,1.0,9/12,14.97%,VEGFC;DAB2IP;VEGFD;GREM1;CCDC88A;ITGA5;ITGB3;CDH5;PGF
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5032329519603981,-1.4280852907617354,0.05412371134020619,0.37053131515284593,1.0,12/28,23.23%,GABRG2;GABRA2;GRIK4;GRIK2;GRIK5;GRID2;GABRG3;GRIK1;CHRNA7;GABRA1;GABRA5;GABRA3
prerank,FAD binding (GO:0071949),-0.515327384118955,-1.4149679240196498,0.08900523560209424,0.3944350154928919,1.0,6/24,10.78%,MICAL3;MICAL2;DDO;PRODH;CRY2;AIFM1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.6850631532336989,1.4134363037273698,0.10892857142857143,0.8789947816365207,1.0,1/12,0.26%,ENTPD1
prerank,CARD domain binding (GO:0050700),0.6670379405683801,1.405255996957763,0.1195840554592721,0.8987053591422218,1.0,10/14,20.27%,NOD1;CASP4;CARD10;CASP1;CARD16;RIPK2;IRGM;CARD9;BCL10;CARD19
prerank,protein kinase C binding (GO:0005080),0.5477291610345015,1.3993752609295775,0.08836524300441827,0.9076141609503123,1.0,13/43,11.25%,NELL2;HDAC9;ADCY4;CAVIN2;PRKD2;HDAC7;TIRAP;PKN1;CCDC88A;TRPV4;HINT1;TWF2;PICK1
prerank,lipoprotein particle binding (GO:0071813),0.600635661381258,1.3984132259113482,0.10880829015544041,0.8927621697826348,1.0,5/20,7.31%,PLTP;SCARB1;STAB1;SCARF1;LPL
prerank,protein phosphatase binding (GO:0019903),0.47095480866390765,1.3965464023300558,0.04522613065326633,0.8819876921030672,1.0,27/117,9.67%,FOXO1;PPP1R16B;CTTNBP2NL;IQGAP1;DAB2IP;STAT3;KCNQ1;MFHAS1;PXN;FLT4;PPP1R9B;JAK3;CEACAM1;ATP2B4;PPP3CB;SKAP1;CDKN1B;JAK1;LCK;PTK2;SNX3;SHOC2;ANAPC7;ANK1;SMG7;FBXL2;AP3B1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.43722001751873063,-1.3961345523596551,0.046052631578947366,0.4328606238129215,1.0,11/48,9.94%,TRPM3;NALCN;PIEZO2;SLC41A1;SLC12A2;ABCC9;TRPC6;TRPC1;CALHM5;ATP6V1B2;UNC80
prerank,glutamate receptor binding (GO:0035254),0.6387417779171579,1.395605968606466,0.12,0.8683763173748901,1.0,3/17,4.02%,SHANK3;HIP1;HOMER2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.649464533335818,1.3948678415432398,0.12544802867383512,0.8537807699927208,1.0,6/14,15.96%,NOD1;MAL;CASP1;RACK1;APAF1;CASP8AP2
prerank,GTPase regulator activity (GO:0030695),0.4358422995014517,1.3943747340538277,0.022274325908558032,0.838585498238659,1.0,44/212,10.46%,CHN2;TBC1D8;ARHGAP31;RGS3;GNAQ;PREX2;RALGAPA2;TBC1D30;ARAP3;DOCK1;SH3BP4;TBC1D4;IQGAP1;BCR;SRGAP2;RALGAPA1;ARHGAP27;SGSM1;RASGRP3;PLCB1;TBC1D22A;TBC1D15;ARHGAP8;PREX1;SIPA1L3;ARHGAP17;RAP1GDS1;OPHN1;CCDC88A;RAPGEF2;TBC1D12;PGAM5;SMAP1;ARRB1;RASA1;BNIP2;TBC1D2;RASA4;LLGL1;ARHGAP28;NPRL2;RGS12;OCRL;LARS1
prerank,NAD binding (GO:0051287),-0.5009043300415881,-1.39179263854472,0.072992700729927,0.43502717095121685,1.0,6/26,7.64%,ALDH1A1;ME1;CRYL1;SIRT2;ALDH2;BDH2
prerank,calcium channel regulator activity (GO:0005246),0.5480535932474954,1.3901389723925386,0.09938837920489296,0.8418691661982732,1.0,4/37,9.01%,PRKG1;FKBP1A;SGK3;MCUB
prerank,protein kinase binding (GO:0019901),0.41459666653830035,1.3859676474880585,0.0062176165803108805,0.844712583495532,1.0,106/479,13.06%,NELL2;FRMD5;HDAC9;BMPR2;CAV1;ESR1;UTRN;SLC12A7;ADCY4;ACVRL1;GCH1;CAVIN2;SMAD1;PLCG1;NEDD9;TJP2;IQGAP1;DAB2IP;PRKD2;STAT3;ADAM10;KCNQ1;NR3C1;HDAC7;MSN;TRIM14;HIF1A;PTPRJ;SIK1;CCNK;TAOK2;PRKAR2B;PLCG2;PPP1R12A;CAV2;PAK2;SOX9;TIRAP;PKN1;RPS19;IKBKB;GHR;CEACAM1;PTPRK;TCF7L2;TRIM68;LRBA;CCDC88A;AURKA;IFNAR2;DUSP22;ACVR1;RAC1;RPS7;SKAP1;SASH1;TRIB3;CDKN1B;PPM1D;GNAT1;HNRNPA0;LCK;PTK2;TCF3;AP2A1;NEK6;GRB7;TRPV4;RHOBTB1;DUSP16;RPTOR;POLA1;LLGL1;ARHGEF7;PTPN1;RELB;MAP3K11;RICTOR;HINT1;CRK;TNIP1;MAP2K3;MAPKAPK3;BCL2L1;SPAG9;MAD2L2;PRKAB1;TWF2;PICK1;EPHA4;IRAK4;STK38;MAP3K13;DUSP2;PEBP1;RELA;GSKIP;WARS1;RHOB;GSTP1;CEP68;RACK1;ZFP36;MYH6;TRIB1;ADIPOR1
prerank,AMP binding (GO:0016208),-0.6135845392411826,-1.3822913151105298,0.12222222222222222,0.4500973759180497,1.0,7/11,17.68%,MPPED2;PFKP;PRKAG2;PRKAG3;ACSS2;PRKAG1;PFKM
prerank,cytokine receptor binding (GO:0005126),0.4738443678586925,1.3767022259349329,0.06233062330623306,0.8726495125991335,1.0,17/83,9.76%,IL6ST;LIFR;KITLG;VEGFC;IL6R;OSMR;SOCS2;PXDN;FKBP1A;SDCBP;VEGFD;IL27RA;USP15;JAK1;ERAP1;CSF1;IL23A
prerank,potassium ion antiporter activity (GO:0022821),-0.5599457114311902,-1.3758914595976097,0.11764705882352941,0.45894917074245345,1.0,4/15,12.38%,SLC24A3;SLC9A9;SLC24A2;SLC9A1
prerank,GTPase activity (GO:0003924),0.43622312249341166,1.3757765120293828,0.036686390532544376,0.8607552402836544,1.0,52/192,17.93%,DNM3;RAB27A;GNAQ;GCH1;RAB11A;GBP5;GBP4;RASD2;GNB1;RAP1B;GPN3;RHOJ;GBP7;RALB;GNAI2;RAC1;NRAS;KRAS;GNAT1;RAP1A;RAB2A;RHOBTB1;GNA12;RAB38;ARL8B;DRG2;RNF112;HBS1L;RAB43;RAB11B;RHOB;GNA13;RAB7A;RAB31;ATL1;GBP3;RAB5A;RAB5B;NKIRAS1;RAB32;RAB18;RAB6A;GNAI3;IRGM;RAB8B;RHOA;RHEB;MFN1;RHOT1;RAB1A;EEF2;RND1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.5768263909318744,-1.3731504670800625,0.10492505353319058,0.45818617799060946,1.0,11/14,39.14%,ALDH4A1;ALDH1L1;MTHFD1;NOXRED1;AASS;BLVRB;PYCR1;PYCR2;MTHFR;CRYM;ALDH1L2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.41446043821587697,-1.3716987888601126,0.066006600660066,0.4536369925327152,1.0,16/53,15.75%,SLC7A11;SLC7A2;SLC1A3;SLC47A1;SLC1A5;SLC6A9;SLC1A2;SLC25A12;SLC66A1;SLC7A6;SLC43A1;SLC6A7;SLC25A13;SLC1A1;SLC22A2;SLC25A18
prerank,alanine transmembrane transporter activity (GO:0022858),0.6804036743172932,1.3692536127331152,0.15070921985815602,0.875280822761634,1.0,3/12,4.96%,SLC38A5;SLC3A2;SLC6A6
prerank,N-acyltransferase activity (GO:0016410),0.5462039837477547,1.3685910384721833,0.11198738170347003,0.8621826826504003,1.0,6/32,10.54%,TGM2;NMT2;CERS4;GLYAT;PLAAT3;SMARCE1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.657936323950519,1.36762907474067,0.12658227848101267,0.8510415939943845,1.0,4/12,2.89%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.6275297436112047,1.3657311602161817,0.1260647359454855,0.8446111477797019,1.0,8/18,16.88%,RPS6KA3;RPS6KA1;XIAP;SERPINB9;GAS6;BIRC3;TNFAIP8;BIRC2
prerank,clathrin adaptor activity (GO:0035615),0.6218644305152736,1.3654427100553463,0.13416815742397137,0.831298496194972,1.0,4/15,7.63%,HIP1;HIP1R;AP2B1;AP2A1
prerank,BMP binding (GO:0036122),0.6746782358169061,1.3597360120157407,0.16111111111111112,0.8418782532129394,1.0,4/11,6.69%,BMPR2;ENG;GREM1;SOST
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.49449534266768524,-1.3559573347047562,0.11604938271604938,0.4866595587578479,1.0,11/27,18.22%,SLC41A1;SLC12A2;CNNM2;TUSC3;MAGT1;SLC9B2;MRS2;CNNM4;SLC8A2;SLC4A8;ATP2A3
prerank,peptidoglycan binding (GO:0042834),0.6764764687659589,1.3537294350687317,0.16795366795366795,0.8559774295797359,1.0,2/10,6.44%,NOD1;PGLYRP2
prerank,low-density lipoprotein particle binding (GO:0030169),0.6155429452487491,1.3461013294615747,0.1537037037037037,0.8735368716132738,1.0,4/16,5.38%,PLTP;SCARB1;STAB1;SCARF1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5667441174283308,-1.3434940921236243,0.12783505154639174,0.5109003273615049,1.0,7/13,23.23%,GLRB;GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,sequence-specific DNA binding (GO:0043565),0.397745582837668,1.3430983503435368,0.0041025641025641026,0.8728669274213613,1.0,89/590,11.49%,ERG;LEF1;ELK3;FLI1;FOXO1;LHX6;EPAS1;PBX1;TBX1;ESR1;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;ELF2;SOX13;HHEX;NR3C1;HIF1A;PKNOX2;TGIF1;PITX1;TCF12;SOX18;HMBOX1;MAFF;SOX9;FOXF1;KLF2;ELK4;FOXQ1;XBP1;MBNL2;FOXL2;TET3;TCF7L1;TCF7L2;TCF4;FOXF2;HOXA10;PITX3;TEAD2;ESRRG;KLF10;JUNB;NR1I3;FOXA3;ELF5;FOSL1;ETS2;KLF13;SPDEF;FOXN2;HOXD1;HOXD8;GMEB2;HNRNPD;BACH2;NEUROD1;CREM;NRL;CREB1;FOXK1;MAFB;MYBBP1A;SMG7;EGR3;SOX4;CREB3L4;SMAD5;NFIB;POU2F1;SP2;USF2;TFAP4;KLF12;CEBPD;CSRNP1;CBFB;ACD;ATF6;PRDM2;SP3
prerank,semaphorin receptor activity (GO:0017154),0.6798372398368232,1.3423112535970598,0.16535433070866143,0.8622268088944582,1.0,3/11,2.79%,NRP2;PLXNA4;PLXND1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.6266477733746637,1.3413830176219754,0.1660839160839161,0.8528965214301512,1.0,6/15,14.75%,SOCS2;PIK3R6;CISH;SLA2;SOCS4;SOCS6
prerank,ephrin receptor binding (GO:0046875),0.5808724702285484,1.3367921329955337,0.13804173354735153,0.8591125143618993,1.0,9/21,10.76%,ANKS1A;LYN;EFNA1;FYN;PIK3CG;PTPN1;CRK;CBL;ANKS1B
prerank,tropomyosin binding (GO:0005523),-0.5468720762113553,-1.3325206239985028,0.15812917594654788,0.5316947806596559,1.0,3/16,5.42%,CALD1;S100A6;TMOD2
prerank,GTP binding (GO:0005525),0.42143398148965155,1.3323108008678903,0.053763440860215055,0.8650649286827381,1.0,38/172,14.26%,RAB27A;TGM2;GCH1;INSR;GBP5;MFHAS1;GBP4;RAP1B;RHOJ;GBP7;RALB;RAC1;ARL4A;NRAS;KRAS;GNAT1;RAP1A;RAB2A;RHOBTB1;DYNC1LI1;RAB38;ARL5A;TUBE1;NUDT16;ARL8B;NMUR2;DRG2;RNF112;RAB26;RAB11B;RHOB;RAB7A;RAB31;ATL1;GBP3;RAB5A;EIF2B2;RAB32
prerank,mRNA 3'-UTR binding (GO:0003730),-0.38532662649077165,-1.3316642172441582,0.051094890510948905,0.5251610274616051,1.0,18/79,15.04%,CELF2;RBMS3;CPEB1;DDX5;CPEB2;CPEB3;HNRNPA2B1;FXR2;DAZAP1;RBMS1;CPEB4;CIRBP;RBM4;CELF1;IGF2BP2;CSDC2;HNRNPU;ELAVL4
prerank,transcription cis-regulatory region binding (GO:0000976),0.3978494464552965,1.3307252666212896,0.0198744769874477,0.8592071248794406,1.0,43/406,7.58%,LEF1;ELK3;FLI1;LHX6;EPAS1;DACH1;PBX1;SMARCA2;MEF2C;SOX7;NR5A2;AHR;ETV6;IRF2;FOXP1;SOX13;HHEX;STAT3;TAL1;NR3C1;HIF1A;RREB1;SOX17;ACTN4;ZFP57;TCF12;SOX18;FOSL2;SOX9;ZBTB46;FOXF1;XBP1;TCF7L2;FOXF2;KLF10;ATMIN;NR1I3;FOXA3;ASCL4;FOXN2;TCF3;HOXD8;NFKB1
prerank,transcription coregulator binding (GO:0001221),0.49659121045549404,1.3296534186208808,0.13839285714285715,0.8507766974767461,1.0,13/50,12.24%,ESR1;PPARD;ZBTB16;LMO2;AHR;VGLL4;MTF2;TEAD2;NEK6;CTBP1;RPL23;CNOT2;RELA
prerank,calcium:sodium antiporter activity (GO:0005432),-0.6129414693471743,-1.3261340963737063,0.1554192229038855,0.5310198608690059,1.0,4/10,8.91%,SLC24A3;SLC8A3;SLC8A1;SLC24A2
prerank,glucose transmembrane transporter activity (GO:0005355),0.5943679094005185,1.3252816336734612,0.17198581560283688,0.8563177292553792,1.0,3/17,6.89%,SLC2A1;MFSD4A;PPBP
prerank,semaphorin receptor binding (GO:0030215),0.5621266755263321,1.3207015160239304,0.14382402707275804,0.8636010262094095,1.0,6/23,10.72%,SEMA6A;SEMA5B;SEMA7A;SEMA6B;SEMA6D;SEMA4D
prerank,protease binding (GO:0002020),-0.36519575018523986,-1.3206658866168253,0.05454545454545454,0.5374079630802552,1.0,24/99,8.03%,COL1A2;COL3A1;COL1A1;TIMP3;PRKN;BCL2;TIMP2;CCBE1;SLC2A13;F3;DPP4;ATP9A;FAP;ADAMTSL4;NTRK2;SELENOS;ITGAV;LDLR;PSAP;STIM1;ANXA2;AMFR;ECM1;BDKRB2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.6429483680446493,1.3197519062681269,0.17318435754189945,0.8550314343792166,1.0,6/12,19.30%,NOD1;CASP1;RACK1;APAF1;CASP8AP2;CTSH
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.5167475077092046,1.3189134580522988,0.15689381933438987,0.846672307863993,1.0,10/33,16.25%,RNF125;DCUN1D3;RNF144B;FOXL2;RNF144A;SIAH1;TRAF6;ARIH2;RNF5;UBE3D
prerank,Toll-like receptor binding (GO:0035325),0.6542319681940316,1.3185563972268186,0.18975332068311196,0.8364341125388783,1.0,2/11,4.33%,DAB2IP;TIRAP
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.5419415875395348,1.3172697942904674,0.15630252100840336,0.8297999825177395,1.0,5/27,5.93%,RNF125;DCUN1D3;RNF144B;FOXL2;RNF144A
prerank,protein serine/threonine kinase activity (GO:0004674),0.400674249642306,1.3167454678778,0.02823018458197611,0.82092023183171,1.0,81/334,14.67%,PRKCH;RPS6KA5;BMPR2;SNRK;ERN1;ACVRL1;PRKD1;CDK6;DAPK1;NEK7;PRKD2;BCR;PIM3;PTK2B;STK10;PRKD3;MAP4K3;SIK1;CCNK;TAOK2;STK24;STK3;PKN3;PKN2;PAK2;KALRN;RPS6KA3;PKN1;STK4;LMTK2;MARK3;IKBKB;MAP3K9;RPS6KA1;HIPK1;ACVR2A;CDC42BPB;MAST2;MAPK8;PLK2;SRPK3;ULK1;LIMK2;AURKA;ACVR1;SIK3;TSSK6;DYRK1A;TNIK;NEK6;SGK3;AKT2;BRD4;SLK;AURKC;MAP3K11;CDK2;MAPK11;MAPKAPK3;NUAK1;AKT3;IRAK4;STK38;MAP3K13;RIPK1;PIM1;SIK2;TRIO;MKNK2;RIPK2;TOP1;TGFBR2;EIF2AK4;UHMK1;MYLK;MAPK6;MAP3K20;NRBP1;ACVR2B;RIOK1;IRAK3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5983208960560329,-1.3135547221609774,0.15942028985507245,0.5477541176589804,1.0,6/10,23.23%,GABRG2;GABRA2;GABRG3;GABRA1;GABRA5;GABRA3
prerank,protein tyrosine kinase binding (GO:1990782),0.4745931760903531,1.313116251239903,0.10869565217391304,0.8243972637417902,1.0,20/71,15.41%,PTPN14;BMPR2;NEDD9;TJP2;PITPNM2;DOCK4;NCK1;GRB14;CEACAM1;DUSP22;ACVR1;PTPN1;CRK;CBL;GAS6;EPHA4;RACK1;CDH5;LRP4;ALKAL2
prerank,retinoid X receptor binding (GO:0046965),0.6391390315197794,1.3129996611138866,0.16569200779727095,0.8142194610976573,1.0,2/11,9.15%,TACC1;NRIP1
prerank,GTPase binding (GO:0051020),0.41849533306472375,1.3127581027315636,0.06053550640279395,0.8045953884097848,1.0,53/194,16.13%,FGD5;FNBP1L;UNC13B;CAV1;LCP1;SPTBN1;EPS8;TBC1D30;RASIP1;RIN3;SH3BP4;IQGAP1;FGD6;ARHGEF2;SRGAP2;GNB1;DOCK4;SGSM1;PAK2;EXPH5;PKN1;BICDL1;NCKAP1;MYCBP2;ULK1;IARS1;RUSC2;RASA1;GCC2;EXOC5;YBX3;EXOC4;CYRIB;OCRL;MYO1C;ANKFY1;BNIP3;CYFIP1;PICALM;CCDC186;RILP;RABGAP1L;EXOC8;EVI5;AIMP1;TNPO3;ERC1;STRN3;YBX1;RAPGEF6;RAB3GAP2;ABCA1;RIC1
prerank,anion:anion antiporter activity (GO:0015301),-0.5303148204474168,-1.3122303445000147,0.13679245283018868,0.5431331551780515,1.0,7/17,18.45%,SLC26A7;SLC26A2;SLC4A3;SLC4A2;SLC26A6;SLC19A1;SLC25A4
prerank,double-stranded DNA binding (GO:0003690),0.3881380126805573,1.3096254964100573,0.011305241521068859,0.806664047784644,1.0,74/531,11.49%,ERG;LEF1;ELK3;FLI1;LHX6;PBX1;TBX1;ESR1;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;ELF2;AIM2;NR3C1;PKNOX2;TGIF1;PITX1;TCF12;SOX18;HMBOX1;MAFF;SOX9;KLF2;ELK4;FOXQ1;XBP1;MBNL2;FOXL2;TCF7L1;TCF4;HOXA10;PITX3;TEAD2;ESRRG;KLF10;JUNB;NR1I3;FOXA3;ELF5;FOSL1;ETS2;KLF13;SPDEF;FOXN2;HOXD1;HOXD8;GMEB2;BACH2;NEUROD1;CREM;NRL;CREB1;FOXK1;CGAS;EGR3;SOX4;CREB3L4;SMAD5;NFIB;SP2;USF2;TFAP4;KLF12;CEBPD;ATF6;ZMYND11;SP3
prerank,phosphatase activator activity (GO:0019211),0.6104680916652863,1.309476138296427,0.18518518518518517,0.7971764514821197,1.0,9/14,26.71%,PPP2R5A;PPP2R5E;PPP2R5B;CALM1;FRS2;PHACTR4;B3GAT3;CALM3;PPP2R5C
prerank,"DNA binding, bending (GO:0008301)",0.6278386266501764,1.3068349461280908,0.18956521739130436,0.7978024925696933,1.0,2/14,2.28%,LEF1;HHEX
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.6105936953732792,1.3028264158640823,0.20035460992907803,0.8038617792537632,1.0,3/13,7.54%,PIP5K1B;PIK3C2A;PIK3CG
prerank,general transcription initiation factor binding (GO:0140296),0.5499407468825058,1.3020433476553117,0.16134453781512606,0.7968800945764316,1.0,7/25,12.86%,ESR1;AHR;HHEX;TAF1B;YEATS2;RELA;GTF2A2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.38424911252870714,1.3007318649796644,0.012244897959183673,0.7923812682997033,1.0,84/597,11.55%,ERG;LEF1;ELK3;FLI1;LHX6;PBX1;TBX1;ESR1;SMARCA2;PPARD;MEF2C;SOX7;NR5A2;AHR;ZIC3;NFATC1;IRF2;FOXP1;GATA2;ELF2;SOX13;HHEX;STAT3;TAL1;NR3C1;PKNOX2;SOX17;TGIF1;PITX1;TCF12;SOX18;HMBOX1;MAFF;SOX9;KLF2;ELK4;FOXQ1;XBP1;MBNL2;FOXL2;TCF7L1;TCF7L2;TCF4;HOXA10;PITX3;TEAD2;ESRRG;KLF10;ATMIN;JUNB;NR1I3;FOXA3;ELF5;FOSL1;ETS2;KLF13;MCM10;SPDEF;FOXN2;HOXD1;HOXD8;NFKB1;GMEB2;BACH2;POLA1;NEUROD1;CREM;NRL;CREB1;FOXK1;EGR3;SOX4;CREB3L4;SMAD5;NFIB;SP2;USF2;GABPB1;TFAP4;KLF12;CEBPD;ATF6;SP3;MCM9
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6443173973631747,1.2989805619299966,0.20733944954128442,0.7895301196395149,1.0,1/10,0.09%,SHANK3
prerank,nuclear receptor binding (GO:0016922),0.43474862998101665,1.29840462029982,0.09702457956015524,0.7823813964631243,1.0,22/111,11.99%,LEF1;TACC1;ESR1;FOXP1;HIF1A;KDM3A;ACTN4;DDX54;NCOA1;PKN1;TCF7L2;TRIM68;JMJD1C;KDM4C;ARID1A;NRIP1;CNOT1;SMARCE1;MMS19;ASXL1;OASL;DCAF1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.588701887065897,-1.2929918755016365,0.17276422764227642,0.5880447814645844,1.0,3/10,9.44%,DSE;RENBP;DSEL
prerank,protein tyrosine kinase activity (GO:0004713),0.4346020563885167,1.2920559553458288,0.08751608751608751,0.7966004328177669,1.0,22/108,7.32%,TEK;FLT1;KDR;TIE1;EPHB4;INSR;PEAK1;LYN;PTK2B;YES1;FYN;SRMS;FLT4;LMTK2;JAK3;HIPK1;RET;DYRK1A;JAK1;BMX;LCK;PTK2
prerank,acid-thiol ligase activity (GO:0016878),-0.5368212057771551,-1.2876607933807807,0.14855875831485588,0.5941018015352756,1.0,4/13,14.68%,ACSL1;AASDH;ACSS2;AACS
prerank,inward rectifier potassium channel activity (GO:0005242),-0.47060769970294136,-1.286426044451138,0.14600550964187328,0.5886938724002956,1.0,9/24,18.12%,ABCC9;KCNJ2;KCNJ13;KCNJ10;KCNN2;KCNJ8;KCNJ15;KCNJ6;KCNN3
prerank,ligand-gated cation channel activity (GO:0099094),-0.3671453402445684,-1.2863484667058274,0.07380073800738007,0.5803194017902693,1.0,22/75,18.45%,GRIN3A;GRIA2;P2RX4;GRIA1;GRIA3;KCNJ2;KCNJ13;GRIK4;GRIA4;GRIN2A;GRIK2;GRIK5;GRIK1;KCNJ10;GRIN2D;KCNN2;CCDC51;KCNJ8;KCNJ15;KCNJ6;KCNN3;CHRNA7
prerank,guanyl ribonucleotide binding (GO:0032561),0.40203639997669255,1.2819219985050079,0.09261430246189918,0.8249489077707517,1.0,49/196,16.52%,RAB27A;TGM2;GCH1;INSR;PDE2A;GBP5;MFHAS1;GBP4;CNGB1;RAP1B;RHOJ;GBP7;RALB;RAC1;RAPGEF2;ARL4A;NRAS;KRAS;GNAT1;RAP1A;RAB2A;RHOBTB1;DYNC1LI1;RAB38;ARL5A;TUBE1;NUDT16;RAB12;ARL8B;NMUR2;DRG2;RNF112;RAB26;RAB11B;RHOB;RAB7A;RAB31;ATL1;GBP3;RAB5A;RAB5B;EIF2B2;RAB32;RAB18;RAB6A;GNAI3;RAB8B;RHOA;RHEB
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3831213817008853,1.2797089319636528,0.03628601921024546,0.8242472514735886,1.0,87/431,13.49%,RPS6KA5;RAB27A;TGM2;SNRK;ERN1;ACVRL1;CDK6;GCH1;INSR;DAPK1;MYH9;PEAK1;PRAG1;GBP5;MFHAS1;GBP4;MAP4K3;SIK1;RAP1B;STK3;RHOJ;STK4;GBP7;LMTK2;RALB;SYN3;CDC42BPB;MAST2;MTHFD1L;ATP1A3;ATP1A1;TAP2;ACVR1;RAC1;SIK3;TSSK6;ARL4A;NRAS;KRAS;STK26;MLKL;MTREX;GNAT1;NEK6;RAP1A;RAB2A;RHOBTB1;TRIP13;DYNC1LI1;PXK;RAB38;HASPIN;AKT2;ARL5A;ABCD4;SMARCA5;TUBE1;NUDT16;ARL8B;PSMA6;NMUR2;ATP7B;TWF2;AKT3;DRG2;STK38;RNF112;LONP1;PIM1;SIK2;RAB26;ABCD1;MKNK2;RAB11B;RHOB;ABCG1;TOP1;RAB7A;TRIB1;RAB31;ATL1;GBP3;RAB5A;HSP90AB1;PFKL;UHMK1;MTPAP
prerank,protein phosphorylated amino acid binding (GO:0045309),0.4959709874191199,1.2789478843197166,0.17734724292101342,0.8179019967381389,1.0,11/42,11.17%,SHE;YES1;FBXW7;PLCG2;BCAR3;LCK;RASA1;NEDD4;SAMSN1;CRK;ABL2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3757156333767584,1.2748176604372683,0.013131313131313131,0.8240903387894459,1.0,98/732,10.52%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;AHR;SMAD1;ZIC3;LRRFIP1;NFATC1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;STAT3;TAL1;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;PKNOX2;SOX17;TGIF1;PITX1;TCF12;SOX18;MAFF;FOSL2;SOX9;KDM6A;FOXF1;KLF2;ELK4;FOXQ1;XBP1;SP6;ZFP92;FOXL2;TCF7L1;TCF7L2;TCF4;FOXF2;HOXA10;H3-3A;PITX3;TEAD2;ESRRG;KLF10;JUNB;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;LYL1;KLF13;FOXN2;TCF3;HOXD1;NFKB1;GMEB2;BACH2;NEUROD1;CREM;NRL;ZNF2;CREB1;FOXK1;BACH1;MAFB;CHD2;RELB;NRIP1;EGR3;SOX4;CREB3L4;SMAD5;NFIB;POU2F1;SKIL;FOXN3;SP2;USF2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5134795954030198,-1.274520583765712,0.2,0.603753407228933,1.0,7/16,17.53%,SLC26A7;SLC26A2;SLC26A6;SLC1A1;CLCN7;CFTR;SLC4A8
prerank,GDP binding (GO:0019003),0.46757773257789537,1.2723001996902685,0.16022889842632332,0.8247374876858935,1.0,20/63,16.52%,RAB27A;RAP1B;RALB;NRAS;KRAS;GNAT1;RAP1A;RAB2A;DYNC1LI1;RAB12;ARL8B;RAB11B;RAB7A;RAB31;RAB5A;RAB5B;RAB18;GNAI3;RAB8B;RHEB
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.37515269800842166,1.2722665820960604,0.012133468149646108,0.8159440725864661,1.0,98/731,10.52%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;AHR;SMAD1;ZIC3;LRRFIP1;NFATC1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;STAT3;TAL1;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;PKNOX2;SOX17;TGIF1;PITX1;TCF12;SOX18;MAFF;FOSL2;SOX9;KDM6A;FOXF1;KLF2;ELK4;FOXQ1;XBP1;SP6;ZFP92;FOXL2;TCF7L1;TCF7L2;TCF4;FOXF2;HOXA10;H3-3A;PITX3;TEAD2;ESRRG;KLF10;JUNB;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;LYL1;KLF13;TCF3;HOXD1;NFKB1;GMEB2;BACH2;NEUROD1;CREM;NRL;ZNF2;CREB1;TRIM24;FOXK1;BACH1;MAFB;CHD2;RELB;NRIP1;EGR3;SOX4;TCF15;CREB3L4;SMAD5;NFIB;POU2F1;SKIL;SP2;USF2
prerank,ribonuclease activity (GO:0004540),0.45858632001186544,1.2707281317931758,0.14206128133704735,0.8130835517154374,1.0,14/56,14.58%,ERN1;SAMHD1;CNOT6;N4BP1;RNASE1;RNASEH2A;ANG;RNASE4;KHNYN;DICER1;EXOSC1;INTS11;CNOT7;ZC3H12C
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.6312896430924058,1.2707000747891333,0.22452830188679246,0.8045770322495542,1.0,7/11,16.32%,DAB2IP;SASH1;TCF3;MAP3K11;STK38;TRAF6;MAP4K2
prerank,frizzled binding (GO:0005109),-0.43634962566815316,-1.2685112603448079,0.15406162464985995,0.6121026957409562,1.0,13/34,17.33%,WNT4;RNF43;WNT6;WNT9A;RYK;LRP6;SFRP1;FZD1;WNT16;FZD7;WNT11;DVL1;MYOC
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5041401126175981,1.2654202308491564,0.17257318952234207,0.8150703329202257,1.0,12/35,16.45%,FOXP1;NR3C1;H3-3A;KLF10;TAF1B;RRN3;POU2F1;SNAPC3;RELA;NPM1;PIH1D1;STAT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4663194882129049,1.2641220601372216,0.16374269005847952,0.8111097395213257,1.0,14/54,15.52%,HDAC9;ACER2;TGM2;GLS2;GLS;ASAH2;SIRT5;PM20D2;HINT1;MIER1;SIRT6;ACR;ASAH1;FAAH
prerank,E-box binding (GO:0070888),0.5009742701351156,1.262370930225111,0.19538461538461538,0.8085368768385108,1.0,8/34,12.27%,AHR;TAL1;TCF4;TCF3;NEUROD1;TCF15;TFAP4;MAX
prerank,transcription coactivator binding (GO:0001223),0.5501509420015321,1.2601536137595095,0.19652173913043477,0.8079715860867095,1.0,6/20,9.29%,ESR1;PPARD;AHR;VGLL4;TEAD2;RPL23
prerank,protein phosphatase 1 binding (GO:0008157),0.542297204813075,1.2578913974435544,0.2155887230514096,0.8079735918250758,1.0,4/21,8.50%,PPP1R16B;KCNQ1;PPP1R9B;SHOC2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5248178836182943,1.2577346446693456,0.18788819875776397,0.8006423003556079,1.0,10/30,16.88%,RPS6KA3;RPS6KA1;XIAP;SERPINB9;GAS6;BIRC3;CARD16;TNFAIP8;CAST;BIRC2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.47271268401909505,-1.2502303762303002,0.19239904988123516,0.6564955339373175,1.0,10/20,28.65%,KMT5A;EHMT2;SETD4;VCPKMT;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;EEF1AKMT3;SETD7
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.40806932255995404,-1.2495474266209743,0.15384615384615385,0.6494720219651319,1.0,8/38,10.28%,SERPING1;TFPI;SERPINH1;SERPINE2;SERPIND1;ANXA2;SERPINF1;SERPINE1
prerank,LRR domain binding (GO:0030275),-0.5271786364303629,-1.2459638727731428,0.19196428571428573,0.650668400920679,1.0,5/14,12.83%,ROBO1;PAWR;LRRFIP2;PMF1;ZXDC
prerank,nucleoside-triphosphatase activity (GO:0017111),0.38349870582589507,1.2442713239858185,0.10372040586245772,0.8401474639815845,1.0,60/248,17.93%,DNM3;RAB27A;GNAQ;GCH1;MYH9;RAB11A;GBP5;GBP4;RASD2;GNB1;RAP1B;KIF26A;GPN3;RHOJ;GBP7;RALB;SMCHD1;GNAI2;ABCA3;RAC1;NRAS;KRAS;GNAT1;RAP1A;RAB2A;RHOBTB1;GNA12;MYO1E;RAB38;ARL8B;DRG2;RNF112;MYL6B;ABCD1;HBS1L;RAB43;RAB11B;RHOB;GNA13;RAB7A;RAB31;ATL1;GBP3;RAB5A;TOR3A;RAB5B;NKIRAS1;RAB32;RAB18;RAB6A;GNAI3;IRGM;RAB8B;RHOA;RHEB;MFN1;RHOT1;RAB1A;EEF2;RND1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.5656706648938162,-1.243473633643182,0.2325056433408578,0.6490013049968206,1.0,1/10,0.53%,DPYSL3
prerank,carbohydrate kinase activity (GO:0019200),-0.5727946987517498,-1.242457224475885,0.2025862068965517,0.6437351104744407,1.0,4/11,16.74%,GALK2;NAGK;HK2;GALK1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.6079778885074687,1.239375498598563,0.2571428571428571,0.8499582136108405,1.0,4/11,14.97%,SGMS1;DPAGT1;GNPTAB;PIGF
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.36258369559603926,1.2389860612206787,0.017119838872104734,0.8432747992169265,1.0,105/831,10.52%,MECOM;DACH2;ERG;LEF1;ELK3;FOXO1;LHX6;EPAS1;TEAD4;DACH1;PBX1;TBX1;ESR1;PPARD;MEF2C;ZBTB16;SOX7;NR5A2;ETV6;SMAD1;ZIC3;LRRFIP1;NFATC1;NLRC5;IRF2;FOXP1;GATA2;SOX13;HHEX;STAT3;TAL1;NR3C1;HIF1A;EBF1;KLF7;RREB1;KLF8;PKNOX2;SOX17;TGIF1;PITX1;ACTN4;ZFP57;TCF12;SOX18;MAFF;FOSL2;SOX9;ZBTB46;KDM6A;FOXF1;KLF2;ELK4;FOXQ1;XBP1;SP6;ZFP92;FOXL2;TCF7L1;TCF7L2;TCF4;FOXF2;HOXA10;H3-3A;PITX3;TEAD2;ESRRG;KLF10;JUNB;NR1I3;FOXA3;FOSL1;HNF1B;ETS2;ASCL4;LYL1;KLF13;TCF3;HOXD1;HOXD8;NFKB1;GMEB2;BACH2;NEUROD1;CREM;NRL;ZNF2;CREB1;FOXK1;BACH1;MAFB;CHD2;RELB;NRIP1;EGR3;SOX4;TCF15;CREB3L4;ZBTB10;SMAD5;NFIB;POU2F1;SKIL;SP2;USF2
prerank,GABA-A receptor activity (GO:0004890),-0.47506709976796024,-1.2330048080618312,0.17312072892938496,0.6621920577723835,1.0,8/18,23.23%,GABRG2;GABRA2;GABRB1;GABRG3;GABRB3;GABRA1;GABRA5;GABRA3
prerank,cytokine activity (GO:0005125),-0.32309016131459234,-1.232772103268061,0.10695187165775401,0.6544465297559984,1.0,23/131,14.54%,BMP6;IL34;WNT4;BMP5;BMP7;IL18;WNT6;BMP4;FGF2;CXCL16;WNT9A;IL16;TNFRSF11B;VEGFA;INHBA;CXCL12;TGFB3;TGFB2;WNT16;GDF11;GDF1;IL17D;WNT11
prerank,nucleotide diphosphatase activity (GO:0004551),-0.525004437056948,-1.2303205322628872,0.20361990950226244,0.6522325854185157,1.0,3/14,2.94%,ENPP1;FHIT;NUDT4
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4205684892677958,1.228130781290766,0.15552699228791775,0.8734348748852052,1.0,19/85,16.22%,PLA2G4A;ABHD2;PGAP1;LIPE;BCHE;ENPP2;PLA2G2D;CA1;LPL;PON2;PLAAT3;PTRH1;GDPD1;PNPLA2;PNPLA6;FAAH;NDST3;CA2;ESD
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5989804913720644,1.2234730002409047,0.23177570093457944,0.8818952496126953,1.0,2/10,1.67%,SLCO2B1;SLCO2A1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5466023044248028,-1.2219468210954774,0.20919540229885059,0.6684205764841927,1.0,2/11,6.08%,SLC22A4;SLC25A47
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4716614498641709,1.2200129466378364,0.19402985074626866,0.8864952121393797,1.0,1/44,0.03%,MECOM
prerank,potassium channel regulator activity (GO:0015459),-0.3806905050811508,-1.219501381267167,0.1503267973856209,0.6673144745651869,1.0,14/49,15.93%,KCNIP3;KCNIP4;WNK4;ABCC9;DLG1;SLC5A3;KCNMB2;KCNS3;DPP6;KCNAB1;WNK1;WNK3;DPP10;LRRC38
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5608275696866651,1.2153982405238144,0.2585278276481149,0.8949537732375183,1.0,7/14,17.84%,MINDY1;MINDY2;USP15;ATXN3;YOD1;DESI2;USP7
prerank,protein tyrosine phosphatase activity (GO:0004725),0.43305830799434336,1.2147306372602522,0.1871584699453552,0.8893482558730786,1.0,10/71,6.15%,PTPRB;PTPRG;PTPN14;PTPRM;PTPN12;PTPRJ;PTP4A2;PTPRK;MTMR6;DUSP22
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.5545498943393675,1.212319815973806,0.26860254083484575,0.8892601505951179,1.0,2/16,3.25%,CD38;BST1
prerank,chemorepellent activity (GO:0045499),0.4941776271068441,1.198616819942149,0.25967741935483873,0.9299427045057166,1.0,3/25,1.70%,SEMA6A;SEMA5B;SEMA7A
prerank,SUMO transferase activity (GO:0019789),-0.47949090137903405,-1.195988972919868,0.23725055432372505,0.7276113341956836,1.0,6/16,18.91%,HDAC4;MDM2;PIAS3;PIAS1;TRIM28;CBX4
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.428145343511279,-1.1950337932607251,0.22340425531914893,0.721416383386698,1.0,11/27,20.63%,SLC8A3;SLC41A1;SLC9A9;SLC8A1;SLC9A1;SLC9B2;CNNM4;SLC8A2;SLC4A8;SLC8B1;SLC9A8
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.43906330360030255,1.1920419657689756,0.21288515406162464,0.9455653275550917,1.0,10/60,5.73%,NRP2;TEK;FLT1;KDR;TIE1;EPHB4;INSR;FLT4;LMTK2;RET
prerank,DNA-binding transcription factor binding (GO:0140297),0.38307389489662874,1.1919376586413346,0.15519253208868145,0.9375577269585293,1.0,32/189,12.24%,HDAC9;LDB2;PPARD;MEF2C;LMO2;CRTC1;NFATC1;HHEX;STAT3;TAL1;HDAC7;TLE4;SIK1;PITX1;TCF12;GTF2I;TCF7L2;EIF4E;FBP1;TCF3;NEK6;CTBP1;NEUROD1;CREM;CREB1;ZFPM1;MAD2L2;USF2;SPEN;RB1;MIER1;RELA
prerank,alpha-actinin binding (GO:0051393),-0.44186453192493597,-1.1912185707241423,0.2175,0.7238211210224015,1.0,5/24,4.28%,CACNA1C;CACNA1D;DAG1;PALLD;PDLIM7
prerank,manganese ion binding (GO:0030145),-0.3762495759720568,-1.1900954779554433,0.16326530612244897,0.7183007422796907,1.0,8/48,9.01%,MPPED2;ADCY2;LARGE1;ME1;FAM20C;NEK4;PPM1M;TDP2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.6002460048701442,1.188958953298445,0.3045774647887324,0.9402547817755432,1.0,3/10,10.80%,ANKRD13A;USP15;FAN1
prerank,kinase binding (GO:0019900),0.35630870745940907,1.1871717810935432,0.10805084745762712,0.9382687978667702,1.0,95/434,14.67%,FRMD5;CAV1;ESR1;UTRN;SLC12A7;PDE8A;ACVRL1;SMAD1;PLCG1;PPP2R5A;IQGAP1;DAB2IP;STAT3;ADAM10;FAS;NR3C1;HDAC7;MSN;TRIM14;HIF1A;PTPRJ;SIK1;CCNK;TTC28;PLCG2;PPP1R12A;CAV2;PAK2;RPS19;PIK3IP1;IKBKB;GHR;CEACAM1;PTPRK;TCF7L2;TRIM68;ATP1A4;LRBA;AURKA;IFNAR2;RAC1;RPS7;SKAP1;SASH1;TRIB3;CDKN1B;BCAR3;GNAT1;HNRNPA0;LCK;PTK2;AP2A1;STX1A;NEK6;CASP1;GRB7;TRPV4;RHOBTB1;RPTOR;POLA1;WWC2;LLGL1;ARHGEF7;PTPN1;RELB;RICTOR;CRK;MAP2K3;BCL2L1;RAD23A;PRKAB1;BTG1;IRAK4;MAP3K13;RB1;CARD16;PEBP1;RELA;GSKIP;WARS1;RHOB;CEP68;ZFP36;MYH6;ADIPOR1;HSP90AB1;PFKL;CDC25C;LRRC14;RPS6;NPM1;TRAF6;BCL2L14;APC;IRAK3
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5240138220470602,-1.1855459774691826,0.255863539445629,0.7225787719444472,1.0,2/11,2.61%,EGFR;MAP3K5
prerank,metalloaminopeptidase activity (GO:0070006),-0.48407492192400553,-1.1844686547648453,0.24129930394431554,0.7170011540457324,1.0,4/16,7.50%,MMP14;MMP16;NPEPPS;ENPEP
prerank,acylglycerol lipase activity (GO:0047372),0.5795800967150373,1.1842500964570362,0.27787934186471663,0.9409988115145668,1.0,2/11,3.91%,ABHD2;LIPE
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4019456066526302,1.1836392608624593,0.21204188481675393,0.9350096541417595,1.0,19/100,12.40%,CERT1;PLA2G4A;ARAP3;PARD3;HIP1;HIP1R;IQGAP1;DAB2IP;DENND1B;TECPR1;PLEKHA5;SNX3;PLEKHA8;SNX24;ARAP2;ANKFY1;CYTH3;KIF16B;SNX11
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5351839695704796,1.1822345790942042,0.28264462809917357,0.9319827347502214,1.0,6/18,14.75%,SOCS2;PIK3R6;CISH;SLA2;SOCS4;SOCS6
prerank,protein homodimerization activity (GO:0042803),0.34994975817813295,1.1813174612941102,0.09034907597535935,0.927621717184114,1.0,107/589,13.49%,ABCG2;PECAM1;NOD1;ZHX3;ST6GAL1;TBX1;CADM1;RBPMS;ZBTB16;ERN1;F11R;GCH1;B2M;AHR;RASIP1;LRRFIP1;PDGFB;MYH9;HIP1;HIP1R;IL6R;DAB2IP;FZD4;HHEX;PDE2A;STAT3;ADAM10;GBP5;TPST2;GBP4;SRGAP2;STK10;TRIM14;TPD52;KLHL7;TPD52L1;ACTN4;TBC1D22A;FLT4;CAV2;ABCB7;ACTN1;CAT;SPPL2A;STK4;SMCHD1;IKBKB;MAP3K9;GHR;CEACAM1;GREM1;TRIM68;MTHFD1L;BOK;CCDC88A;DROSHA;ACVR1;MID2;EEA1;TOX3;SH3GLB1;SYNE1;STK26;PDGFC;LPL;TCF3;PKD2;CITED1;GSTA4;CHMP4A;CHMP4B;ANG;SLK;MAP3K11;CSF1;NUDT16;CEP57;DEFA6;IKBKG;IZUMO1;BCL2L1;CYP2R1;GGCT;INPP5F;USF2;SCARB2;TFAP4;MKLN1;BNIP3;CLN6;MAP3K13;RIPK1;ABCD1;RELA;XDH;NECTIN1;WARS1;MID1;RIPK2;RACK1;ABCG1;GTF2A2;FMR1;GBP3;HSP90AB1;AOC1;MTPAP
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5574994139210596,1.1780027530680233,0.3016453382084095,0.931623601346516,1.0,4/12,16.45%,TRAF1;BABAM2;TRAF6;STAT1
prerank,ATP binding (GO:0005524),0.3634716239502143,1.174407209801392,0.17206703910614526,0.936740900900846,1.0,59/266,15.84%,RPS6KA5;SNRK;ERN1;ACVRL1;CDK6;INSR;DAPK1;MYH9;PEAK1;PRAG1;MAP4K3;SIK1;STK3;STK4;LMTK2;SYN3;CDC42BPB;MAST2;MTHFD1L;ATP1A3;ATP1A1;TAP2;ACVR1;SIK3;TSSK6;STK26;MLKL;MTREX;NEK6;TRIP13;PXK;HASPIN;AKT2;ABCD4;SMARCA5;ATP7B;TWF2;AKT3;STK38;LONP1;PIM1;SIK2;ABCD1;MKNK2;ABCG1;TOP1;TRIB1;HSP90AB1;PFKL;UHMK1;MTPAP;EIF2B2;MAP3K20;IRAK3;PMVK;PNPLA8;RPS6KA4;PANK3;ABCA1
prerank,phosphotyrosine residue binding (GO:0001784),0.46078555239290375,1.1741448585477638,0.2623688155922039,0.9300636753232215,1.0,9/37,11.17%,SHE;YES1;PLCG2;BCAR3;LCK;RASA1;SAMSN1;CRK;ABL2
prerank,voltage-gated cation channel activity (GO:0022843),-0.32315059828201154,-1.173629130883274,0.1801470588235294,0.7416820450152048,1.0,18/97,10.93%,CACNA1C;CACNA2D3;CACNA2D1;KCNB2;CACNA1D;GRIN3A;KCNMA1;KCNQ3;KCND2;KCND3;CACNB2;ITGAV;KCNC2;KCNS3;KCNQ4;CACNB1;KCNQ5;GRIN2A
prerank,G protein-coupled receptor activity (GO:0004930),0.36717626323101504,1.1726973616433318,0.1871476888387824,0.9274260251148773,1.0,15/239,6.59%,ADGRG6;ADGRL4;CALCRL;CYSLTR1;ADGRL2;NPR1;S1PR1;ADGRG3;ADGRE5;ADGRG1;ADRB1;CX3CR1;HCRTR1;MCHR1;OPN4
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.46565519765527896,1.1703667619052625,0.2674050632911392,0.9281697441427539,1.0,15/34,22.63%,CNOT6;PAN3;CNOT6L;ISG20;ANGEL2;CNOT1;REXO2;CNOT2;CNOT7;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.37396222086962155,1.1691157609464704,0.17511520737327188,0.9252717388299686,1.0,18/188,6.54%,FLI1;PBX1;SMARCA2;MEF2C;SOX7;NR5A2;AHR;SOX13;HHEX;STAT3;TAL1;SOX17;TCF12;SOX18;LIN54;TCF7L2;ATMIN;FOXA3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.4479572845447766,1.1669762320843204,0.2722063037249284,0.9253352175839207,1.0,12/49,10.07%,MINDY1;BABAM2;RNF169;MINDY2;UBL7;BRCC3;ZRANB1;TNIP1;IKBKG;RAD23A;ZFAND2B;RAD18
prerank,DNA binding (GO:0003677),0.3453709275401451,1.165210944654177,0.0942622950819672,0.9244361267478054,1.0,111/694,14.73%,MECOM;ERG;LEF1;FLI1;FOXO1;EPAS1;PBX1;TBX1;SMARCA2;APP;PPARD;TSHZ2;ZBTB16;NR5A2;AHR;ZIC3;LRRFIP1;IRF2;SOX13;HHEX;STAT3;AIM2;SAMHD1;HIF1A;ARID3B;TSHZ1;RPS15;HMBOX1;MAFF;SOX9;ZNF292;FOXF1;KLF2;ELK4;XBP1;FOXL2;TCF7L1;TCF7L2;TCF4;FOXF2;MTF2;LIN9;CNBP;JUNB;ETS2;LYL1;RPA1;MCM10;SPDEF;TCF3;ARID1A;POLA1;NEUROD1;CREM;NRL;CDT1;EZH1;TAF4B;SUB1;SMARCA5;BRIP1;MAFB;ANG;CHD2;MYBBP1A;CGAS;RAD51D;APLP2;RNF4;RAD23A;RAD18;MEIOB;NFIB;POU2F1;GLYR1;USF2;FAN1;TFAP4;KLF12;CSRNP1;CBFB;RPS27;SNAPC3;ATF6;ZMYND11;PRDM2;MCM9;UNG;OASL;LONP1;RELA;MAX;RPL6;WDR76;MPG;ERCC4;TOP1;SLTM;IMPDH1;ZBTB6;ACR;ESRRB;MEF2A;YY1;TOPORS;RYBP;ZNF496;ZNF423;ENDOV;MBD5;ARID5B
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.45470241384349297,1.1647580215035285,0.27205882352941174,0.9185868817494725,1.0,11/38,15.34%,PLA2G4A;PARD3;HIP1;DAB2IP;TECPR1;PLEKHA5;SNX3;KIF16B;SNX13;ATG2A;ATG2B
prerank,hexosyltransferase activity (GO:0016758),0.3965804171404934,1.164599346826012,0.24903225806451612,0.912066375366313,1.0,13/101,8.89%,CSGALNACT1;TMTC2;LFNG;MGAT4A;GBE1;MFNG;B3GNT3;B4GALT4;B3GNT4;MTAP;B4GALT5;B3GNT6;B4GAT1
prerank,transcription corepressor binding (GO:0001222),0.48131382652463506,1.1644157062994023,0.2875816993464052,0.9057531057496503,1.0,9/27,17.58%,ESR1;ZBTB16;MTF2;NEK6;CTBP1;CNOT2;FAM89B;EHMT1;LCOR
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4219072457555217,1.164238599870761,0.2386206896551724,0.8993998010977957,1.0,12/60,6.15%,TEK;FLT1;KDR;TIE1;EPHB4;ACVRL1;INSR;FLT4;LMTK2;ACVR2A;RET;ACVR1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.4412594743053182,-1.1634837613268543,0.2729528535980149,0.7638008119436113,1.0,5/21,18.45%,GRM5;GRIA1;GRM1;CHRFAM7A;CHRNA7
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5117212368450624,-1.1619200337074336,0.2801724137931034,0.759938115908281,1.0,3/11,4.77%,KCNK2;KCND2;KCND3
prerank,zinc ion binding (GO:0008270),0.35608360531309013,1.161135631379528,0.17965367965367965,0.902725173682516,1.0,63/293,17.88%,MYRIP;SHANK3;TNFSF10;RNF125;GCH1;MSRB3;ARHGEF2;PDE2A;GDA;SAMHD1;KLF7;TES;TET3;ENPP2;MYCBP2;PAM;ASAH2;EEA1;ADAMDEC1;SIRT5;KDM4C;ERAP1;PRIMPOL;ZNF2;TRIM24;PGGT1B;PTPN1;AFM;SIAH1;RC3H1;RPS27;ZMYND11;PRDM2;PITRM1;ADH1A;RNF112;TET2;SORD;SIRT6;TMEM163;AOC1;ACR;IFIH1;RPS29;S100A9;ARIH2;MSRB2;KAT6A;RNF5;ACE;ZFPL1;CA2;CHORDC1;TAB3;BIRC2;ZNF8;KDM5C;LITAF;KDM4A;APIP;PHF5A;NQO2;PLSCR1
prerank,ion channel inhibitor activity (GO:0008200),0.4664503298155274,1.1596565661090343,0.30141287284144425,0.9009542235808269,1.0,10/35,12.80%,NEDD4L;FKBP1A;STX7;RASA1;STX1A;NEDD4;MCUB;VAMP8;STX8;RACK1
prerank,Tat protein binding (GO:0030957),0.5801380956002702,1.1590983891973357,0.3026315789473684,0.8959940878595587,1.0,5/10,16.14%,DLL1;DNAJA1;GABARAPL1;NPM1;CTDP1
prerank,solute:sodium symporter activity (GO:0015370),-0.40976113320334107,-1.1557615051643348,0.271505376344086,0.7703756182883598,1.0,6/27,17.53%,SLC4A10;SLC5A3;SLC20A1;SLC5A6;SLC5A11;SLC4A8
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5230993296570174,-1.1528870274934833,0.3086680761099366,0.770407130511766,1.0,4/10,13.16%,B3GALT1;B4GALT6;B3GALT5;B4GALT7
prerank,cholesterol transfer activity (GO:0120020),0.5212961209246079,1.1522742997122783,0.3304647160068847,0.9125969164867319,1.0,2/16,3.04%,PLTP;STARD5
prerank,endopeptidase activity (GO:0004175),-0.2783197986004917,-1.1495817868317868,0.07017543859649122,0.7711970315388839,1.0,59/257,19.58%,TRABD2B;ADAMTS12;THSD4;ADAMTS2;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS10;ADAMTS5;F3;RHBDL3;DPP4;HTRA3;PCSK5;ADAMTSL1;FAP;ADAMTS17;ADAMTSL4;MMP14;MMP16;USP11;USP24;ADAMTS15;TASP1;ADAM19;ADAMTS1;ADAM33;KLK2;USP13;PLAT;RHBDF1;SFRP1;USP49;MMP2;USP33;ADAMTS14;USP10;ADAM9;KDM8;MMP11;PCSK6;CTSZ;MMP19;HTRA4;USP47;PREP;USP14;USP2;ADAMTSL2;TPP1;CTSL;ACE2;UCHL1;PSMB6;CLPP;HTRA2;PDIA3;BACE1;USP28
prerank,sterol transfer activity (GO:0120015),0.5161184866364071,1.1478277552508096,0.3310225303292894,0.9212391711685733,1.0,2/17,3.04%,PLTP;STARD5
prerank,protein phosphatase regulator activity (GO:0019888),0.425636377707813,1.1475170823651466,0.260806916426513,0.9154496620606167,1.0,20/53,20.45%,PPP1R16B;PPP2R5A;PPP1R2;PPP1R9B;LMTK2;PPP2R2C;PPP2R5E;SHOC2;PPP2R5B;MGAT5;PPP2R2D;PPP2R3A;RCAN1;PPP1R7;CALM1;PPP2R2A;EIF2AK2;PPP4R1;PPP2R1A;PPP2R1B
prerank,hormone receptor binding (GO:0051427),0.53414883682325,1.1474446209562037,0.30594405594405594,0.9090246092503795,1.0,2/14,6.74%,SOCS2;JAK1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.542674613051539,1.1469631033278216,0.32616487455197135,0.9040705515512403,1.0,3/12,8.92%,CDK6;CCNK;BRD4
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.35821552167465104,-1.1463775248723242,0.22108843537414966,0.7724161393960125,1.0,12/55,8.91%,SLC24A3;CACNA1D;PKD1;MCU;CACNB2;TRPC3;ANXA2;ANXA6;TRPC1;ATP2A2;RYR2;SLC24A2
prerank,ubiquitin-specific protease binding (GO:1990381),-0.43653719955235526,-1.1440693908284931,0.25853658536585367,0.7712728687044907,1.0,3/19,7.10%,PRKN;SELENOS;AMFR
prerank,potassium channel activity (GO:0005267),-0.32091741091821263,-1.1428849060549793,0.18326693227091634,0.7665101123798083,1.0,22/89,14.18%,KCNK2;KCNB2;KCNK5;KCNMA1;KCNQ3;ABCC9;KCND2;KCND3;KCNC2;KCNMB2;KCNS3;KCNQ4;GRIK4;KCNQ5;TMEM38A;GRIK2;GRIK5;KCNA6;GRIK1;KCNT1;KCNN2;CCDC51
prerank,receptor ligand activity (GO:0048018),-0.2775253953871309,-1.1426462020242625,0.1282051282051282,0.7592530778173966,1.0,46/245,14.60%,BMP6;IGF1;IL34;EPHA7;SEMA3D;PTN;NBL1;EDA;WNT4;BMP5;FGF1;BMP7;IL18;DPP4;SEMA5A;WNT6;BMP4;GREM2;FGF2;WNT9A;IL16;TNFRSF11B;IGF2;NGF;JAG1;SEMA3B;NRG3;OSGIN2;SEMA3A;VEGFB;VEGFA;INHBA;TGFB3;TGFB2;WNT16;TAFA2;FGF7;SEMA6C;GDF11;SEMA4B;GDF1;HBEGF;IL17D;SEMA3G;WNT11;TAFA1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5621670131429556,1.142070355572892,0.3233644859813084,0.9132856010814953,1.0,1/11,3.16%,CNGB1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5053169986668162,-1.1395929323668141,0.31614349775784756,0.7597624963661572,1.0,5/11,12.87%,TRPC3;TRPC6;TRPC1;TRPC4;TRPC5
prerank,myosin binding (GO:0017022),0.42152237699231115,1.139009466406615,0.27393225331369664,0.9169621286515817,1.0,10/55,10.12%,MYRIP;SHROOM4;RAB11A;NKD2;SHROOM1;LMTK2;SPATA6;LLGL1;USH2A;CXCR4
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.46791178642614883,-1.1383221524702125,0.29603729603729606,0.7557587131827335,1.0,5/14,21.00%,NOX4;AIFM1;CYBB;NOX1;NCF2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5117224000484937,1.1381698620470901,0.33828382838283827,0.9132104888028773,1.0,5/18,6.15%,BMPR2;ENG;ACVRL1;ACVR2A;ACVR1
prerank,intracellular chloride channel activity (GO:0061778),0.5088645458653884,1.1359573560506104,0.3375224416517056,0.907821629512574,1.0,4/16,10.53%,ANO2;TTYH2;NMUR2;ANO6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.5088645458653884,1.1359573560506104,0.3375224416517056,0.907821629512574,1.0,4/16,10.53%,ANO2;TTYH2;NMUR2;ANO6
prerank,phosphate ion binding (GO:0042301),0.570457177453644,1.1349947922739934,0.33146067415730335,0.9046077839202893,1.0,4/10,19.92%,PDE2A;RELA;ADSS2;PNP
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.49346640320570606,1.1348896197633098,0.30247933884297523,0.8987722548937067,1.0,3/21,8.29%,POLK;POLA1;PRIMPOL
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.36476966063211314,1.1345924781418162,0.23167848699763594,0.8935699502095751,1.0,33/181,12.24%,LDB2;TACC1;PPARD;LMO2;NFATC1;STAT3;TAL1;HIF1A;NFKBIA;PITX1;ACTN4;GTF2I;NCOA1;DLL1;DTX3L;TCF7L2;FBP1;DNAJA1;TCF3;ARID1A;NEUROD1;CREB1;TAF4B;NRIP1;ZFPM1;PSMA6;MAD2L2;SMARCE1;SPEN;RB1;MIER1;GABARAPL1;RELA
prerank,dynactin binding (GO:0034452),-0.4866213694169521,-1.1302119659859748,0.32450331125827814,0.7703909531136537,1.0,5/12,13.69%,BICD1;SNX6;SNX5;HTT;BICD2
prerank,small GTPase binding (GO:0031267),0.36478542567491834,1.1299600275860036,0.2541966426858513,0.9025725071778129,1.0,43/169,16.13%,FGD5;UNC13B;CAV1;EPS8;TBC1D30;RIN3;SH3BP4;IQGAP1;FGD6;ARHGEF2;SRGAP2;DOCK4;SGSM1;PAK2;EXPH5;PKN1;BICDL1;NCKAP1;MYCBP2;ULK1;RUSC2;GCC2;EXOC5;YBX3;EXOC4;CYRIB;OCRL;MYO1C;ANKFY1;CYFIP1;PICALM;CCDC186;RILP;RABGAP1L;EXOC8;EVI5;TNPO3;ERC1;STRN3;RAPGEF6;RAB3GAP2;ABCA1;RIC1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3520341940688073,1.1281940462371511,0.23404255319148937,0.9019656012362742,1.0,73/254,19.94%,FOXO1;FZD6;FZD4;MFHAS1;FBXW7;HIF1A;TNFRSF1B;NFKBIA;NKD2;CASP8;PRKAR2B;TRAF1;TMBIM6;RALB;SMAD7;HERC2;CD40;PRR5L;TRIB3;JAK1;DNAJA1;ARRB1;ATXN3;UBE2G1;SNCAIP;ARRDC1;WRAP53;NEK6;RPL23;IKBKG;SPOPL;RAD18;SMAD5;CXCR4;SUMO2;MC1R;MC4R;CUL1;RB1;RIPK1;GABARAPL1;RELA;MID1;PA2G4;TRIB1;HSP90AB1;ASB4;NDUFS2;UBE2K;TXNIP;TRAF6;APC;UBXN1;BAG4;RPL11;CHEK2;NEDD8;BAG1;KDM4A;CUL3;YOD1;RNF40;USP7;PRKACB;SMAD2;USP25;CUL2;TSG101;UBE2L3;BCL10;NLK;GPI;UQCRC1
prerank,store-operated calcium channel activity (GO:0015279),-0.5138035416219864,-1.126691431285419,0.33488372093023255,0.7719578655621818,1.0,6/10,13.62%,TRPC3;TRPC6;TRPC1;TRPC4;TRPC5;ORAI2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.47010761563970344,-1.126604128393033,0.3292079207920792,0.7646053209092143,1.0,8/15,10.33%,HS3ST3A1;HS6ST3;HS3ST3B1;HS2ST1;HS3ST4;HS6ST2;HS6ST1;HS3ST5
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5481899765831939,1.1262484800790744,0.36589698046181174,0.9019624916687399,1.0,5/12,18.19%,PIK3C2A;PIK3R6;PIK3CG;IPMK;PIK3C2B
prerank,solute:proton symporter activity (GO:0015295),0.5168900623926296,1.1232890679563843,0.33570159857904086,0.9052930003013868,1.0,4/16,9.38%,SLC39A8;SLC2A9;SLC15A2;SLC15A1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3478476987404388,1.1216940593099063,0.23314917127071824,0.9041902863851974,1.0,77/269,19.94%,FOXO1;FZD6;FZD4;MFHAS1;FBXW7;HIF1A;TNFRSF1B;NFKBIA;NKD2;CASP8;PRKAR2B;TRAF1;TMBIM6;RALB;DTX3L;SMAD7;HERC2;CD40;PRR5L;TRIB3;JAK1;DNAJA1;ARRB1;ATXN3;UBE2G1;SNCAIP;ARRDC1;WRAP53;NEK6;RPL23;IKBKG;SPOPL;RAD18;SMAD5;CXCR4;SUMO2;MC1R;MC4R;CUL1;RB1;RIPK1;GABARAPL1;RELA;MID1;PA2G4;TRIB1;HSP90AB1;ASB4;NDUFS2;UBE2K;TXNIP;TRAF6;APC;UBXN1;BAG4;STAT1;RPL11;CHEK2;NEDD8;BAG1;KDM4A;CUL3;YOD1;RNF40;USP7;PARP9;PRKACB;SMAD2;STAM;USP25;CUL2;TSG101;UBE2L3;BCL10;NLK;GPI;UQCRC1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5419099401146517,1.1216355891320753,0.3473491773308958,0.8984687314039077,1.0,5/12,21.78%,SPPL2A;PSEN1;SPPL3;DDI2;NAPSA
prerank,vinculin binding (GO:0017166),0.5428551789271345,1.1187728936768209,0.34177215189873417,0.9012670735237469,1.0,6/11,13.25%,UTRN;PXN;ACTN1;CTNNA1;SYNM;RTCB
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.48896696996047595,-1.1154458576509323,0.3303769401330377,0.7894665737306865,1.0,6/12,7.12%,IGF1;IRS1;GNAS;IGF2;YWHAG;SHC1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.4361501219588456,1.1131350282102728,0.31432973805855163,0.9132851435513147,1.0,5/38,4.47%,SHANK3;NCK1;SH2B2;CARD10;SORBS1
prerank,phospholipase binding (GO:0043274),-0.4687175648734654,-1.11275641078439,0.321353065539112,0.7900656828474933,1.0,2/13,1.14%,ARHGAP6;PRKN
prerank,adenyl ribonucleotide binding (GO:0032559),0.34106578206297056,1.1104566354449381,0.2662266226622662,0.9158571670573293,1.0,63/291,15.84%,RPS6KA5;SNRK;ERN1;ACVRL1;CDK6;INSR;DAPK1;MYH9;PEAK1;PDE2A;PRAG1;PDE4D;MAP4K3;SIK1;STK3;STK4;LMTK2;SYN3;CDC42BPB;MAST2;MTHFD1L;ATP1A3;ATP1A1;TAP2;ACVR1;SIK3;RAPGEF2;FBP1;TSSK6;STK26;MLKL;MTREX;NEK6;TRIP13;PXK;HASPIN;AKT2;ABCD4;SMARCA5;ATP7B;TWF2;AKT3;STK38;LONP1;PIM1;SIK2;ABCD1;MKNK2;ABCG1;TOP1;TRIB1;HSP90AB1;PFKL;UHMK1;MTPAP;EIF2B2;MAP3K20;IRAK3;PMVK;PNPLA8;RPS6KA4;PANK3;ABCA1
prerank,glycine binding (GO:0016594),-0.4983349499023214,-1.108870183349826,0.3630434782608696,0.7940107126730298,1.0,2/11,4.10%,GRIN3A;GLRB
prerank,poly-purine tract binding (GO:0070717),-0.39166659467441867,-1.1054195269531315,0.3333333333333333,0.796829944471755,1.0,5/27,8.21%,RBMS3;ATXN1;DAZAP1;RBMS1;TIA1
prerank,sulfotransferase activity (GO:0008146),-0.3686751389244605,-1.1051007783110485,0.32231404958677684,0.790133817338701,1.0,7/33,10.32%,UST;HS3ST3A1;CHST15;TPST1;HS2ST1;CHST3;HS6ST1
prerank,calcium channel inhibitor activity (GO:0019855),0.5412930126360619,1.104134715173656,0.3844731977818854,0.930689941315493,1.0,3/11,16.72%,FKBP1A;MCUB;CALM1
prerank,DNA polymerase activity (GO:0034061),0.4737259634097407,1.1028661048466541,0.3295081967213115,0.9289279556286115,1.0,3/22,8.29%,POLK;POLA1;PRIMPOL
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.39259904156345427,1.102065895391027,0.3179916317991632,0.9256895061270148,1.0,11/73,10.93%,CALCRL;CYSLTR1;NPR1;NLRP6;CX3CR1;HCRTR1;MCHR1;INPP5K;APLNR;MC1R;MC4R
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.501321740018575,1.0996511783014657,0.375886524822695,0.9276605130520517,1.0,8/16,19.67%,MTM1;MTMR6;SYNJ1;INPP5F;MTMR12;MTMR9;SACM1L;MTMR2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5622763677968563,1.0987715664784885,0.4087719298245614,0.9247353336293737,1.0,2/10,10.80%,ANKRD13A;FAN1
prerank,nuclear receptor coactivator activity (GO:0030374),0.40651745949283247,1.0987044948464577,0.34156976744186046,0.9192415934044745,1.0,11/52,11.43%,TACC1;CNOT6;ACTN4;ACTN1;NCOA1;PKN1;SS18;RBM14;RNF4;ZMIZ1;ENY2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4483593775812043,1.0971538940846028,0.3333333333333333,0.9185723679290233,1.0,8/28,16.45%,DAB2IP;TRAF1;BABAM2;RIPK1;BID;TRAF6;CASP8AP2;STAT1
prerank,RNA polymerase binding (GO:0070063),0.49164757267647075,1.0967519604253972,0.35972461273666095,0.9143516073441992,1.0,6/18,16.74%,STOM;PKN2;NEDD4;ZFP36;PHRF1;ANP32B
prerank,phospholipase activator activity (GO:0016004),-0.5079064895851633,-1.096634995726016,0.35294117647058826,0.8069073283059713,1.0,3/10,10.17%,ARHGAP6;SRC;STX4
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.41403553989205405,-1.0961836293175338,0.3384615384615385,0.8008510277557191,1.0,9/21,33.53%,P2RX4;GLRB;GRIK2;CHRNA7;CHRNB2;P2RX7;P2RX3;P2RX5;P2RX6
prerank,serine-type peptidase activity (GO:0008236),-0.30589384843409595,-1.0946360704649438,0.26609442060085836,0.7980164298508623,1.0,12/96,10.16%,F3;RHBDL3;DPP4;HTRA3;PCSK5;FAP;HTRA1;NAALAD2;KLK2;PLAT;RHBDF1;MMP2
prerank,histone deacetylase binding (GO:0042826),0.3800445298637154,1.0936502442539777,0.32814526588845655,0.9180525248430009,1.0,18/88,14.87%,LEF1;HDAC9;MEF2C;TAL1;PKN2;PKN1;MAPK8;HOXA10;PHF6;SP2;TFAP4;MIER1;RELA;HSP90AB1;MEF2A;TRAF6;MEF2D;KAT2B
prerank,secondary active transmembrane transporter activity (GO:0015291),0.4092478461258456,1.0920061265344834,0.3390804597701149,0.9173965759006615,1.0,10/51,10.57%,SLCO2B1;SLCO2A1;SLC25A16;SLC16A2;SLC35E4;CLCN3;ANKH;SLC35D2;SLC25A30;SLCO1B1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.5313179960611346,1.0915735290852944,0.3775862068965517,0.9132170619646017,1.0,3/12,1.37%,BMPR2;ENG;ACVRL1
prerank,NADP binding (GO:0050661),0.4321832909170221,1.0907336374952232,0.3653543307086614,0.9104760988816916,1.0,3/32,4.20%,NOS3;LBR;CAT
prerank,cAMP response element binding (GO:0035497),-0.484607305468077,-1.0905849427704017,0.3776223776223776,0.8022352513189129,1.0,4/10,19.87%,CREB5;E4F1;CREB3L1;NR4A3
prerank,phospholipase C activity (GO:0004629),-0.38903994643353745,-1.0897561082413634,0.3628808864265928,0.7974788858584384,1.0,7/25,8.03%,PLCL1;PLCE1;EDNRA;PLCD3;PLCB3;PLCD1;BDKRB2
prerank,double-stranded RNA binding (GO:0003725),0.38827766209356535,1.0895173240007496,0.33980582524271846,0.9088779096391524,1.0,16/70,13.74%,LRRFIP1;ADARB1;MSN;SLC3A2;ACTN1;MBNL1;DROSHA;RFTN1;DICER1;RC3H1;ADAR;OASL;FMR1;DHX15;HSP90AB1;IFIH1
prerank,phosphatidylglycerol binding (GO:1901611),0.5219648912954293,1.0866120809103847,0.37392795883361923,0.9121167191249236,1.0,6/13,22.88%,PLTP;PITPNC1;PITPNA;OPA1;STOML2;UQCC3
prerank,cGMP binding (GO:0030553),0.5541664112773885,1.0842323721844829,0.3800738007380074,0.9139241874593204,1.0,3/11,6.24%,PDE2A;CNGB1;RAPGEF2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.48078517036403406,-1.084141442449874,0.371824480369515,0.8059105160367558,1.0,3/12,7.12%,IRS1;GAB2;SHC1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3458146893239509,1.0833313743192992,0.31786542923433875,0.9113987093770043,1.0,13/173,3.67%,ELK3;DACH1;PPARD;ZBTB16;ETV6;LRRFIP1;FOXP1;SOX13;HHEX;NR3C1;KLF8;TGIF1;ZFP57
prerank,deubiquitinase activity (GO:0101005),0.37057203331295885,1.0823554425485913,0.34342105263157896,0.9090975522939312,1.0,19/88,18.89%,USP53;MINDY1;USP3;MINDY2;EIF3H;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4;USP12;OTULIN;YOD1;USP8;DESI2;USP7;USP25;USP21
prerank,cell-cell adhesion mediator activity (GO:0098632),0.41681908916663146,1.0784495933006157,0.3658170914542729,0.9152049296700254,1.0,6/42,4.15%,ESAM;CD200;BSG;ROBO4;TMOD3;PDLIM1
prerank,glucuronosyltransferase activity (GO:0015020),0.4889823745352958,1.0775114205854952,0.3912310286677909,0.91280620095855,1.0,1/19,0.48%,CSGALNACT1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.49145739709034253,-1.0769741893616702,0.3870967741935484,0.8191548833096626,1.0,4/10,21.00%,NOX4;CYBB;NOX1;NCF2
prerank,rRNA binding (GO:0019843),0.4128773138252584,1.0755834985526664,0.36476043276661513,0.9134019697234957,1.0,16/42,21.50%,RPS14;CAVIN1;RRS1;ANG;MRPS18A;RPL23;NOP53;FASTKD2;RPS13;EMG1;RPL11;MRPL11;PTCD3;RPS3;SBDS;RCC1L
prerank,CoA-ligase activity (GO:0016405),-0.44085692877999755,-1.072828256205784,0.3883720930232558,0.8237860076908556,1.0,4/14,20.69%,ACSL1;ACSS2;AACS;ACSBG1
prerank,myosin II binding (GO:0045159),0.5227033487941322,1.0722062585957677,0.3888888888888889,0.9186971827521481,1.0,3/10,8.56%,SHROOM4;SHROOM1;LLGL1
prerank,phospholipase A2 activity (GO:0004623),0.45632211060408445,1.0709996842236247,0.41363636363636364,0.9168937714769473,1.0,3/26,8.63%,PLA2G4A;PLA2G2D;PLAAT3
prerank,tau-protein kinase activity (GO:0050321),0.4646160013143569,1.0708316710998733,0.37643207855973815,0.9121763613338657,1.0,5/20,6.62%,FYN;TAOK2;MARK3;SIK3;DYRK1A
prerank,triglyceride lipase activity (GO:0004806),0.4664743838654283,1.070270120772901,0.3835616438356164,0.908631070302014,1.0,4/20,19.24%,LIPE;LPL;PNPLA2;CEL
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.33248317151204504,-1.0679668036756746,0.3488372093023256,0.8307392245362456,1.0,11/49,14.65%,ATP1A2;MPPED2;DUSP11;PXYLP1;EPHX2;LHPP;DUSP10;PTPN22;SBF1;ACP6;PPP1CB
prerank,lipase activator activity (GO:0060229),-0.49168498578930014,-1.0671389154840958,0.39705882352941174,0.8261079256706293,1.0,1/10,0.11%,ARHGAP6
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.4030297210657541,-1.0658892270993565,0.3932291666666667,0.8226370960905317,1.0,12/21,17.12%,AKAP7;AKAP6;ARFGEF2;PRKACA;EZR;AKAP8L;RYR2;WASF3;WASF1;ACBD3;PRRC1;PJA2
prerank,voltage-gated sodium channel activity (GO:0005248),-0.40073568739391924,-1.0648939332179241,0.39952153110047844,0.8185389256766082,1.0,11/22,28.90%,SCN7A;CACNA1G;SCN2B;SCN1A;SCN8A;SCN2A;SCN1B;SCN5A;SCN9A;CACNA1H;HCN4
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3788827514540233,1.0637162978749608,0.3729281767955801,0.922623081752653,1.0,19/78,19.30%,CTSC;CASP4;CASP8;USP15;TINAG;CASP7;CASP1;CTSK;CTSO;MALT1;PIGK;LGMN;CAPN5;USP12;USP8;USP7;CAPN12;USP25;CTSH
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5159918064714095,1.0627002220695283,0.4197080291970803,0.9203631354409502,1.0,1/11,2.26%,PPP1R2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3717301142781048,1.061021177492275,0.3691275167785235,0.9201352704101585,1.0,9/72,4.77%,FLII;PARD3;HIP1;HIP1R;KCNQ1;PLCB1;FCHO2;TIRAP;SDCBP
prerank,voltage-gated ion channel activity (GO:0005244),0.48038332999381855,1.061006754809506,0.42086956521739133,0.9151615146060629,1.0,4/14,10.53%,CACNA1E;PKD2;VDAC3;ANO6
prerank,SUMO binding (GO:0032183),0.5009921579655247,1.0604874562903022,0.3985102420856611,0.9118408073317912,1.0,7/13,22.40%,HERC2;RNF4;SERBP1;CASP8AP2;USP25;RNF111;SIMC1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.45811763548554996,1.057363343787543,0.4170940170940171,0.9160234616805628,1.0,8/22,20.21%,PPM1F;DUSP23;DUSP16;DUSP2;DUSP7;MTMR2;DUSP18;DUSP19
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.40438676505270055,-1.0564148249600447,0.3970223325062035,0.8357126697587464,1.0,6/20,16.64%,MOGAT3;LPGAT1;AGPAT4;LCLAT1;AGPAT3;LPCAT1
prerank,cysteine-type peptidase activity (GO:0008234),0.3749398645434484,1.0555102834363521,0.3892709766162311,0.9166890946923727,1.0,10/73,8.38%,CTSC;CASP4;CASP8;USP15;TINAG;CASP7;CASP1;CTSK;CTSO;MALT1
prerank,ephrin receptor activity (GO:0005003),-0.4175736930693136,-1.0544596691314216,0.38345864661654133,0.8273110364544615,1.0,5/17,10.26%,EPHA3;EPHA7;EPHA8;EPHA6;EPHA10
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.4175736930693136,-1.0544596691314216,0.38345864661654133,0.8273110364544615,1.0,5/17,10.26%,EPHA3;EPHA7;EPHA8;EPHA6;EPHA10
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4853414506001937,1.0539373938492935,0.40947546531302875,0.9162386225488746,1.0,1/16,1.47%,PIR
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.44512597237933454,1.053725004816697,0.40253565768621236,0.9120054146913823,1.0,12/28,23.39%,EDC3;DROSHA;RNASEH2A;DICER1;NUDT16;RPP30;RPP25;ENDOV;PRORP;MRPL44;RNASEH1;DBR1
prerank,mRNA 5'-UTR binding (GO:0048027),0.4416913432658453,1.0520987150908745,0.39145299145299145,0.9118926384072263,1.0,10/24,26.73%,IGF2BP3;RPS14;RPS7;FMR1;RPS13;DHX36;RPL26;SYNCRIP;MRPS11;RPL41
prerank,heme binding (GO:0020037),0.37925581930374563,1.0518855359285653,0.3840682788051209,0.907799284825833,1.0,6/65,5.77%,NOS3;PTGS2;PXDN;CYP26A1;CAT;CYCS
prerank,5'-3' exonuclease activity (GO:0008409),0.49375365166341134,1.0517172364373117,0.4206773618538324,0.9035107023098706,1.0,5/14,17.47%,FAN1;DCP2;TRIR;XRN2;DCLRE1C
prerank,thyroid hormone receptor binding (GO:0046966),0.4199553366426121,1.050997238585662,0.3919354838709677,0.9007686824285889,1.0,8/28,22.79%,TACC1;JMJD1C;OASL;GTF2H1;TAF7;GAS2L1;MED12;MED17
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5188526762215785,1.0507468952488075,0.41197822141560797,0.8969136760019526,1.0,1/12,1.10%,TENT4A
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4238045756727005,1.0475022284907822,0.4213938411669368,0.901356604394558,1.0,4/34,2.07%,ARAP3;PARD3;HIP1R;IQGAP1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.37196917027422755,-1.0456329788371714,0.38341968911917096,0.8456580465146674,1.0,3/27,3.59%,LRP1;HSPG2;SYT1
prerank,steroid hydroxylase activity (GO:0008395),-0.4239013354792308,-1.0454254137484376,0.3862559241706161,0.8393176266284563,1.0,3/16,5.06%,CYP7B1;CYP27A1;CYP1B1
prerank,cation transmembrane transporter activity (GO:0008324),-0.32215611271362365,-1.043296771131855,0.3923611111111111,0.8383603402057247,1.0,5/48,3.49%,SLC7A2;SLC41A1;SLC1A5;SLC6A9;SFXN2
prerank,Notch binding (GO:0005112),-0.3831593970655319,-1.04203543573524,0.38271604938271603,0.8351431730065553,1.0,5/22,7.71%,SNED1;AAK1;CCN3;JAG1;DTX1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.4519783831345401,1.0405561465330915,0.4251592356687898,0.9162600701452456,1.0,4/23,3.83%,PLCB4;PLCG1;PLCB1;PLCG2
prerank,NF-kappaB binding (GO:0051059),0.44609025646921896,1.039067298319414,0.4246353322528363,0.9156358035584866,1.0,6/24,14.08%,NFKBIA;TAF4B;PSMA6;RELA;RNF25;NPM1
prerank,gamma-tubulin binding (GO:0043015),0.45355364246325924,1.0372911782262315,0.4342105263157895,0.9162614004819171,1.0,4/21,9.50%,DIXDC1;RAB11FIP5;ARHGEF7;RAD51D
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.41351869326831214,1.0335922940432338,0.42543171114599687,0.9219496845677613,1.0,13/33,22.63%,CNOT6;CNOT6L;ISG20;ANGEL2;REXO2;DCP2;CNOT7;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,calcium-activated potassium channel activity (GO:0015269),-0.4494809465984009,-1.0329643037130272,0.45964125560538116,0.8544360189409471,1.0,5/11,20.07%,KCNMA1;KCNMB2;KCNN2;KCNN3;KCNU1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4007418556863368,1.031631817199136,0.4205748865355522,0.9230239479576511,1.0,8/37,15.56%,GARS1;FARS2;TARS3;IARS1;LARS1;WARS1;RARS1;KARS1
prerank,calcium activated cation channel activity (GO:0005227),-0.4094849258565876,-1.0277006215037823,0.4223300970873786,0.8627302677273246,1.0,5/17,14.06%,KCNMA1;ANO1;KCNMB2;TMEM63A;KCNN2
prerank,diacylglycerol kinase activity (GO:0004143),0.4995386202860965,1.0262910046097804,0.4418604651162791,0.9332157272736817,1.0,3/11,11.33%,DGKZ;DGKH;DGKE
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4900684633872196,1.0252819457872044,0.4524647887323944,0.9312942109491938,1.0,5/13,17.75%,SH3BP4;CCDC88A;GDI2;EIF5;ARHGDIA
prerank,phosphatase inhibitor activity (GO:0019212),0.452086764130749,1.0242796020585163,0.4231404958677686,0.9293818441403041,1.0,5/20,15.04%,PPP1R2;PPP1R9B;LMTK2;MGAT5;STYX
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4865680454189464,1.0242500706171995,0.44165170556552963,0.9249039206291305,1.0,3/13,4.24%,KCNQ1;PRKAR2B;SOX9
prerank,transition metal ion binding (GO:0046914),0.3083827542036572,1.0230249440249868,0.4393305439330544,0.9236758324948698,1.0,79/397,17.91%,MYRIP;SHANK3;NOS3;TNFSF10;RNF125;GCH1;MSRB3;ARHGEF2;PDE2A;GDA;SAMHD1;KLF7;KDM3A;TES;LCN2;TET3;ENPP2;MYCBP2;PAM;ASAH2;EEA1;ABO;ADAMDEC1;SIRT5;RNF7;KDM4C;ERAP1;PRIMPOL;ZNF2;TRIM24;PGGT1B;ANG;PTPN1;NUDT16;AFM;CYP2R1;SIAH1;MGAT5;ATP7B;RC3H1;ABL2;RPS27;ZMYND11;PRDM2;PITRM1;ADH1A;RNF112;PIM1;TET2;SORD;ETHE1;SIRT6;TMEM163;AOC1;MTPAP;ACR;IFIH1;SOD2;RPS29;S100A9;ARIH2;MSRB2;KAT6A;RNF5;ACE;ZFPL1;CA2;CHORDC1;TAB3;BIRC2;ZNF8;KDM5C;LITAF;KDM4A;APIP;PHF5A;NQO2;PLSCR1;SCO2
prerank,voltage-gated potassium channel activity (GO:0005249),-0.2912909609774611,-1.0222979243326935,0.41007194244604317,0.8708395697413699,1.0,23/80,18.60%,KCNK2;KCNB2;KCNMA1;KCNQ3;KCND2;KCND3;KCNC2;KCNJ2;KCNS3;KCNQ4;KCNJ13;KCNQ5;KCNA6;KCNT1;KCNJ10;KCNN2;KCNJ8;LRRC38;KCNJ15;KCNJ6;KCNN3;KCNE4;KCND1
prerank,calcium ion binding (GO:0005509),-0.24662379229687928,-1.0212985698306833,0.2926829268292683,0.8668270332768561,1.0,52/323,11.08%,LRP1;FBN1;GSN;CDH11;FBLN1;ADGRV1;ENPP1;SPARC;CLEC3B;KCNIP4;ANXA5;CDH13;SLC8A1;THBS1;GJB2;SYT1;ASPH;C2CD5;SMOC2;CDH1;AMY1A;AMY1B;AMY1C;SCUBE1;S100A6;PCLO;ANXA1;NRXN1;RASGRP2;RCN3;STIM1;THBS3;SYT9;PLSCR2;SYT11;SYT12;ANXA2;ASPN;S100B;ANXA6;PITPNM3;RCN1;ANXA3;ATP2A2;ENPP3;RYR2;SLC25A12;TKT;S100A10;SLIT2;MICU1;ANXA4
prerank,protein phosphatase activator activity (GO:0072542),0.48195477076287807,1.0212212531423117,0.4442446043165468,0.9243152189500335,1.0,3/13,8.58%,PPP2R5A;PPP2R5E;PPP2R5B
prerank,amino acid binding (GO:0016597),0.4110157408443048,1.0198577770553312,0.4249201277955272,0.9233752312310002,1.0,2/31,4.84%,NOS3;PADI4
prerank,anion channel activity (GO:0005253),0.3659247713762751,1.0192105669065403,0.4396551724137931,0.920764090254747,1.0,11/61,15.26%,LRRC8C;ANO2;LRRC8B;BEST1;CLCN3;VDAC3;ANO6;GABRD;CLIC4;GABRE;LRRC8A
prerank,UDP-glycosyltransferase activity (GO:0008194),0.36322432375500524,1.0190192785318908,0.4207650273224044,0.9168858185048917,1.0,8/70,8.89%,CSGALNACT1;LFNG;MGAT4A;MFNG;B3GNT3;B3GNT4;B3GNT6;B4GAT1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.33919145224109,-1.0172277336867754,0.42136498516320475,0.8715413481151613,1.0,8/35,9.50%,PLCL1;MPPED2;PLCE1;ENPP1;PLCB3;ENPP3;TDP2;SMPD3
prerank,metalloexopeptidase activity (GO:0008235),-0.3172543621422103,-1.0158567858701903,0.43322475570032576,0.8688440432923783,1.0,8/51,9.43%,AEBP1;CPQ;MMP14;MMP16;NPEPPS;CPXM2;ENPEP;CPXM1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.4513380535997393,-1.0137349017264383,0.4446902654867257,0.8684418260426856,1.0,8/11,36.13%,NDUFAF7;CARM1;PRMT9;PRMT8;PRMT2;PRMT7;PRMT6;PRMT1
prerank,neurexin family protein binding (GO:0042043),-0.46061636986260984,-1.013571488809206,0.4557235421166307,0.8623839935544138,1.0,5/10,10.59%,NLGN2;NLGN1;SYTL2;SYTL5;NLGN3
prerank,histone acetyltransferase binding (GO:0035035),0.4358981178097499,1.0134218122645615,0.4531772575250836,0.9274075751173616,1.0,3/21,5.55%,EPAS1;HIF1A;TRIM68
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.34440883508276826,-1.0117542784223383,0.4431818181818182,0.8612655855611314,1.0,10/33,19.51%,AR;RECQL5;CTR9;PAF1;ERCC5;DRAP1;WDR43;HNRNPU;UVSSA;ELP4
prerank,protein heterodimerization activity (GO:0046982),0.32242670805690876,1.0093820469200931,0.45993031358885017,0.9335665023537725,1.0,23/178,8.35%,EPAS1;ZHX3;RALGAPA2;MEF2C;AHR;PDGFB;HIP1;FZD4;HIF1A;RALGAPA1;KCNB1;ADRB1;SDCBP;IKBKB;XBP1;TCF4;ATP1A1;BOK;AURKA;ITGA3;TCF3;MICU2;NEUROD1
prerank,MHC class II protein complex binding (GO:0023026),-0.4534982181532021,-1.005619453539216,0.4796380090497738,0.8718741007173499,1.0,3/11,10.58%,ATP1B1;HSP90AA1;CD81
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.4957916719160474,1.004628122869217,0.50293542074364,0.9419199504479453,1.0,2/11,7.12%,KCNQ1;KCNE2
prerank,syntaxin-1 binding (GO:0017075),0.42696282006288977,1.0022023208170954,0.4594594594594595,0.9439162950774327,1.0,3/22,4.38%,UNC13B;DAPK1;SYPL1
prerank,endopeptidase regulator activity (GO:0061135),-0.32430874438356055,-1.0014874679518215,0.45224719101123595,0.8767005315119836,1.0,7/40,10.76%,TFPI;ITIH2;RENBP;RECK;SERPIND1;APH1B;CST3
prerank,I-SMAD binding (GO:0070411),0.48806357337199335,1.000683940681732,0.4919210053859964,0.9434350782599514,1.0,4/13,10.09%,SMAD1;SMURF1;SMAD7;SMAD5
prerank,retinoic acid binding (GO:0001972),0.480836651433343,1.0001031933781759,0.47217235188509876,0.9406263171890994,1.0,2/12,6.67%,CYP26A1;CYP26C1
prerank,kinase activity (GO:0016301),0.3371540143644093,0.9998716445412488,0.4682230869001297,0.9368737050926736,1.0,26/109,18.19%,PRKD1;DGKZ;LYN;PRKD3;PIK3C2A;PKN2;DGKH;TRIB3;ITPKB;PIK3CG;CERKL;PANK2;NMRK1;GK5;DGKE;EPHA4;IDNK;CHKA;PMVK;PANK3;RFK;PAPSS1;DOLK;IPMK;CSNK2A1;PIK3C2B
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.4662140012743766,0.9994663594694083,0.4510166358595194,0.9336040588595698,1.0,2/13,10.71%,ECI1;ECH1
prerank,pyrophosphatase activity (GO:0016462),0.37467661423686627,0.9993774874139111,0.46745562130177515,0.9295355242000828,1.0,14/50,19.72%,ENTPD1;PLPP1;BNIP2;NUDT16;PRUNE1;RNGTT;DCP2;NUDT15;NUDT14;PLPP5;ENTPD3;NUDT1;ADPRM;NUDT9
prerank,titin binding (GO:0031432),-0.43179724430857913,-0.9987659604829577,0.4772727272727273,0.8777553258485403,1.0,2/13,10.68%,ACTN2;TRIM63
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.42442804196633954,0.9969987743505182,0.46153846153846156,0.9315699924935037,1.0,4/23,7.58%,HIP1;HIP1R;PLEKHA5;SNX3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4424270895230073,-0.9964014743094635,0.46120689655172414,0.8775333772473495,1.0,3/10,12.32%,KDM7A;KDM2A;KDM8
prerank,lipid phosphatase activity (GO:0042577),0.46242400542948925,0.9962142363402704,0.4607329842931937,0.9294476259364028,1.0,3/14,6.76%,PLPP1;SGPP2;INPP5K
prerank,DNA replication origin binding (GO:0003688),0.427225446771306,0.9959634165424978,0.47266881028938906,0.9258709292976992,1.0,6/23,16.38%,MCM10;POLA1;MCM9;GRWD1;ORC5;ORC3
prerank,thioesterase binding (GO:0031996),0.48197198327746305,0.9958683664983996,0.497196261682243,0.9219015909770285,1.0,3/11,14.13%,TRAF1;RAC1;TRAF6
prerank,transforming growth factor beta receptor binding (GO:0005160),0.44540069062183035,0.9933436334128146,0.48856209150326796,0.9243077842090999,1.0,5/18,7.19%,ENG;FKBP1A;SMAD7;USP15;TGFB1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.4474846812373981,-0.9927899232081357,0.4771689497716895,0.880758669460738,1.0,3/11,2.95%,AKAP13;SH3RF1;KSR1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.41592151084888496,0.9917321974708746,0.47716535433070867,0.9242059600211402,1.0,4/26,8.89%,CSGALNACT1;B3GNT3;B3GNT4;B3GNT6
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.43096272909931616,-0.9907129582431158,0.47096774193548385,0.8804027707029747,1.0,4/11,20.04%,AMFR;UBE4B;UBE4A;UBR5
prerank,carboxy-lyase activity (GO:0016831),-0.3582958235856668,-0.990443434181311,0.45112781954887216,0.8749411817842595,1.0,6/23,19.75%,ECHDC1;GGCX;ODC1;AZIN1;PCK2;DDC
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.45914910112878105,0.9894823826625733,0.48282097649186256,0.9259495179387003,1.0,6/14,19.67%,MTM1;MTMR6;SYNJ1;MTMR12;MTMR9;MTMR2
prerank,cell adhesion mediator activity (GO:0098631),0.42154541920053346,0.9890352346841909,0.4991896272285251,0.9231132157398783,1.0,5/24,8.99%,ESAM;BSG;ROBO4;BCAM;DSCAM
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3601265997826367,-0.9880851219858178,0.4859335038363171,0.8750161464246609,1.0,7/27,7.79%,SLC26A7;SLC22A8;SLC26A2;ANO1;SLC22A6;SLC39A14;SLC5A5
prerank,ADP binding (GO:0043531),0.4123815490906007,0.9875402301843296,0.4781906300484653,0.9226112412230271,1.0,5/25,12.83%,ERN1;MYH9;LONP1;ABCD1;ABCG1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4907343639285141,0.984802953100081,0.4923954372623574,0.9258847220329519,1.0,4/10,17.75%,ATXN3;OTUD4;YOD1;DESI2
prerank,cAMP binding (GO:0030552),0.47558052498224745,0.9829562030666417,0.5036630036630036,0.9266496800365578,1.0,3/11,6.24%,PDE2A;PDE4D;RAPGEF2
prerank,iron ion binding (GO:0005506),-0.3110879415700859,-0.9814759738742288,0.48307692307692307,0.886923829327641,1.0,13/48,20.73%,AGMO;AOX1;KDM7A;TET1;EGLN3;FDX1;SCD;SNCA;FTO;ACO2;NFU1;SCD5;ABCE1
prerank,gated channel activity (GO:0022836),0.4483403741459094,0.9814598959463873,0.48845470692717585,0.926453996020225,1.0,1/14,1.00%,PIEZO1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.3064893025315647,-0.9811637600530142,0.5387205387205387,0.8815729091516192,1.0,7/53,6.01%,MICAL3;MICAL2;DDO;AOX1;DPYD;NOX4;PRODH
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.39282470420173343,-0.9807872744097863,0.47745358090185674,0.8765331144122285,1.0,6/16,30.79%,SLC22A4;SLC25A42;SLC22A2;SLC22A3;SLC5A7;SLC29A4
prerank,fibroblast growth factor binding (GO:0017134),-0.3729519633247987,-0.9786787082864099,0.4853658536585366,0.8761653263383002,1.0,4/21,10.53%,FGFR2;THBS1;ITGAV;FGFR4
prerank,RNA cap binding (GO:0000339),-0.3786914890162594,-0.9755456366430387,0.4988558352402746,0.8786116318130883,1.0,3/16,10.88%,CYFIP2;EIF4A1;EIF4E3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.4130110949991821,0.9743015065046084,0.5083892617449665,0.9401769651592276,1.0,3/25,2.06%,ARAP3;HIP1;HIP1R
prerank,lysophospholipase activity (GO:0004622),0.42895667691086936,0.9738518828516293,0.4991735537190083,0.9371815110048891,1.0,4/20,14.82%,PLA2G4A;ENPP2;GDPD1;PNPLA6
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3816515962445646,-0.9731833708612054,0.5079726651480638,0.8791921602557978,1.0,8/17,24.89%,DPYD;TECR;BDH2;MECR;DECR1;DHCR24;DHCR7;PECR
prerank,sodium channel activity (GO:0005272),-0.32371855732334437,-0.9715890396243018,0.5181818181818182,0.8772244612861625,1.0,15/37,29.04%,SCN7A;CACNA1G;GRIK4;GRIK2;GRIK5;GRIK1;SCN1A;SCN8A;SCN2A;SCN1B;SCN5A;SCN9A;CACNA1H;HCN4;SCNN1A
prerank,ATPase binding (GO:0051117),0.34459648554039785,0.9714189159915331,0.5214384508990318,0.9391759713599087,1.0,15/71,9.04%,CAV1;ESR1;PPP3CA;PDE4D;NKD2;RALB;ATXN3;ATP1B3;LCK;PKD2;ATP6V0A1;PSEN1;CHMP4A;PEX26;ANK1
prerank,PDZ domain binding (GO:0030165),0.3493612575696948,0.9687593206027609,0.5344352617079889,0.9419255943162438,1.0,11/61,6.66%,CADM1;F11R;USHBP1;FZD4;SNTG2;DOCK4;ADRB1;CLCN3;ATP2B4;RAPGEF2;TMEM88
prerank,actinin binding (GO:0042805),-0.36986456979908267,-0.9675324205718895,0.4963144963144963,0.8827455376837998,1.0,3/21,2.99%,CACNA1C;CACNA1D;DAG1
prerank,nucleotidyltransferase activity (GO:0016779),0.42839775023580295,0.9674021646020718,0.4883720930232558,0.9413099573809361,1.0,6/19,19.32%,TENT4A;CGAS;MTPAP;PNPT1;PAPSS1;YRDC
prerank,chemokine binding (GO:0019956),-0.33838974906876534,-0.9665817561745801,0.5261707988980716,0.8795336778214733,1.0,4/30,5.66%,PDPN;CCR9;FGF2;ITGAV
prerank,mechanosensitive ion channel activity (GO:0008381),0.4592169858995619,0.9660254333351223,0.5194085027726433,0.940506017951012,1.0,1/12,1.00%,PIEZO1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3410652983478716,0.9653486413554789,0.5111731843575419,0.9381965614809965,1.0,16/69,15.91%,PLA2G4A;CERS4;LPCAT3;GLYAT;SOAT2;KAT6B;ZDHHC18;PLAAT3;ZDHHC9;HHAT;MOGAT1;KAT2B;KAT6A;DGAT1;NAA16;MOGAT2
prerank,adenylyltransferase activity (GO:0070566),0.4165333289795136,0.964859441875103,0.49493243243243246,0.9354976955353171,1.0,5/21,15.56%,TENT4A;GPHN;OASL;MTPAP;KARS1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3813156065226264,-0.9648031532080582,0.5247058823529411,0.8723031951882527,1.0,4/16,12.61%,ATP6V0A4;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3813156065226264,-0.9648031532080582,0.5247058823529411,0.8723031951882527,1.0,4/16,12.61%,ATP6V0A4;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,copper ion binding (GO:0005507),-0.31552356310436735,-0.9644824753953352,0.46706586826347307,0.8674341089519453,1.0,10/42,18.23%,MOXD1;P2RX4;LOXL3;SOD3;LACC1;CCS;SNCA;GPC1;MT3;COX17
prerank,hyaluronic acid binding (GO:0005540),0.47721714519003106,0.9624552276187243,0.5,0.9373992812771308,1.0,1/10,1.14%,LAYN
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.43468930300088376,-0.9601523268347326,0.49767441860465117,0.8736695174525456,1.0,5/10,25.83%,NAA40;BRCA2;KAT8;NAA60;USP22
prerank,ubiquitin protein ligase activity (GO:0061630),0.29876148236239575,0.9597196670466352,0.5612602100350058,0.9401247980533263,1.0,52/228,17.22%,RNF125;SMURF1;RNF144B;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;HERC2;TRIM68;PELI1;MYCBP2;XIAP;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;RNF167;NEDD4;TRIM25;RNF139;UBR1;TRIM24;NEURL1B;NEURL3;SIAH1;UBE2D3;CBL;RC3H1;MYLIP;UBE3A;BIRC3;RNF112;COP1;HECTD1;RNF25;RNF215;UBE2K;TRAF6;TOPORS;MSL2;ARIH2;AREL1;RNF5;UBE3D;BIRC2;NHLRC1;CUL3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3252814918663316,0.9585812516388246,0.5367741935483871,0.9389799245704655,1.0,11/91,7.58%,FLII;PARD3;HIP1;HIP1R;KCNQ1;PLCB1;FCHO2;TIRAP;SDCBP;PLEKHA5;SNX3
prerank,U6 snRNA binding (GO:0017070),0.4436580572901523,0.9575571451447754,0.5249110320284698,0.9375450196458709,1.0,9/14,27.52%,LSM8;LSM3;LSM7;PRPF4;SART3;EIF5A;LSM2;METTL16;TUT1
prerank,syntaxin binding (GO:0019905),0.3439303881353536,0.9558524731134447,0.5189504373177842,0.9377930018438831,1.0,7/61,5.41%,UNC13B;DAPK1;RAB11A;SYPL1;STX6;CACNA1A;STX7
prerank,active ion transmembrane transporter activity (GO:0022853),0.3696455013647902,0.9553079148085724,0.524812030075188,0.9353208471050566,1.0,2/37,1.67%,SLCO2B1;SLCO2A1
prerank,transaminase activity (GO:0008483),-0.42317877803873055,-0.9549521650359659,0.5254629629629629,0.8811549860122802,1.0,3/11,12.82%,ABAT;GOT1;OAT
prerank,O-acyltransferase activity (GO:0008374),0.3884478532414448,0.9547948404003872,0.5118483412322274,0.9326986719941601,1.0,7/30,15.91%,PLA2G4A;LPCAT3;SOAT2;MBOAT1;MOGAT1;DGAT1;MOGAT2
prerank,telomerase RNA binding (GO:0070034),0.4123374028030791,0.9545798325697323,0.5187074829931972,0.9294318857822725,1.0,9/22,24.28%,WRAP53;PINX1;SMG7;DCP2;HNRNPC;DHX36;SMG6;SNRPD3;TENT4B
prerank,thiol-dependent deubiquitinase (GO:0004843),0.32932145565866777,0.9541316251464519,0.5367156208277704,0.9267382164903907,1.0,16/83,18.89%,USP53;USP3;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4;USP12;OTULIN;YOD1;USP8;DESI2;USP7;USP25;USP21
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.377969484201628,0.9518439212180069,0.49922239502332816,0.9283178695386342,1.0,4/34,4.44%,IQGAP1;CCNK;STK3;STK4
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.44516442004065593,0.9515587876038922,0.5107142857142857,0.9253153759638515,1.0,2/13,2.69%,SLC7A7;SLC38A5
prerank,MAP kinase activity (GO:0004707),-0.4001971892743507,-0.9507869309710474,0.5401459854014599,0.8861147726606665,1.0,2/14,7.16%,MAPK4;MAPK10
prerank,galactosyltransferase activity (GO:0008378),0.47327611812305637,0.9507400360401655,0.5317919075144508,0.923639509062261,1.0,4/11,10.41%,B4GALT4;B4GALT5;B3GNT6;A4GALT
prerank,serine-type endopeptidase activity (GO:0004252),-0.2742983051889617,-0.9489833154801223,0.5551470588235294,0.8852466593359334,1.0,9/80,10.16%,F3;RHBDL3;DPP4;PCSK5;FAP;KLK2;PLAT;RHBDF1;MMP2
prerank,alpha-tubulin binding (GO:0043014),0.3865067179686626,0.9483753803090829,0.518341307814992,0.9255053371887518,1.0,5/31,10.05%,FYN;DIP2B;TTLL7;TRPV4;ARL8B
prerank,RNA binding (GO:0003723),0.27669163540795627,0.9479646465389138,0.7101303911735206,0.9227231015294123,1.0,437/1321,25.15%,NANOS3;SORBS2;NOVA2;PRPF38B;RBPMS;SPTBN1;FLNB;LRRFIP1;MYH9;ADARB1;STAT3;FASN;ANP32A;SAMHD1;MSN;DHX40;SNTB2;SLC3A2;ACTN4;LBR;DDX54;RPS15;PKN2;TMSB4X;ACTN1;TES;IGF2BP3;IMP3;RPS19;PTBP3;RPS14;RBM20;MBNL1;MBNL2;RPSA;CAVIN1;RPS16;RPL38;FARS2;EIF4E;NANOS2;N4BP1;CTNNA1;EIF3H;EDC3;UCHL5;RPS20;RPL39;RPL34;DROSHA;PPP1R10;HNRNPF;CNBP;RPS7;SF3B4;UBAP2;NXF2;MBNL3;SYNE1;SEC63;TASOR;RPS24;ZNFX1;MTREX;HNRNPK;HNRNPA0;RBM14;FCF1;ASCC3;NOSIP;SPATS2;RPL37A;ZNF326;EIF1AX;EIF1;SRBD1;WRAP53;GTF2E2;RPF1;HNRNPD;TRIM25;RPS18;DDX50;RPL36;RSL24D1;WDR33;SAMSN1;DYNC1LI1;NELFE;RFTN1;PINX1;RPL15;RBM25;PHF6;SUCLG1;RRS1;DNTTIP2;SUB1;RPL14;THOC2;NAP1L4;ANG;CHD2;GLRX3;YBX3;TBCA;PTPN1;KHNYN;LSM8;GDI2;DICER1;NPM3;RPS8;PUM1;RPL23;RPL17;MYBBP1A;SMG7;DUT;NUDT16;NIFK;G3BP1;PTRH1;HELZ;HNRNPLL;RPL9;HELB;RPL4;SERBP1;RBM18;PSMA6;CNOT1;RPL13A;RPS11;RBM3;TWF2;RPL32;SUMO2;RPL22;OTUD4;EXOSC1;FSCN1;PPHLN1;RBM15;SPEN;DRG2;YTHDC1;DCP2;RC3H1;RPL31;KCTD12;RPS27;TFB2M;RO60;RNPS1;CFAP65;RPS23;DDX51;ADAR;LSM3;OASL;MRPL13;RPL13;EIF5B;PUM2;SRP9;RPP30;MRPS12;RPS12;LONP1;NUP98;FAU;PEBP1;UTP4;RPP25;RSRC2;APEH;RPL6;NOP53;NOP16;HNRNPC;GRWD1;PA2G4;RACK1;TOP1;ZFP36;FMR1;EIF2AK4;BTF3;RNMT;SLTM;RPL10;FASTKD2;RTCB;DHX15;FBLL1;HSP90AB1;MRPL41;MTPAP;NOL10;POLR1G;CAST;IFIH1;RPS6;SF3B6;R3HDM1;NPM1;PELP1;MAP3K20;SCAF11;RPS25;YY1;SRFBP1;FBRSL1;NSRP1;ZFP36L1;RRP9;AIMP1;ZC3H12C;LARP4B;ENDOV;QKI;RPL35A;RPL29;SNW1;ADAT1;MRPL4;YBX1;RPS13;XRN2;RPL18;RPL27A;ZCCHC17;YLPM1;RPL7L1;RPS21;TPT1;MAK16;LSM14A;RPL27;MRPS5;NELFCD;MRPL23;EMG1;KARS1;BAG4;EIF5;RRP1B;DDX20;AGFG1;HNRNPUL1;RBM42;UTP6;ZC3H4;LUC7L2;CEBPZ;AQR;G3BP2;PNPT1;RPS10;MRPL37;RDX;VIRMA;LSM7;XPOT;RPL11;TRMT6;PRDX1;PDCD11;CWC22;ANXA11;ESF1;ALYREF;NOP14;CSDE1;PRPF40A;UBE2I;PRKRIP1;HEATR1;GRB2;ZCCHC7;PHF5A;HSPE1;CDC40;METTL14;EEF2;HELZ2;MRPL11;RPL8;PTCD3;DIAPH1;PPP1CC;TXN;HNRNPM;KDM1A;LARP4;RALY;EIF2AK2;MRPS26;STRAP;CISD2;BST2;FUS;MRPL54;HMGN5;DHX36;CPNE3;RPL18A;DHX34;NUDT1;YRDC;HNRNPAB;BCCIP;SRSF10;MRPS9;UBE2L3;MEX3C;NOM1;THOC5;ZNF638;HDGF;SART3;RPS3;RPL21;ERH;SART1;RPL3;MRPL43;LSM1;CCDC47;DAZL;PEF1;SETX;GNL2;MRPL12;PPIB;KPNB1;MRPL44;DEK;CCDC9B;NOL4;PURA;ELAVL1;RPN1;RNASEH1;TOE1;RPS28;DDX47;SBDS;ZCCHC3;CPSF6;ZC3H14;TAF15;RCC1L;SF3A2;DENR;PRKRA;RTF1;URB1;JMJD6;CDK11B;RPL7;LUC7L;MRPS30;TCOF1;GCN1;RTRAF;RIDA;PRPF3;THUMPD1;NOA1;MRPL1;TRNAU1AP;LACTB2;FUBP1;NOCT;RPL26;PURB;SRP19;HMGB1;SND1;EIF4ENIF1;RARS2;TRA2B;RBM7;MAP4;DBR1;NOL6;YWHAE;PIN4;SMG6;PPIA;EIF4E2;DDX28;JUN;NGDN;PUS7;ZFR;SNRPD3;DCP1B;SRSF4;CSRP1;RPUSD2;FKBP4;TENT4B;NUP42;SYNCRIP;LYAR;RRP12;DIDO1;NSUN6;MTIF2;DNAJC2;EIF5A;MRPL15;ALKBH8;DAP3;PCDHGA9;RBM33;PSPC1;MRPL14;MRPL32;MKRN2;SECISBP2L;RBMX;EIF3G;EIF4H;SYF2;LAS1L;MRPL39;MRPS11;LSM2;CPSF3;MRPL9;SNRNP200;NOLC1;PPIG
prerank,poly(A) binding (GO:0008143),-0.359172474560174,-0.947735287600047,0.5474452554744526,0.8827917504818362,1.0,5/21,15.04%,RBMS3;RBMS1;TIA1;HNRNPU;ELAVL4
prerank,exoribonuclease activity (GO:0004532),0.4534132340828964,0.9471132553686779,0.5255198487712666,0.9212303992693245,1.0,3/12,13.14%,CNOT6;EXOSC1;CNOT7
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.4498356634920324,0.9464116074757898,0.5267857142857143,0.9191357656997291,1.0,4/12,16.45%,H3-3A;POU2F1;RELA;STAT1
prerank,chemoattractant activity (GO:0042056),0.3954461176867407,0.9459019215647909,0.5344262295081967,0.9167655487195108,1.0,3/26,5.18%,PDGFB;VEGFC;VEGFD
prerank,nuclear export signal receptor activity (GO:0005049),0.4593212969158701,0.9444178055944967,0.5490909090909091,0.9166671315807357,1.0,5/11,24.33%,XPO1;NUP214;CSE1L;EIF4ENIF1;NUP42
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2926220854263656,0.9443036857695534,0.5754060324825986,0.9133243985726228,1.0,51/232,17.22%,RNF125;SMURF1;RNF144B;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;ZNRF3;DTX3L;UHRF2;HERC2;TRIM68;PELI1;MYCBP2;XIAP;RNF144A;UBE3B;CBLL1;IRF2BPL;RNF7;RNF167;NEDD4;TRIM25;RNF139;UBR1;TRIM24;NEURL1B;NEURL3;SIAH1;UBE2D3;CBL;RC3H1;MYLIP;UBE3A;BIRC3;RNF112;COP1;HECTD1;RNF25;RNF215;TRAF6;TOPORS;MSL2;ARIH2;AREL1;RNF5;UBE3D;BIRC2;NHLRC1;CUL3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.43596238314541347,0.9420712657776434,0.5483304042179262,0.915171888065864,1.0,3/15,7.58%,PLA2G4A;PLEKHA5;SNX3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.39570876050927095,-0.9412115109076501,0.5412026726057907,0.8936449947838002,1.0,2/14,2.95%,SLC26A7;SLC26A2
prerank,G protein-coupled receptor binding (GO:0001664),-0.2486363296438007,-0.9409066324460142,0.6284153005464481,0.8888801954911957,1.0,25/132,13.53%,PRKN;WNT4;GRK3;RNF43;BICD1;WNT6;TULP3;GNAO1;WNT9A;GNAS;RYK;AGTR1;LRP6;GPRASP2;GNAI1;SFRP1;CXCL12;USP33;FZD1;WNT16;GPRC5B;FZD7;GNA14;S1PR2;ARHGEF11
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.3837952893545908,0.9407865555328919,0.5511182108626198,0.91463609415133,1.0,4/29,11.79%,ACER2;CTBS;PARG;OVGP1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.35709392139904483,0.9399128968585556,0.5714285714285714,0.9130963067680428,1.0,4/49,3.39%,MCTP1;PLA2G4A;CPNE8;ESYT2
prerank,Wnt-activated receptor activity (GO:0042813),0.4373267577274933,0.939425228375123,0.5337954939341422,0.9106857936406312,1.0,4/15,4.73%,FZD6;FZD4;LRP5;TSPAN12
prerank,peptidase activator activity (GO:0016504),0.3966926318372009,0.9372941452907135,0.5521885521885522,0.9119770438101835,1.0,6/22,15.96%,CAV1;MAL;APH1A;PSME1;VSIR;CASP8AP2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.46657281949004886,0.9352964397762419,0.5307557117750439,0.9132395992923,1.0,2/10,7.54%,PIK3C2A;PIK3CG
prerank,androgen receptor binding (GO:0050681),0.39628389094723926,0.9347857384731322,0.5606557377049181,0.9109574760895978,1.0,5/25,8.15%,FOXP1;KDM3A;PKN1;TRIM68;KDM4C
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.45276392050399705,0.9342455698914426,0.553763440860215,0.9088649185812555,1.0,2/11,13.20%,PADI4;PADI1
prerank,sterol binding (GO:0032934),-0.28519904287066067,-0.9338841445984547,0.5645161290322581,0.9010987563972216,1.0,17/56,15.29%,SIDT1;GRAMD1B;GRAMD1C;INSIG2;APOD;RORA;OSBPL8;OSBPL5;ANXA6;SOAT1;OSBPL3;CD81;OSBPL6;VDAC1;INSIG1;SCP2;SYP
prerank,kinase activator activity (GO:0019209),-0.329222192487122,-0.9338808264173011,0.5780346820809249,0.8955829615539184,1.0,15/30,28.57%,GPRC5C;PRKAG2;SPDYA;STRADA;RGCC;WNK1;GPRC5B;WNT11;MT3;AGAP2;GPRC5A;TPX2;EPO;FGF13;TREM2
prerank,ankyrin binding (GO:0030506),-0.35600982810243254,-0.9326980062959703,0.5765765765765766,0.8930781579276174,1.0,5/19,8.66%,CACNA1D;SLC8A1;CDH1;FLNC;NRCAM
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4431267227359678,0.9315187978302693,0.5423423423423424,0.9113827812225932,1.0,6/12,21.92%,KDM3A;JMJD1C;KDM4C;KDM4A;KDM1A;PHF2
prerank,protein kinase regulator activity (GO:0019887),-0.2597460499005256,-0.9314041255366213,0.5991189427312775,0.8910269567355035,1.0,30/95,19.51%,PARVA;TAOK3;GPRC5C;PRKAG2;CCND2;DNAJC3;KIDINS220;SPDYA;STRADA;CCNL2;RGCC;PRKAR1B;WNK1;PRKAG3;CCNL1;GPRC5B;PRKAR1A;CDKN1A;CCNT2;CCNG2;WNT11;SNCA;SMCR8;CDKN1C;MT3;PRKAG1;CSNK2B;DUS2;CCNF;ELP4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3151911144520915,-0.9311835910040527,0.5628415300546448,0.8861348888070539,1.0,9/32,16.32%,KDM7A;TET1;EGLN3;KDM2A;P4HTM;KDM8;BBOX1;FTO;PHYHD1
prerank,ribosomal small subunit binding (GO:0043024),0.4106339247535962,0.9296328721684465,0.5467625899280576,0.9120299686206602,1.0,8/17,24.95%,EIF1;UNG;PIM1;NPM1;MTIF3;PTCD3;MTIF2;EIF4H
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3907405576951608,-0.9294547001176958,0.565410199556541,0.8851013231311072,1.0,7/13,27.66%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC11A1;SLC9A4;SLC9A2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.39090338528928376,0.9286457464588241,0.5483870967741935,0.9107348054524982,1.0,4/26,10.31%,PPP1R2;PPP1R9B;LMTK2;MGAT5
prerank,organic anion transmembrane transporter activity (GO:0008514),0.30622509429296857,0.9279760211599701,0.6095238095238096,0.9088661163687599,1.0,9/134,4.96%,ABCC4;SLCO2B1;ABCG2;SLC39A8;SLCO2A1;SLC38A5;SLC3A2;SLC35B3;SLC6A6
prerank,adrenergic receptor binding (GO:0031690),-0.37311649718988843,-0.9259312523347912,0.5600961538461539,0.888544138985959,1.0,4/16,8.20%,MAGI2;DLG4;GNAS;ADRA2A
prerank,kinesin binding (GO:0019894),-0.33498149733041677,-0.9257902734444411,0.5778894472361809,0.8836038850208229,1.0,16/27,31.85%,ARHGEF10;IFT88;PLEKHM2;RAB29;KIF1B;TTBK2;SNCA;KIFAP3;PRC1;KLC2;KIF18B;TOR1A;TOR1B;CROCC;FAM83D;NEFH
prerank,hydro-lyase activity (GO:0016836),-0.3073287661922766,-0.9249381660482933,0.5871313672922251,0.8804720866905845,1.0,13/41,16.77%,GMDS;HACD3;ECHDC1;ENO2;CA4;HACD1;ECHDC3;ECHDC2;L3HYPDH;CBS;NAXD;ENO3;ACO2
prerank,cation:chloride symporter activity (GO:0015377),0.45567991034766575,0.9248145430064637,0.5571687840290381,0.9123284818353788,1.0,2/10,7.77%,SLC12A7;SLC12A9
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.3965472914037153,0.9247342657831672,0.5822147651006712,0.9091378097385054,1.0,4/21,2.89%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,omega peptidase activity (GO:0008242),0.31748276557608723,0.9246272535542365,0.5862977602108037,0.9059961495079295,1.0,18/89,18.89%,USP53;USP3;USP15;UCHL5;ATXN3;BRCC3;ZRANB1;OTUD4;APEH;GGH;USP12;OTULIN;YOD1;USP8;DESI2;USP7;USP25;USP21
prerank,protein kinase inhibitor activity (GO:0004860),-0.2922395761380532,-0.9244138694105233,0.5750798722044729,0.876483193201175,1.0,12/42,15.56%,SPRED1;PARVA;TAOK3;CIT;DNAJC3;CAMK2N1;SPRED2;CDKN1A;CEP43;SNCA;SMCR8;CDKN1C
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.3776789534423526,-0.9243971899501857,0.5697940503432495,0.871440319323404,1.0,2/15,7.68%,P2RX4;P2RY14
prerank,ion gated channel activity (GO:0022839),0.3895481562838984,0.9235845670285784,0.5670103092783505,0.904863186085831,1.0,4/24,10.53%,ANO2;TTYH2;NMUR2;ANO6
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4140991289134281,-0.9220202455063716,0.5855263157894737,0.8717502481193825,1.0,4/10,7.83%,DPP4;FAP;NAALAD2;DPP6
prerank,C-C chemokine binding (GO:0019957),0.3956881652445198,0.9207629905493124,0.5683690280065898,0.9074815735920672,1.0,6/22,21.06%,ACKR1;CX3CR1;CXCR4;ZFP36;CCR1;CXCR6
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4005016754384189,0.9201248144785803,0.5911330049261084,0.9055138520200672,1.0,5/24,12.28%,DAPK1;PTK2B;MAPKAPK3;EEF2K;MKNK2
prerank,magnesium ion binding (GO:0000287),0.3005001006589703,0.9186796905742404,0.5920398009950248,0.9054417500861002,1.0,37/135,20.87%,SNRK;ERN1;PDE2A;SIK1;STK3;STK4;CDC42BPB;MAST2;SIK3;TSSK6;STK26;NEK6;DUT;NUDT16;HPRT1;PDXP;FAN1;NT5C3A;ABL2;STK38;SIK2;MTPAP;MAP3K20;ENDOV;IRAK3;RHEB;YDJC;PLSCR1;PRKACB;NIM1K;DHX36;PLK1;NLK;PGM1;PDCD6;MAP2K7;MSH2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4476389649568948,0.9180300711052871,0.5549348230912476,0.9003527567618521,1.0,5/11,21.14%,GRPEL1;BAG4;BAG1;SIL1;BAG2
prerank,adenyl nucleotide binding (GO:0030554),0.4476389649568948,0.9180300711052871,0.5549348230912476,0.9003527567618521,1.0,5/11,21.14%,GRPEL1;BAG4;BAG1;SIL1;BAG2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.38688153244102685,0.9174144265641881,0.5886178861788618,0.8984174461582045,1.0,4/23,2.89%,PDE8A;PDE2A;PDE7B;PDE4D
prerank,histone deacetylase activity (GO:0004407),0.4080399165189201,0.9129002894782003,0.5823429541595926,0.9046939849727982,1.0,1/19,0.53%,HDAC9
prerank,hexosaminidase activity (GO:0015929),-0.398928050736071,-0.9120392146155308,0.5882352941176471,0.8892739218108743,1.0,6/12,30.89%,CEMIP;HEXA;HYAL1;NAGA;HYAL3;HEXD
prerank,neuropeptide binding (GO:0042923),0.40709240082707654,0.9117857634905543,0.5574324324324325,0.9037639730631669,1.0,4/18,18.82%,MCHR1;NMUR2;MC4R;OPRL1
prerank,sodium:proton antiporter activity (GO:0015385),-0.3946687880306202,-0.9106539383579064,0.6069114470842333,0.8874831224238757,1.0,6/11,27.66%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC9A4;SLC9A2
prerank,phosphatase binding (GO:0019902),0.30906907631923664,0.9104594664622975,0.5982256020278834,0.9032489594542836,1.0,20/105,10.29%,CTSC;IQGAP1;STAT3;PXN;FLT4;JAK3;CEACAM1;MAST2;SKAP1;CDKN1B;JAK1;LCK;PTK2;SNX3;SHOC2;ANAPC7;ANK1;FBXL2;AP3B1;SH3YL1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.31851426351066014,0.9094171118680429,0.596514745308311,0.902299051731635,1.0,11/75,13.45%,ABCC4;RDH16;HADHA;CBR1;GLYR1;SPR;LDHD;ADH1A;SORD;IMPDH1;HADH
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3503223612800173,0.9074657024570936,0.6133333333333333,0.903170214538681,1.0,8/46,10.31%,LFNG;MGAT4A;MFNG;B3GNT3;B3GNT4;B3GNT6;B4GAT1;MGAT5
prerank,receptor tyrosine kinase binding (GO:0030971),0.3443164406203002,0.9073667118936428,0.6062767475035663,0.9001997643403153,1.0,12/56,15.41%,PTPN14;PITPNM2;DOCK4;NCK1;SH2B2;GRB14;PTPN1;CBL;GAS6;RACK1;LRP4;ALKAL2
prerank,DNA secondary structure binding (GO:0000217),0.36952234142267126,0.9042743305801554,0.5759493670886076,0.9033911173920113,1.0,5/31,10.37%,MEF2C;LIN54;RAD51D;RAD18;XRCC2
prerank,sequence-specific mRNA binding (GO:1990825),-0.40330228967033466,-0.9001991680045833,0.5844155844155844,0.9066102061991383,1.0,5/10,28.37%,LARP6;SHFL;RBM24;SSB;DHX9
prerank,cyclic nucleotide binding (GO:0030551),0.3971164670161665,0.8997138194410172,0.6132231404958678,0.9097255587483825,1.0,4/21,6.24%,PDE2A;PDE4D;CNGB1;RAPGEF2
prerank,insulin-like growth factor I binding (GO:0031994),0.42935810013363496,0.8986730853923939,0.5798922800718133,0.9087144964821863,1.0,2/13,1.57%,ITGA6;INSR
prerank,endoribonuclease activity (GO:0004521),0.3585077658081581,0.8982178184194718,0.5885093167701864,0.9063809181412383,1.0,12/32,25.10%,ERN1;KHNYN;DICER1;INTS11;ZC3H12C;ENDOV;ENDOG;RIDA;LACTB2;SND1;SMG6;CPSF3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.4282121064706044,0.8982067468996967,0.5846702317290553,0.9032691610509764,1.0,4/12,8.89%,B3GNT3;B3GNT4;B3GNT6;B4GAT1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2707212252956022,0.896781149756704,0.7104413347685683,0.9030549573914763,1.0,60/346,14.98%,RNF125;SMURF1;RNF144B;RNF141;NEDD4L;NEURL2;TRIM14;RNF38;ZNRF1;TRAF1;ZNRF3;UBA7;DTX3L;UHRF2;KCTD10;HERC2;TRIM68;PELI1;MYCBP2;XIAP;RNF144A;UBE3B;CBLL1;IRF2BPL;UBE2G1;RNF7;TRIM47;RNF167;NEDD4;TRIM25;RNF139;MALT1;UBR1;TRIM24;UBE2H;RNF146;NEURL1B;NEURL3;FBXW2;RNF4;SIAH1;UBE2D3;CBL;RC3H1;CUL1;MYLIP;UBE3A;BIRC3;RNF112;COP1;HECTD1;RNF25;RNF215;ASB4;UBE2K;TRAF6;FBXL3;TOPORS;MSL2;ARIH2
prerank,transforming growth factor beta binding (GO:0050431),0.3858643889983544,0.890192871760964,0.6134868421052632,0.9127740259320608,1.0,4/23,6.15%,ENG;ACVRL1;NRROS;ACVR1
prerank,aminopeptidase activity (GO:0004177),-0.323628090130491,-0.8898606329032492,0.6153846153846154,0.9249036131255579,1.0,6/26,16.51%,MMP14;MMP16;NPEPPS;ENPEP;KDM8;BLMH
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.41575013316730824,0.8893429448796504,0.5992844364937389,0.9112479787118922,1.0,2/14,7.12%,KCNQ1;KCNE2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.37624621331501307,-0.8891189879960097,0.6325167037861915,0.9212825325800359,1.0,2/12,10.88%,CYFIP2;EIF4E3
prerank,GABA receptor binding (GO:0050811),-0.40055245518239435,-0.8869034507773714,0.6238532110091743,0.9210152613314796,1.0,6/11,26.07%,ARFGEF2;SHISA7;TRAK1;PLCL2;GABARAP;JAKMIP1
prerank,phosphatidic acid binding (GO:0070300),0.3877683358985189,0.8858643037631722,0.5959595959595959,0.9153550318742587,1.0,8/19,22.88%,PLTP;RAPGEF2;PITPNC1;RAPGEF6;PACSIN2;OPA1;MAPKAP1;UQCC3
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3582633357177334,-0.8840230967620816,0.6073170731707317,0.9224096766994172,1.0,12/15,53.11%,COX6B1;NDUFA4L2;COX4I2;COX7A1;NDUFA4;COX10;COX6A2;COX5B;COX15;COX8A;CYB5A;COX7A2L
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4341158373790039,0.8833795200564786,0.590316573556797,0.9173307649912316,1.0,2/10,8.52%,GDA;DCTD
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.368600023620442,0.8824898657971276,0.6109324758842444,0.9162441890783687,1.0,4/26,4.96%,ABCG2;SLC16A2;SLC16A9;SLC6A6
prerank,G protein-coupled amine receptor activity (GO:0008227),0.38140156969957256,0.8757678247576298,0.6247848537005164,0.9202469166543424,1.0,1/22,1.96%,HTR2A
prerank,serotonin receptor activity (GO:0099589),0.38140156969957256,0.8757678247576298,0.6247848537005164,0.9202469166543424,1.0,1/22,1.96%,HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.38140156969957256,0.8757678247576298,0.6247848537005164,0.9202469166543424,1.0,1/22,1.96%,HTR2A
prerank,amyloid-beta binding (GO:0001540),0.3013174267868391,0.875710169151616,0.6786666666666666,0.9173018772594224,1.0,14/79,12.67%,APBB2;INSR;FZD6;FZD4;BCHE;CACNA1A;ATP1A3;ITM2A;CLSTN1;ITGA2;EPHA4;GRIN1;PICALM;PFDN1
prerank,filamin binding (GO:0031005),-0.39248313337617,-0.8750537837133205,0.6255230125523012,0.9371137153924047,1.0,1/11,0.53%,DPYSL3
prerank,phosphatase activity (GO:0016791),-0.25348765526492373,-0.874776993647393,0.7196969696969697,0.9327154713153499,1.0,15/73,15.30%,ATP1A2;PLPP3;ALPL;DUSP11;PXYLP1;LPIN1;EPHX2;LHPP;DUSP10;PTPN22;SBF1;ACP6;PPP1CB;PLPPR5;APTX
prerank,water transmembrane transporter activity (GO:0005372),-0.3775172090584998,-0.8742179684178037,0.6327433628318584,0.9289460077161127,1.0,1/11,1.61%,PDPN
prerank,SH2 domain binding (GO:0042169),0.3564371216686186,0.8730253702362607,0.6465798045602605,0.91945275678447,1.0,8/31,9.25%,AFAP1L2;SH2B2;CCDC88A;SKAP1;LCK;PTK2;TRPV4;CRK
prerank,methylation-dependent protein binding (GO:0140034),0.3182594104938633,0.8705282718628541,0.6396011396011396,0.9212770747011592,1.0,16/57,18.95%,KMT2E;SPIN1;MTF2;CDYL;CHD1;TRIM24;GLYR1;ZMYND11;FMR1;ATRX;KDM4A;CXXC1;PHF19;ZCWPW2;ING3;RBBP5
prerank,insulin-like growth factor binding (GO:0005520),0.40625123603598323,0.8691353669438158,0.6145648312611013,0.9209824319850323,1.0,2/15,1.57%,ITGA6;INSR
prerank,chloride channel regulator activity (GO:0017081),0.4020521832374967,0.8690931284737717,0.6179577464788732,0.9180377985007854,1.0,5/14,11.54%,STX7;STX1A;SGK3;VAMP8;STX8
prerank,bHLH transcription factor binding (GO:0043425),0.38796175045445963,0.8684908709291915,0.6308943089430894,0.9161834397332869,1.0,4/19,10.52%,LMO2;TCF12;TCF3;USF2
prerank,mannosyltransferase activity (GO:0000030),0.37360285068610816,0.8684167774459279,0.6483704974271012,0.9133224038522748,1.0,1/21,0.81%,TMTC2
prerank,growth factor activity (GO:0008083),-0.2474471930916134,-0.8655130322901043,0.7491039426523297,0.9426762151443779,1.0,18/74,18.69%,PTN;FGF1;FGF2;IGF2;NGF;JAG1;NRG3;OSGIN2;VEGFB;VEGFA;INHBA;FGF7;HBEGF;PDGFA;FGF10;MDK;ANGPTL3;CLCF1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.3249130912718534,-0.8643916887358909,0.6501240694789082,0.9399112299163682,1.0,10/21,34.84%,FGF1;FGF2;FGF7;FGF10;NPTN;FGF18;KLB;FGF22;FGF5;FGF9
prerank,metal ion binding (GO:0046872),0.2572995437889187,0.8638714215673183,0.8085327783558793,0.9192085945438937,1.0,59/477,11.94%,CSGALNACT1;MCTP1;TGM2;SNRK;LCP1;ERN1;PIR;PLA2G4A;IQGAP1;PDE2A;PPP3CA;PITPNM2;TPD52;SIK1;ESYT2;RASGRP3;STK3;SELP;CDH2;STK4;PADI4;CDC42BPB;MAST2;ENPP2;PAM;ASAH2;SPARCL1;RET;PPP3CB;CHP2;SIK3;RAPGEF2;PLA2G2D;FBP1;TSSK6;STK26;LPL;NEK6;PKD2;BNIP2;MICU2;AGRN;ITPR3;CDH15;IHH;DUT;NUDT16;CDH23;HPRT1;PDXP;FAN1;CD320;NT5C3A;ABL2;SYT15;GRIN1;STK38;CDHR5;SIK2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.38665280434036564,-0.8602019315492272,0.6363636363636364,0.9437654985426285,1.0,2/11,14.95%,AKR1B1;RDH13
prerank,metallocarboxypeptidase activity (GO:0004181),-0.31182335189031296,-0.8588209039406602,0.6889460154241646,0.9417819810834591,1.0,10/26,25.29%,AEBP1;CPXM2;CPXM1;AGBL4;CPM;ACE2;AGBL1;AGBL2;CPZ;PEPD
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.36811313913261945,-0.8581926153731315,0.6763392857142857,0.9379622565124643,1.0,6/12,27.66%,SLC9A9;SLC9A1;SLC9B2;SLC9A8;SLC9A4;SLC9A2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3640506479345922,0.854145199949635,0.6644518272425249,0.932068371395089,1.0,2/21,3.20%,CDK6;CCNK
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3640506479345922,0.854145199949635,0.6644518272425249,0.932068371395089,1.0,2/21,3.20%,CDK6;CCNK
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.3029780133228586,-0.8516620244720515,0.7094972067039106,0.9461621283709944,1.0,9/29,12.90%,SPRED1;YWHAG;PKIA;CIT;PRKAG2;PRKAR1B;SPRED2;PRKAR1A;CDKN1A
prerank,symporter activity (GO:0015293),-0.384056688944321,-0.8493651729366087,0.6623093681917211,0.9459391905015174,1.0,3/10,14.00%,SLC5A5;SLC5A6;MFSD2A
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.4239310125780604,0.8487369768526625,0.629277566539924,0.9362996619123364,1.0,3/10,13.67%,DUSP16;DUSP2;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.4239310125780604,0.8487369768526625,0.629277566539924,0.9362996619123364,1.0,3/10,13.67%,DUSP16;DUSP2;DUSP7
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.36109958374183704,-0.8486126134303735,0.6659192825112108,0.9425763127544868,1.0,4/13,16.64%,AGPAT4;LCLAT1;AGPAT3;LPCAT1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3838123746901573,0.8466270417864363,0.6637931034482759,0.9371873267151055,1.0,6/18,17.34%,TMOD3;PDLIM1;CNN3;PAK4;STXBP6;PDLIM5
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3897293334754717,-0.8458658526141775,0.6617647058823529,0.9432336027072336,1.0,2/10,4.57%,ANO1;CLCN2
prerank,carboxylic acid binding (GO:0031406),0.32644190987297855,0.8443326838899416,0.6732223903177005,0.9385958739202749,1.0,4/38,11.51%,NOS3;PADI4;UBR1;GRIN1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3936352671572462,0.8426152509004141,0.6631016042780749,0.9389077516241078,1.0,3/14,20.74%,AK4;CMPK1;DTYMK
prerank,telomeric DNA binding (GO:0042162),0.3411483009831477,0.8420036799795496,0.6706766917293233,0.9370680706915009,1.0,12/32,23.91%,HMBOX1;RPA1;HNRNPD;SMG7;ACD;UPF2;TERF1;KDM1A;TEN1;PURA;SMG6;TELO2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3381880606425681,0.8409462024329017,0.6726384364820847,0.9360066569796024,1.0,2/30,3.31%,SLC39A8;SLC31A1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.31794463372378534,-0.8375446895366189,0.7149425287356321,0.9552898542715356,1.0,4/19,13.39%,P2RX4;RYR2;GRIN2A;GRIN2D
prerank,chloride channel activity (GO:0005254),-0.25549304309377874,-0.836705395439401,0.794392523364486,0.9517794874206835,1.0,13/59,15.32%,SLC26A7;ANO1;GLRB;CLCN2;GABRG2;ANO4;GABRA2;GABRB1;ANO3;GABRG3;GABRB3;FXYD1;CLCN7
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.42129280115311785,0.8344019390873882,0.6753246753246753,0.9451152439671135,1.0,2/10,9.72%,CD200;IZUMO1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.36312062233176645,0.8338830714775897,0.6597582037996546,0.943148512502439,1.0,1/20,0.93%,SLC39A8
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3763492079323079,-0.8325688351217531,0.6884531590413944,0.9547098910566828,1.0,4/11,19.58%,HNRNPA2B1;RAD50;HNRNPA1;TERF2
prerank,miRNA binding (GO:0035198),-0.2848070485338071,-0.8287075487911199,0.7663043478260869,0.9573367129266106,1.0,10/30,20.39%,HNRNPA2B1;AGO3;RBM4;HNRNPA1;ZC3H7B;DDX21;TUT4;ZNF346;SOX2;MATR3
prerank,histone methyltransferase binding (GO:1990226),0.4028104986687208,0.8275921944303021,0.6534296028880866,0.9513341565349599,1.0,6/11,22.56%,LCORL;HSP90AB1;CTNNB1;LCOR;PHF1;PRDM4
prerank,histone demethylase activity (GO:0032452),0.33808760249831055,0.8205738061511758,0.6868852459016394,0.9606941777737338,1.0,10/27,21.92%,KDM3A;KDM6A;JMJD1C;KDM4C;JARID2;KDM5C;KDM4A;KDM1A;JMJD6;PHF2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.3819670628683199,0.8205356215780095,0.6947935368043088,0.9577786850463472,1.0,2/15,6.75%,SLC39A8;SLC26A1
prerank,tau protein binding (GO:0048156),-0.2694438134138135,-0.8199742154694887,0.7905604719764012,0.9691125410026343,1.0,10/40,16.43%,ROCK2;MAP2;BRSK1;HSP90AA1;S100B;BIN1;APOE;TTBK2;SNCA;TTBK1
prerank,disordered domain specific binding (GO:0097718),0.35886507356785785,0.818858954249784,0.7037671232876712,0.9578413223099819,1.0,7/23,18.87%,FYN;TEAD2;RB1;HSP90AB1;CALM1;SMAD2;NUMA1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.35790071228530435,0.8183382857875484,0.6890625,0.9557273145507926,1.0,4/22,9.69%,RNF169;MINDY2;ZRANB1;IKBKG
prerank,MAP kinase phosphatase activity (GO:0033549),0.3946255877133429,0.8160443603199562,0.6594202898550725,0.9569113099465377,1.0,3/12,13.67%,DUSP16;DUSP2;DUSP7
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.3617478302173289,-0.8153352085807227,0.7262443438914027,0.9731071202818086,1.0,2/12,12.00%,AOX1;FDX1
prerank,sodium channel regulator activity (GO:0017080),0.32171904371338217,0.814366185124122,0.7329286798179059,0.9567408110424134,1.0,5/37,8.66%,NEDD4L;FXYD6;ATP2B4;NEDD4;SGK3
prerank,ribosomal large subunit binding (GO:0043023),0.39919064141696087,0.8112683247742392,0.6904761904761905,0.9593245109172741,1.0,4/11,14.08%,RBM3;EIF6;MRRF;NPM1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3374023766427312,0.8110584778274204,0.680921052631579,0.9567247798564987,1.0,12/28,23.27%,MAP3K9;RPS6KA1;AURKA;AURKC;MAP2K3;MAPKAPK3;PRKCG;MAP2K4;MAP2K5;MAP2K7;MAP2K6;MAPK14
prerank,cardiolipin binding (GO:1901612),-0.36349434079463044,-0.809926562237368,0.7040358744394619,0.9781753699440948,1.0,1/10,3.98%,GSDME
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.23745014107485343,-0.809669094504897,0.86328125,0.9737449978979493,1.0,16/74,16.74%,NADK2;PI4KA;GK;FAM20C;FAM20A;DGKD;GALK2;PAPSS2;DGKI;HK2;DCAKD;SPHK1;PIK3CD;DGKQ;MVK;GALK1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.34832709173296705,-0.8083039236289777,0.7277227722772277,0.9714131179891459,1.0,5/12,17.88%,SLC25A42;SLC19A1;SLC25A25;SLC25A23;SLC17A9
prerank,potassium:proton antiporter activity (GO:0015386),-0.35956882852890715,-0.8081696858705252,0.7224669603524229,0.9668646823575588,1.0,5/10,27.66%,SLC9A9;SLC9A1;SLC9A8;SLC9A4;SLC9A2
prerank,nuclease activity (GO:0004518),0.3052985724861973,0.8076097683136966,0.752906976744186,0.959728655530702,1.0,7/52,8.97%,SAMHD1;ISG20;N4BP1;RNASE1;RNASEH2A;ANG;RNASE4
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.30114652978438233,-0.8061263815441174,0.7885117493472585,0.9655718540439719,1.0,5/22,12.61%,ATP6V0A4;ATP2A2;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.36058374536805016,0.8044575902606305,0.6833910034602076,0.9623672290533896,1.0,3/17,20.74%,AK4;CMPK1;DTYMK
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3365522275683285,0.8003402647840108,0.7457886676875957,0.9662624522147959,1.0,8/32,15.68%,SLC38A5;SLC3A2;SLC6A6;SLC43A2;SLC38A1;SLC25A38;SLC36A4;SLC7A5
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.33818613154624244,0.800246700488085,0.7394822006472492,0.9634962057279133,1.0,4/24,14.86%,ITPKB;AK4;CMPK1;PMVK
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.3508348158143392,-0.7978293697983841,0.7506053268765133,0.9752114491998316,1.0,5/11,17.88%,SLC25A42;SLC19A1;SLC25A25;SLC25A23;SLC17A9
prerank,carboxypeptidase activity (GO:0004180),-0.26592009904032843,-0.7977158858862353,0.8055555555555556,0.9705678726905452,1.0,11/35,18.92%,AEBP1;NAALAD2;CPXM2;CPXM1;AGBL4;SCPEP1;CTSZ;BLMH;CPM;ACE2;AGBL1
prerank,methylated histone binding (GO:0035064),0.28607017906890553,0.7969262565360343,0.7507042253521127,0.9661235125432669,1.0,19/62,21.92%,KMT2E;SPIN1;MTF2;CDYL;CHD1;TRIM24;GLYR1;ZMYND11;FMR1;ATRX;KDM4A;CXXC1;PHF19;ZCWPW2;ING3;RBBP5;TAF7;PHF1;PHF2
prerank,histone acetyltransferase activity (GO:0004402),0.32429169076630837,0.7955283270685981,0.7531055900621118,0.965589554097483,1.0,8/30,15.74%,EPC1;ARRB1;KAT6B;HAT1;SRCAP;KAT2B;KAT6A;BAZ1A
prerank,DNA polymerase binding (GO:0070182),-0.3178178455525988,-0.7925136993980283,0.7325301204819277,0.9745083461464445,1.0,4/18,12.21%,HSP90AA1;RTEL1;SMARCA4;FANCI
prerank,chloride channel inhibitor activity (GO:0019869),0.3958529325871249,0.7911342214971783,0.7345794392523365,0.9701418985170445,1.0,4/10,11.54%,STX7;STX1A;VAMP8;STX8
prerank,MAP kinase kinase activity (GO:0004708),0.3668756599245591,0.7906366244081017,0.7283531409168081,0.968016515320694,1.0,8/15,23.27%,MAP3K9;MAP2K3;MAPKAPK3;MAP2K4;MAP2K5;MAP2K7;MAP2K6;MAPK14
prerank,mRNA binding (GO:0003729),0.24450585601639188,0.7896470735505134,0.8931034482758621,0.9667606991150326,1.0,50/249,16.06%,NANOS3;NOVA2;RBPMS;ADARB1;IGF2BP3;PTBP3;RPS14;RBM20;NANOS2;N4BP1;EDC3;CNBP;RPS7;HNRNPK;HNRNPA0;RBM14;SRBD1;MARF1;RBM25;THOC2;YBX3;KHNYN;PUM1;NUDT16;G3BP1;HNRNPLL;SERBP1;ANGEL2;RPL13A;RBM15;YTHDC1;RC3H1;RNPS1;MRPL13;PUM2;NUP98;HNRNPC;ZFP36;FMR1;SF3B6;NSRP1;ZFP36L1;ZC3H12C;LARP4B;QKI;RPS13;LSM14A;LUC7L2;AQR;G3BP2
prerank,signal sequence binding (GO:0005048),0.3094080423327791,0.7894359427603704,0.7573872472783826,0.9642661295105247,1.0,4/35,5.01%,NFKBIA;BABAM2;CAT;AP2B1
prerank,peptide hormone receptor binding (GO:0051428),-0.34562614544699544,-0.7844711255685366,0.7136258660508084,0.9830947586688623,1.0,8/11,50.72%,CCK;PSMC5;ADCYAP1;PTHLH;VIP;UCN2;GPHB5;GHRH
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3127352008203053,0.7837102321809413,0.7308868501529052,0.9706925111156316,1.0,15/34,27.02%,UBE2G1;UBE2H;UBE2D3;UBE2K;UBE2I;CDC34;UBE2Q1;UBE2L3;UBE2F;UBE2J2;UBE2R2;UBE2D1;UBE2E1;AKTIP;UBE2N
prerank,NAD+ binding (GO:0070403),-0.34294794344814644,-0.7823047949930271,0.7431578947368421,0.9817111860236986,1.0,2/12,4.27%,CRYL1;SIRT2
prerank,3'-5' exonuclease activity (GO:0008408),0.30221533822564794,0.7819998238393221,0.7852852852852853,0.9707109846623272,1.0,13/45,22.63%,CNOT6;CNOT6L;ISG20;ANGEL2;REXO2;CNOT7;TRIR;XRN2;PNPT1;PAN2;DIS3L;TOE1;NOCT
prerank,lysine-acetylated histone binding (GO:0070577),-0.3048626887458086,-0.781194354563645,0.753731343283582,0.9741929719585699,1.0,9/20,17.60%,PSME4;TAF1;SMARCA4;THAP7;BRD9;ZMYND8;BAZ2A;BRDT;CARM1
prerank,acetylation-dependent protein binding (GO:0140033),-0.3048626887458086,-0.781194354563645,0.753731343283582,0.9741929719585699,1.0,9/20,17.60%,PSME4;TAF1;SMARCA4;THAP7;BRD9;ZMYND8;BAZ2A;BRDT;CARM1
prerank,microtubule plus-end binding (GO:0051010),-0.2978164256281303,-0.7810388512704387,0.7828282828282829,0.9698445574672315,1.0,3/20,6.27%,CLIP4;CLIP3;STIM1
prerank,P-type ion transporter activity (GO:0015662),0.37746857793864325,0.7805489730111013,0.7208872458410351,0.9703322133445783,1.0,3/12,10.44%,ATP2B4;ATP2C1;ATP7B
prerank,receptor antagonist activity (GO:0048019),-0.3075081577775991,-0.7797022581954703,0.764172335600907,0.9674181412113865,1.0,2/17,11.19%,DKK3;DKK2
prerank,WW domain binding (GO:0050699),0.3246998241919324,0.7784297790516879,0.7715231788079471,0.9710242044988089,1.0,7/26,20.00%,RAPGEF2;DAZAP2;PMEPA1;CDC25C;NDFIP2;LITAF;TCEAL9
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.3949139689764839,0.7778829544296855,0.7242647058823529,0.9690558651505429,1.0,3/10,14.87%,CDKN1B;INCA1;KAT2B
prerank,ATPase regulator activity (GO:0060590),0.3048051916962981,0.7768539599823575,0.7660550458715596,0.9679297470842055,1.0,11/38,21.14%,FNIP2;DNAJA1;GRPEL1;ATP1B3;BAG4;BAG1;DNAJB1;SIL1;DNAJC10;DNAJB6;BAG2
prerank,endopeptidase activator activity (GO:0061133),0.38132895071271,0.7729993090613118,0.7338403041825095,0.9708623507792832,1.0,3/10,15.51%,APH1A;PSME1;VSIR
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3412732931962189,-0.7720289538382284,0.740990990990991,0.9746650809360782,1.0,3/11,14.03%,SLC5A3;SLC2A10;SLC5A11
prerank,motor activity (GO:0003774),0.2770366357408159,0.7688573144723183,0.8062678062678063,0.9745751040648002,1.0,12/60,12.38%,MYH9;STARD9;KIF26A;DNAH3;KIF22;MYO1E;DYNLRB1;KIF19;KIF23;MYL6B;DNAH17;KIF16B
prerank,methyl-CpG binding (GO:0008327),-0.28647795422105504,-0.7670400513796586,0.7797927461139896,0.9777817100782452,1.0,4/22,12.56%,TET1;CXXC4;ZBTB38;CXXC5
prerank,phosphatidate phosphatase activity (GO:0008195),0.3653794359850261,0.7667412948536555,0.7415929203539823,0.9750382300113272,1.0,2/13,5.61%,PLPP1;LPIN3
prerank,epidermal growth factor receptor binding (GO:0005154),0.3201603844946354,0.7663683248928714,0.77491961414791,0.9728291760434973,1.0,9/25,18.76%,HIP1;CCDC88A;TGFA;SNX4;GRB2;SNX1;PLSCR1;LINGO1;BTC
prerank,MHC class I protein binding (GO:0042288),0.3637472594030552,0.7650103435034786,0.7282809611829945,0.9721506084242609,1.0,5/13,29.51%,TAP2;TAP1;TAPBP;ATP5F1B;ABCB9
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3674870329110983,0.7649103175295521,0.7477638640429338,0.969515851798516,1.0,5/14,19.40%,RPP30;RPP25;TSEN34;TSEN2;PRORP
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.35236326041535415,-0.7633114451027477,0.7536231884057971,0.9791652559450374,1.0,3/10,9.16%,ECHDC1;ECHDC3;ECHDC2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.336911000213634,0.7620806967491545,0.7564766839378239,0.9711228147307648,1.0,4/20,13.69%,TJP2;AK4;MAGI3;CMPK1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.32586099619580655,-0.7614147017675895,0.7626728110599078,0.9774340968188966,1.0,4/13,28.58%,TARBP1;THUMPD3;METTL1;TRMT10B
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3369535792405523,-0.7612486191290915,0.7539863325740319,0.9731956429752868,1.0,2/11,10.04%,NUDT4;NUDT7
prerank,myosin V binding (GO:0031489),0.35491045424119116,0.761065114207858,0.7418803418803419,0.9698354436829655,1.0,5/15,23.06%,RAB11A;RAB11B;RAB6A;RAB25;RAB3A
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3128516971332407,-0.7598675078657398,0.7822014051522248,0.9708067089057666,1.0,4/15,16.64%,AGPAT4;LCLAT1;AGPAT3;LPCAT1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3045669850908561,0.7583053405704824,0.7967479674796748,0.9711982609375798,1.0,5/32,10.81%,KCNQ1;KCNB1;KCNE2;KCNG4;KCNA4
prerank,CXCR chemokine receptor binding (GO:0045236),-0.33302378596354254,-0.7573473414964553,0.7705627705627706,0.970043236192499,1.0,3/11,14.57%,CXCL12;ITCH;YARS1
prerank,protein kinase activator activity (GO:0030295),0.27441720367326017,0.7545596563554536,0.8284518828451883,0.9739005823305129,1.0,9/60,11.07%,IQGAP1;AFAP1L2;STK3;PAK2;STK4;RPLP1;RPTOR;RICTOR;GAS6
prerank,mannose binding (GO:0005537),0.35739134282694207,0.7542971336022392,0.7615658362989324,0.9714747883041315,1.0,3/12,25.02%,ACR;CLN5;LMAN2L
prerank,transferrin receptor binding (GO:1990459),-0.3459629169029782,-0.753454798139103,0.7567567567567568,0.9710486755665274,1.0,3/10,10.66%,RGMA;CD81;CHUK
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3722080346081778,0.7486672280781717,0.7635009310986964,0.9768599544969468,1.0,2/10,4.12%,PRKAR2B;PKIG
prerank,pentosyltransferase activity (GO:0016763),-0.2504025597241037,-0.7449256340076787,0.85,0.9784610790893129,1.0,9/36,20.94%,LARGE1;SIRT2;PARP3;PARP11;LACC1;QPRT;ART3;PARP8;TIPARP
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.31350792194228233,-0.7435536921198209,0.8215962441314554,0.9758407255799156,1.0,1/15,2.78%,CCR9
prerank,mRNA methyltransferase activity (GO:0008174),0.3643466673769008,0.7421955081671724,0.7464285714285714,0.9833861956166243,1.0,6/12,27.24%,RNMT;METTL14;TRMT61B;METTL16;TRMT10C;NSUN2
prerank,tRNA methyltransferase activity (GO:0008175),-0.29543825984787003,-0.737025747100732,0.830952380952381,0.9799881704227192,1.0,10/16,44.80%,TARBP1;THUMPD3;BCDIN3D;METTL2A;METTL2B;TRMT9B;TRMT13;THUMPD2;TRMT44;FTSJ1
prerank,channel activity (GO:0015267),-0.23534494043153092,-0.7360590595592131,0.9067524115755627,0.976955157364629,1.0,2/41,1.61%,BCL2;PDPN
prerank,nucleosomal DNA binding (GO:0031492),-0.28381741684885864,-0.7347447096273434,0.8376288659793815,0.9742684777173979,1.0,8/21,24.51%,CHD4;SMARCA4;SMARCB1;MTA2;ACTL6A;RBBP4;SMARCD2;RCC1
prerank,GTPase inhibitor activity (GO:0005095),0.34198322185763597,0.7347139715592663,0.7814207650273224,0.9910550470614408,1.0,1/13,2.07%,IQGAP1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.35864441056951546,0.733810913034942,0.7850467289719626,0.9895180809471349,1.0,2/12,12.33%,OPN4;OPN5
prerank,endonuclease activity (GO:0004519),0.27394126610429226,0.7334586609936615,0.8472834067547724,0.9872180826187741,1.0,13/49,23.55%,ERN1;ANG;KHNYN;DICER1;INTS11;ERCC4;ZC3H12C;RPS3;ENDOG;LACTB2;SND1;MBD4;SMG6
prerank,RNA stem-loop binding (GO:0035613),-0.32656823761870135,-0.7329192595113084,0.8112359550561797,0.9720668401128314,1.0,3/12,15.84%,CPEB3;LARP6;RC3H2
prerank,muscle alpha-actinin binding (GO:0051371),-0.29878344560705294,-0.7319622853975302,0.7959183673469388,0.9690642208203368,1.0,5/15,17.25%,PALLD;PDLIM7;PDLIM4;LDB3;PDLIM2
prerank,tubulin binding (GO:0015631),0.2215949343460471,0.7318649039229603,0.9669239250275634,0.9866352382356465,1.0,37/295,14.61%,DNM3;MTUS1;DIXDC1;RAB11A;ARHGEF2;REEP1;DST;STARD9;FYN;KIF26A;DIP2B;RAB11FIP5;MAST2;TTLL7;CCDC88A;MID2;TRPV4;KIF22;PHF6;ARHGEF7;TBCA;RAD51D;CEP57;ARL8B;PRUNE1;KIF19;KIF23;EML6;GABARAPL1;KIF16B;MID1;FMR1;NDEL1;PEX14;TTLL5;S100A9;APC
prerank,snRNA binding (GO:0017069),-0.23499462987466394,-0.729010928551121,0.9025157232704403,0.9684051131050772,1.0,7/42,15.84%,SNRNP70;DDX39B;CCNT2;CDK9;HNRNPU;DDX21;RNPC3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.3209587709899794,-0.7289368739836588,0.782312925170068,0.9642690823398031,1.0,7/10,39.18%,POLD1;EXO1;DCLRE1B;FEN1;EXD2;MGME1;TATDN1
prerank,R-SMAD binding (GO:0070412),-0.29224862035942434,-0.7286197604771915,0.837378640776699,0.9604242418908572,1.0,4/18,9.58%,DDX5;SMAD6;SMAD3;RGCC
prerank,monocarboxylic acid binding (GO:0033293),0.3212993011353419,0.7260205020158651,0.7904599659284497,0.9920236668577846,1.0,2/18,6.67%,CYP26A1;CYP26C1
prerank,leucine zipper domain binding (GO:0043522),-0.32712804551513014,-0.7189016780252997,0.825531914893617,0.9680349442584156,1.0,1/10,0.74%,PAWR
prerank,CoA hydrolase activity (GO:0016289),-0.28872748682261745,-0.7174774540179509,0.8554502369668247,0.9653587150805893,1.0,8/16,39.33%,ACOT11;NUDT7;ACOT8;ACOT9;ACOT1;ACOT7;ACOT12;HIBCH
prerank,cholesterol binding (GO:0015485),0.26493544652141915,0.7172476661294247,0.8485294117647059,1.0,1.0,5/47,8.05%,CAV1;STARD5;PROM1;OSBPL10;SOAT2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3153100941726624,0.7148352232462375,0.7973856209150327,1.0,1.0,6/19,16.70%,AFAP1L2;PAK2;GREM1;GAS6;ALKAL2;ABI1
prerank,methyltransferase activity (GO:0008168),-0.22615543723811465,-0.7117334621257347,0.9297124600638977,0.9676573559176419,1.0,23/46,38.06%,FTSJ3;METTL27;COQ5;NDUFAF7;LCMT1;ASMT;EEF1AKMT1;BUD23;NNMT;PRMT8;RRP8;AS3MT;BCDIN3D;EEF1AKMT3;PRMT7;NTMT1;MEPCE;EEF1AKMT4;COMTD1;PRMT1;METTL4;AMT;EEF1AKMT2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.23757274833434605,-0.6997278785532117,0.907859078590786,0.9761819493535545,1.0,13/34,28.65%,KMT5A;EHMT2;SETDB1;DOT1L;MEN1;SETD4;VCPKMT;EEF1AKMT1;METTL21A;ANTKMT;EEF2KMT;EEF1AKMT3;SETD7
prerank,nuclear localization sequence binding (GO:0008139),0.3112819936502188,0.6963616419914498,0.8344709897610921,1.0,1.0,5/18,21.60%,NFKBIA;NUP214;NUP153;KPNB1;KPNA4
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2821620933593166,0.6956607569610825,0.8569206842923794,1.0,1.0,13/31,27.02%,UBE2G1;UBE2H;UBE2D3;UBE2K;CDC34;UBE2Q1;UBE2L3;UBE2J2;UBE2R2;UBE2D1;UBE2E1;AKTIP;UBE2N
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2518753998552775,0.6951715970965396,0.90625,1.0,1.0,8/60,7.29%,PPP3CA;PPM1F;PPM1L;PPP3CB;MTMR6;PGAM5;PPM1D;LCK
prerank,exonuclease activity (GO:0004527),0.2657831015784723,0.6948301360348476,0.873900293255132,1.0,1.0,9/46,15.02%,CNOT6;ISG20;ENPP2;EXOSC1;FAN1;REXO2;CNOT7;TRIR;XRN2
prerank,translation initiation factor activity (GO:0003743),0.27582981419484603,0.6947641374333331,0.8571428571428571,1.0,1.0,8/36,15.59%,EIF4E;EIF3H;EIF1;EIF2B5;EIF5B;EIF2B2;MTIF3;EIF5
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.2803993782639066,0.689349204354896,0.8716744913928013,1.0,1.0,3/31,7.77%,SLC12A7;PKD2;SLC12A9
prerank,regulatory RNA binding (GO:0061980),-0.22916620039371308,-0.6882129310418743,0.9494047619047619,0.9835702129647329,1.0,11/38,22.10%,HNRNPA2B1;AGO3;RBM4;HNRNPA1;ZC3H7B;DDX21;TUT4;ZNF346;SOX2;MATR3;PIWIL2
prerank,phospholipase activity (GO:0004620),0.2484722654722341,0.6869677547776027,0.9208731241473397,1.0,1.0,7/67,10.21%,PLCB4;PLA2G4A;ENPP2;PLA2G2D;LPL;PLAAT3;GDPD1
prerank,microtubule binding (GO:0008017),0.21214968581737437,0.6854944570744417,0.9850230414746544,1.0,1.0,32/222,17.33%,DNM3;MTUS1;RAB11A;ARHGEF2;REEP1;DST;STARD9;KIF26A;MAST2;CCDC88A;MID2;CAMSAP2;TRPV4;KIF22;CEP57;KIF19;KIF23;EML6;KIF16B;MID1;FMR1;NDEL1;PEX14;S100A9;APC;CEP290;TERF1;CHP1;CEP295;ABRAXAS2;FNTA;WHAMM
prerank,RNA polymerase II complex binding (GO:0000993),-0.23317982272274873,-0.6811293330092082,0.9212827988338192,0.9862213415807263,1.0,8/32,19.51%,RECQL5;CTR9;PAF1;ERCC5;WDR43;HNRNPU;UVSSA;ELP4
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3413797802254952,0.6791683271424543,0.8240917782026769,1.0,1.0,4/10,24.44%,NAA11;NAA16;NAA30;NAA50
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.26992443120388426,0.6766607664143479,0.8712121212121212,1.0,1.0,11/34,27.07%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7;NDUFA6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.26992443120388426,0.6766607664143479,0.8712121212121212,1.0,1.0,11/34,27.07%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;NDUFS4;NDUFS6;NDUFB9;NDUFC1;NDUFS8;NDUFB7;NDUFA6
prerank,translation elongation factor activity (GO:0003746),0.3237812088065014,0.6742869743992091,0.8307952622673435,1.0,1.0,6/14,30.53%,EEFSEC;EEF2;EIF5AL1;EIF5A;GFM1;GFM2
prerank,kinase inhibitor activity (GO:0019210),0.2695163412554491,0.6727350465702024,0.8924889543446245,1.0,1.0,10/33,17.44%,NCK1;CDKN1B;GMFG;GSKIP;WARS1;TRIB1;NPM1;MBIP;SH3BP5L;PRKRIP1
prerank,death domain binding (GO:0070513),0.32358726492075596,0.6701865974671795,0.83399209486166,1.0,1.0,5/11,16.07%,CRADD;BCL2L1;RIPK1;RACK1;IRGM
prerank,death receptor binding (GO:0005123),0.30951415512545766,0.6677562529984994,0.8491228070175438,1.0,1.0,4/15,15.96%,DAB2IP;RIPK1;BID;CASP8AP2
prerank,neuropeptide receptor activity (GO:0008188),-0.22868841352732114,-0.6591481525240496,0.9168900804289544,1.0,1.0,3/29,7.20%,SORCS2;SORCS1;SORCS3
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2557045687456163,0.6587688076609739,0.9155145929339478,1.0,1.0,8/42,17.02%,CCNK;CDKN1B;CCNYL1;CCNY;INCA1;KAT2B;CCNJ;CCNC
prerank,3'-5' DNA helicase activity (GO:0043138),-0.2689183714215688,-0.6576001406231414,0.8730512249443207,0.998660523331454,1.0,2/16,6.00%,NAV2;RECQL5
prerank,snoRNA binding (GO:0030515),0.27162405918025784,0.6572139839619623,0.9065573770491804,1.0,1.0,8/30,19.13%,IMP3;ISG20;NUDT16;RRP9;UTP6;NOP14;HEATR1;NUDT1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.30468843272487345,0.6566491273871391,0.8482142857142857,1.0,1.0,2/15,7.54%,PIK3C2A;PIK3CG
prerank,RNA methyltransferase activity (GO:0008173),0.2880390324116966,0.653467311595462,0.877221324717286,1.0,1.0,3/19,13.29%,TGS1;FBLL1;HENMT1
prerank,hormone activity (GO:0005179),-0.19312726413796436,-0.6440374685233884,0.9855907780979827,1.0,1.0,1/54,0.34%,IGF1
prerank,aspartic-type peptidase activity (GO:0070001),0.3169062773981828,0.6413834677813014,0.8646209386281588,1.0,1.0,4/10,27.20%,PSEN1;DDI2;NAPSA;CTSE
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.2847302866432689,-0.6407130439498948,0.8955555555555555,1.0,1.0,4/11,27.87%,APEX2;NEIL3;NTHL1;NEIL1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.30365616449623023,0.63862763023841,0.8684684684684685,1.0,1.0,3/12,18.17%,CBR1;NQO2;CBR4
prerank,lipase activity (GO:0016298),0.24069733102070523,0.6359216972360429,0.9454277286135693,1.0,1.0,8/43,19.24%,ABHD2;LIPE;LPL;PNPLA2;PNPLA8;FAAH;LIPA;CEL
prerank,voltage-gated anion channel activity (GO:0008308),0.28986888951450707,0.6345498395465918,0.8681318681318682,1.0,1.0,3/15,10.53%,CLCN3;VDAC3;ANO6
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.30356193890984895,0.6331427831627138,0.88268156424581,1.0,1.0,3/13,14.65%,DICER1;FAN1;ENDOV
prerank,ubiquitin binding (GO:0043130),0.22479460146806848,0.6301042512061137,0.9715832205683356,1.0,1.0,22/73,23.65%,MVB12B;FBXW7;N4BP1;NEDD4;IKBKG;RAD23A;VPS28;CXCR4;ILRUN;BUB3;UBXN1;DDI2;BIRC2;WDR48;GGA3;USP25;TSG101;UBXN2A;FBXO7;VPS36;UCHL3;ADRM1
prerank,microtubule motor activity (GO:0003777),0.22902643993338884,0.619756315653368,0.9583333333333334,1.0,1.0,9/51,12.38%,STARD9;KIF26A;DNAH3;KIF22;DYNLRB1;KIF19;KIF23;DNAH17;KIF16B
prerank,ribosome binding (GO:0043022),-0.2004675551844658,-0.6194821015495772,0.9742765273311897,1.0,1.0,4/46,7.23%,CPEB1;CPEB2;CPEB3;CPEB4
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2758394189619909,0.6181333539702525,0.9120689655172414,1.0,1.0,2/18,13.52%,RDH16;SRD5A2
prerank,NADPH binding (GO:0070402),0.29098398435853123,0.6160701197605135,0.8814159292035398,1.0,1.0,1/13,3.48%,LBR
prerank,exopeptidase activity (GO:0008238),0.22819825615074116,0.6134918634911821,0.9598853868194842,1.0,1.0,9/50,15.85%,PRCP;CPE;PM20D2;ERAP1;NUDT16;LAP3;GGH;ZMPSTE24;ACE
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.21699942342023607,-0.6127962622202155,0.9546599496221663,1.0,1.0,11/27,30.44%,POLR2B;POLR3H;MED20;POLRMT;POLR2I;TERT;MED21;POLR3K;POLR2D;CRCP;POLR2G
prerank,microtubule minus-end binding (GO:0051011),0.2887324464764076,0.608062737045293,0.9120879120879121,1.0,1.0,7/13,30.05%,CAMSAP2;CEP290;NUMA1;TUBGCP2;CAMSAP1;HAUS4;TUBGCP3
prerank,O-methyltransferase activity (GO:0008171),-0.2729821529542954,-0.6049796009948372,0.9304347826086956,1.0,1.0,4/10,30.72%,FTSJ3;ASMT;BCDIN3D;MEPCE
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.25423756471670866,0.5965473711671923,0.9425087108013938,1.0,1.0,4/22,11.68%,MESD;DNAJA1;AP2A1;PICALM
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.26090943098316227,0.5963300253220144,0.9221854304635762,1.0,1.0,7/20,18.89%,EIF3H;COPS2;YOD1;DESI2;USP7;USP25;USP21
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.2418072297108238,-0.5957196726091751,0.9464720194647201,1.0,1.0,7/17,32.91%,ACOT11;PLA2G6;PPT1;ACOT8;ACOT9;ACOT1;ACOT7
prerank,5'-nucleotidase activity (GO:0008253),0.27959285313342763,0.5898931602269553,0.9084380610412927,1.0,1.0,2/13,11.05%,NT5C2;NT5C3A
prerank,N-acetyltransferase activity (GO:0008080),0.2610172641111258,0.5884995650909436,0.9354838709677419,1.0,1.0,3/19,14.87%,NAT2;SMARCE1;KAT2B
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.21376131837064005,-0.5859287069210423,0.974293059125964,1.0,1.0,3/25,7.95%,SIRT2;PARP3;PARP11
prerank,histone methyltransferase activity (GO:0042054),-0.19715171499776307,-0.5807470383610003,0.9766839378238342,1.0,1.0,12/32,30.27%,KMT5A;EHMT2;SETDB1;DOT1L;CARM1;MEN1;PRMT8;FBL;PRMT2;SETD7;PRMT7;NTMT1
prerank,Hsp70 protein binding (GO:0030544),0.23866581638895337,0.5745663553958463,0.9657320872274143,1.0,1.0,2/31,6.81%,ERN1;DNAJA1
prerank,four-way junction DNA binding (GO:0000400),-0.22628533018357544,-0.5740606118844525,0.9643705463182898,1.0,1.0,9/17,31.73%,RAD51B;MSH6;MEN1;HMGB2;RAD51C;GEN1;XRCC3;BLM;WRN
prerank,ATPase activator activity (GO:0001671),0.2524197580383348,0.5731267264836506,0.9508196721311475,1.0,1.0,5/20,19.29%,DNAJA1;ATP1B3;DNAJB1;DNAJC10;DNAJB6
prerank,acetylcholine receptor activity (GO:0015464),-0.21238728976133536,-0.5703873763089834,0.9712918660287081,1.0,1.0,13/22,46.02%,CHRFAM7A;CHRNA7;CHRM3;CHRM2;CHRM1;CHRNB2;CHRM5;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3
prerank,acetyltransferase activity (GO:0016407),-0.1982182664290505,-0.5697751709087598,0.9853801169590644,1.0,1.0,6/31,15.58%,PAFAH2;ACAT1;SPHK1;SAT1;KAT8;PAFAH1B2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.266911221433002,0.5637882599174303,0.9312169312169312,1.0,1.0,2/14,11.75%,RDH16;ADH1A
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.22571990247859008,0.5631532851177664,0.9724770642201835,1.0,1.0,13/35,33.08%,PTRH1;NT5C3A;QRSL1;DTWD2;MTFMT;AARS2;LCMT2;TRMT12;TRIT1;GATC;ALKBH1;TYW3;PUS10
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.2279807763321075,-0.5616451677675166,0.9767981438515081,1.0,1.0,6/15,30.52%,SETD4;KMT2D;SETMAR;WDR5;SETD1A;WDR82
prerank,neuropeptide receptor binding (GO:0071855),-0.23414012088517752,-0.5573372885898242,0.9468822170900693,1.0,1.0,4/14,31.97%,SHANK1;NPY;NTS;APLN
prerank,glutathione transferase activity (GO:0004364),0.23825006316598626,0.5542347129809198,0.9596774193548387,1.0,1.0,4/23,12.71%,ALOX5AP;GSTA4;LTC4S;GSTP1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.17888041364814525,-0.5488933120070475,0.9942528735632183,1.0,1.0,16/40,30.72%,DNMT3A;HNMT;TARBP1;LCMT1;TPMT;ASMT;NNMT;PRMT8;FBL;THUMPD3;RRP8;AS3MT;METTL18;PRMT7;GNMT;MEPCE
prerank,single-stranded DNA binding (GO:0003697),0.18750894378122898,0.5476847672951107,0.9961190168175937,1.0,1.0,12/93,12.92%,SAMHD1;RPA1;MCM10;POLA1;SUB1;RAD51D;RAD23A;MEIOB;MCM9;LONP1;ERCC4;TOP1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.22745678870186428,-0.5459189550552137,0.9729119638826185,1.0,1.0,4/14,30.80%,ACO2;NFU1;RSAD2;CIAO3
prerank,calcium-release channel activity (GO:0015278),0.24544599943061227,0.5436906197673804,0.95,1.0,1.0,2/17,7.99%,PKD2;ITPR3
prerank,nucleotidase activity (GO:0008252),0.24657433136062673,0.5414991223943957,0.9363957597173145,1.0,1.0,2/15,11.05%,NT5C2;NT5C3A
prerank,C-C chemokine receptor activity (GO:0016493),0.23385290866697112,0.5390985447333145,0.9641693811074918,1.0,1.0,4/21,21.06%,CX3CR1;CXCR4;CCR1;CXCR6
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.21953574069623505,0.5324457361501725,0.9653465346534653,1.0,1.0,9/27,26.48%,POLR1A;PRIMPOL;POLR1B;POLR3B;POLR3A;POLR2L;POLR2J;POLR3F;PRIM1
prerank,vitamin D receptor binding (GO:0042809),0.24654975796675271,0.5298868239933326,0.9568480300187617,1.0,1.0,4/14,22.79%,SNW1;TAF7;MED12;MED17
prerank,ribonuclease P RNA binding (GO:0033204),0.2674283406587896,0.5295683110479555,0.9246323529411765,1.0,1.0,2/10,12.37%,RPP30;RPP25
prerank,RNA polymerase core enzyme binding (GO:0043175),0.21470319579557323,0.5285919150497412,0.9843260188087775,1.0,1.0,8/33,19.34%,ZNF326;RRN3;RPRD1B;ESRRB;RPRD2;ERBB2;CDC73;RPRD1A
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.25867205317876724,0.5276323404186083,0.9501915708812261,1.0,1.0,4/10,28.95%,SETD5;PRDM9;NSD2;SMYD2
prerank,chemokine receptor binding (GO:0042379),0.2072605053425669,0.5263936048788046,0.9827315541601256,1.0,1.0,3/35,10.48%,CX3CR1;PPBP;CCL14
prerank,ATP hydrolysis activity (GO:0140603),0.19900200713263638,0.5248243098340386,0.992526158445441,1.0,1.0,6/41,13.59%,KIF26A;SMCHD1;ABCA3;MYO1E;ABCD1;TOR3A
prerank,ribonuclease P activity (GO:0004526),0.26278800197363367,0.5235061593759056,0.9630314232902033,1.0,1.0,5/11,28.17%,RPP30;RPP25;PRORP;RPP14;RPP38
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.1918023128964288,-0.521148363357537,0.9868073878627969,1.0,1.0,2/24,8.29%,GLUL;ZDHHC20
prerank,tRNA binding (GO:0000049),0.1998667682795844,0.5206081284225399,0.9879154078549849,1.0,1.0,21/43,33.53%,FARS2;EIF2AK4;AIMP1;KARS1;XPOT;YRDC;TRNAU1AP;NSUN6;ALKBH8;AARS2;TRMT10C;NSUN2;CARS1;RPUSD4;NEMF;ALKBH1;TRMT10A;EIF2A;NAT10;TYW5;SARS2
prerank,damaged DNA binding (GO:0003684),-0.16665280527825427,-0.5192098166446375,0.9968152866242038,1.0,1.0,16/44,30.14%,CRY2;ERCC5;DDB2;APTX;XPC;DDB1;HMGB2;NEIL3;SMC6;TDG;NTHL1;POLD1;RAD1;DCLRE1B;ERCC1;RPA2
prerank,neuropeptide hormone activity (GO:0005184),0.21915829145728635,0.5158982468567043,0.9612794612794613,1.0,1.0,22/22,78.11%,UCN;AGRP;PPY;NPFF;SPX;GAL;PNOC;QRFP;OXT;CORT;NMB;HCRT;GHRH;NPPA;CALCB;CRH;VIP;PENK;GRP;ADCYAP1;NPY;CCK
prerank,CCR chemokine receptor binding (GO:0048020),-0.18107534472882883,-0.5148009373031623,0.9920212765957447,0.9979488583723899,1.0,16/28,47.31%,NES;CCL19;CCR2;CCL2;CCRL2;CCL5;CCL4;CCL8;MSMP;CCL7;DEFB130A;CCL1;CCL3;CCL11;DEFB1;CXCL13
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.22411678978681066,-0.5099685950204571,0.9833333333333333,0.9952275361548777,1.0,3/11,20.90%,NAA40;NAA80;NAA60
prerank,palmitoyltransferase activity (GO:0016409),0.20606880714336978,0.5043254668009396,0.9791666666666666,1.0,1.0,9/28,23.86%,ZDHHC18;ZDHHC9;HHAT;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC8;ZDHHC17;ZDHHC2
prerank,deoxyribonuclease activity (GO:0004536),-0.2037089459404837,-0.5033811368040841,0.9872340425531915,0.9929352871360171,1.0,6/14,36.88%,ERCC5;MAP1S;DNASE1L2;DNASE1L1;ZRANB3;APLF
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.18016063511468391,0.4948650662227192,0.994579945799458,1.0,1.0,13/57,25.56%,NDUFA8;NDUFA7;NDUFA10;NDUFS2;UQCRQ;NDUFS4;NDUFS6;UQCRC1;NDUFB9;NDUFC1;NDUFS8;NDUFB7;COX6A1
prerank,single-stranded DNA helicase activity (GO:0017116),0.21038748979463684,0.4853092035290995,0.9767827529021559,1.0,1.0,19/19,78.99%,HELB;RFC3;RFC5;MCM6;RFC2;MCM2;MCM7;RAD51;RFC4;MCM5;WRNIP1;POLQ;PIF1;CHTF8;CHTF18;DHX9;DSCC1;HELQ;DNA2
prerank,pseudouridine synthase activity (GO:0009982),0.22725990606893098,0.4803039826923835,0.9694244604316546,1.0,1.0,8/13,33.08%,PUS7L;TRUB1;PUS7;RPUSD2;PUSL1;RPUSD4;RPUSD1;PUS10
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.2269582389406718,0.4697998221319665,0.974025974025974,1.0,1.0,1/11,7.99%,ITPR3
prerank,chemokine receptor activity (GO:0004950),0.19908690269415288,0.4689409956963865,0.9792332268370607,1.0,1.0,2/24,10.12%,CX3CR1;CXCR4
prerank,N-methyltransferase activity (GO:0008170),0.1992078136638763,0.45396254009705017,0.9832214765100671,1.0,1.0,3/20,13.07%,TFB2M;PEMT;RNMT
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.20473380210949266,0.436417958830708,0.9896373056994818,1.0,1.0,14/14,79.54%,CAPN5;CAPN12;CAPN10;CAPN3;CAPN13;CAPN9;CAPNS2;CAPN11;CAPN8;CAPN15;CAPNS1;CAPN1;CAPN6;CAPN2
prerank,single-stranded RNA binding (GO:0003727),0.16583959653203773,0.43010951754520543,0.9984709480122325,1.0,1.0,15/43,27.93%,HNRNPF;CNBP;LONP1;FMR1;IFIH1;ENDOV;AQR;JMJD6;LACTB2;RBM7;ZFR;EIF4H;DDX60;DDX11;DHX58
prerank,proton transmembrane transporter activity (GO:0015078),0.1679319435384296,0.4284701481463073,0.9985507246376811,1.0,1.0,2/39,6.45%,CLCN3;OTOP2
prerank,beta-tubulin binding (GO:0048487),0.17497533891145783,0.42600916607520395,0.9968,1.0,1.0,9/31,23.15%,TTLL7;TRPV4;ARL8B;GABARAPL1;PEX14;TAOK1;RACGAP1;UXT;APPL1
prerank,endodeoxyribonuclease activity (GO:0004520),0.18563948295615731,0.42416858566091586,1.0,1.0,1.0,9/20,28.75%,ERCC4;ENDOV;DCLRE1C;RPS3;ENDOG;MBD4;RBBP8;APEX1;EXOG
prerank,chemokine activity (GO:0008009),-0.14167309138643616,-0.40847358365512665,1.0,1.0,1.0,2/31,10.27%,CXCL16;CXCL12
prerank,MHC protein binding (GO:0042287),0.17756782657323417,0.4055233235098199,0.9948542024013722,1.0,1.0,1/20,5.82%,TAP2
prerank,nuclear import signal receptor activity (GO:0061608),-0.16842531125692106,-0.40429413508405,0.9976359338061466,0.9983066814069725,1.0,7/15,36.81%,TNPO2;KPNA2;IPO5;IPO9;IPO4;KPNA6;KPNA3
prerank,ferrous iron binding (GO:0008198),0.17168449686546702,0.40156585654676297,0.9983361064891847,0.9990191916661613,1.0,5/21,22.36%,EGLN1;TET2;ACP5;EGLN2;FXN
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.18448308329671717,0.36990646160684393,0.992619926199262,0.9986501055036996,1.0,11/11,81.56%,CHRNB1;CHRNA9;CHRNA4;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNB2;CHRNA7
